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Background – Sustained activation of spliced x-box binding protein-1 (XBP1), an 
endoplasmic reticulum stress response transcription factor, results in the development 
of atherosclerosis in apoE -/- mice.  Histone deacetylases (HDACs) play a crucial role 
in transcriptional regulation through modulation of chromatin structure.  In particular, 
HDAC3 is involved in maintaining endothelial integrity.  HDAC3 and XBP1 are 
similarly expressed in the bifurcation regions of aorta.  Unspliced XBP1 (XBP1u) is 
expressed in a similar manner in endothelial cells.  In the present study we 
investigated the role of XBP1u and XBP1s in the maintenance of endothelial integrity 
and endothelial cell migration.  Furthermore, the crosstalk between HDAC3 and 
XBP1 signalling pathways was examined. 
 
Methods and Results – Our study demonstrated that disturbed flow upregulated 
HDAC3 and XBP1u protein production through the VEGF receptor 2 / PI-3-kinase 
pathway.  Knockdown of XBP1 by shRNA lentiviral transfection ablated disturbed 
flow-induced HDAC3 upregulation.  Similarly to HDAC3, overexpression of XBP1u 
by adenoviral gene transfer increased Akt phosphorylation at serine 473 and haem 
oxygenase 1 gene transcription, which showed a protective role in hydrogen peroxide-
induced apoptosis of endothelial cells.  Co-immunoprecipitation assays demonstrated 
that HDAC3 physically associates with XBP1u and Akt.  The use of truncated 
HDAC3 constructs demonstrated that XBP1 binds to the central section of HDAC3, 
which is predicted to contain a nuclear export signal.  Furthermore, we identified a 
role for XBP1 in mediating endothelial cell migration.  Overexpression of both 
XBP1u and XBP1s enhanced the ability of endothelial cells to migrate.  Ablation of 
XBP1 expression and XBP1 splicing, through knockdown of IRE1α expression, 
reduced endothelial cell migration; however this was without a corresponding 
decrease in eNOS expression and NO production.  Further studies using XBP1-null 
endothelial cells demonstrated that XBP1 is crucial for mediating migration and that 
this may occur through mediating focal adhesion kinase expression.  These studies 
were aided through the isolation of coronary microvascular endothelial cells from 
wild type and heterozygous mice hearts. 
 
 3 
Conclusions – These results suggest that XBP1u protects endothelial cells from 
oxidative stress, including that produced by disturbed flow.  The interaction with 
HDAC3 could be crucial for this effect.  The ratio between XBP1u and XBP1s is also 
crucial for correct endothelial cell migration.  Modulation of this balance and the 
interaction with HDAC3 may provide novel therapeutic strategies in vascular disease 
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Chapter 1 – Introduction 
 
1.1 The vascular system 
 
The cardiovascular system is a complex organ involved in the transport of 
blood around the body, providing nutrients and oxygen and removing waste products 
and carbon dioxide.  The human embryonic vasculature is the earliest organ to 
develop.  Once the embryo exceeds a specific size passive diffusion is no longer 
sufficient to supply nutrients to all cells.  The embryonic vasculature develops from 
progenitor cells that migrate and differentiate into endothelial cells (ECs).  These form 
a vascular plexus alongside smooth muscle cells (SMCs), which are recruited by ECs, 
to form the arterial and venous systems (Carmeliet, 2000a).  De novo vascular 
development occurs in three processes: vasculogenesis, the formation of new blood 
vessels from progenitor cells and predominantly occurs during embryogenesis (Risau 
and Flamme, 1995); angiogenesis, the sprouting of new vessels from pre-existing 
vessels which can be induced by hypoxia and occurs in multiple diseases, including 
many forms of cancer (Carmeliet, 2003); and arteriogenesis, induced by physical 
forces such as shear stress, and involves remodelling of the existing vasculature and 
expansion of collateral vessels (Carmeliet, 2000b; Heil et al., 2006). 
 
1.1.1 The vascular structure 
 
Large arteries have three distinct layers; the intima, the media and the 
adventitia.  The intima, the layer in closest proximity to the lumen, is bordered on the 
lumenal side by a layer of ECs and on the basal side by an elastic basal lamina.  
Surrounding the ECs is a mixture of extracellular connective tissue matrix, 
predominantly composed of proteoglycans and collagen.  The media is composed 
primarily of SMCs.  SMCs have a contractile role and influence vasodilation and 
vasoconstriction of arteries thereby controlling vessel diameter and influencing blood 
pressure.  The adventitia, the outermost layer, is predominantly composed of 
connective tissue although SMCs and fibroblasts are also present.  Large arteries only 
contribute to a small percentage of the total human vasculature.  The majority of the 
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vascular system is composed of small capillary networks, which form widespread 
meshes.  Capillaries differ in structure to arteries as they are not surrounded by SMCs 
and therefore only passive changes in diameter are possible.  Although capillaries 
contribute to the majority of the vascular system, disruption of the larger arteries and 
arterioles is of greater interest for research.  Dysfunction of these vessels results in 
more serious complications due to the larger areas of the body reliant on the blood 
supply provided by these vessels.  Venules and veins are responsible for the return of 
blood to the heart.  They have a poorly developed media layer, allowing for an easier 
flow of low-pressure blood into them. 
 
1.1.2 Endothelial cells 
 
 ECs are crucial cellular components located on the intima of all blood vessels, 
where they function as a selectively permeable barrier between blood and tissues.  
They are one of the largest organs of the human body covering an approximate 
surface area of 4000 – 7000 m2 (Wolinsky, 1980).  The endothelium can display 
different structures depending on the vessel type.  Arteries and veins have a more 
continuous, thicker endothelium as compared to the more fenestrated endothelium of 
capillaries.  The endothelial monolayer is actively involved in several regulatory 
processes and controls vascular function in response to various stimuli.  It forms a 
semi-permeable barrier for the transport of blood-borne solutes to the underlying 
tissues, regulates haemostasis, vascular tone, cellular cholesterol and lipid 
homeostasis. 
 
 ECs are polar with apical and basal surfaces.  The basal surface is surrounded 
by extracellular matrix proteins and enclosed by the basal lamina, which together are 
enveloped by mural cells.  The mural cells can be SMCs, cardiomyocytes or pericytes 
depending on the size and location of the vessel that they help form.  Under normal 
physiological conditions, ECs are in close contact, growth inhibited and protected 
from apoptosis.  ECs in the tubular regions of arteries, where blood flow is laminar, 
are ellipsoid in shape, aligned in the direction of flow and express a range of anti-
apoptotic genes (Hahn and Schwartz, 2009; Malek et al., 1999).  The magnitude and 
direction of endothelial shear stress, caused by the force of contacts between 
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components of the blood and the endothelial wall, is detected by mechanosensors in 
the EC membrane and results in specific gene expression patterns, such as KLF2 
instigated signalling (Fledderus et al., 2008; Fledderus et al., 2007).  The regions of 
the vasculature subjected to high shear stress during laminar, pulsatile flow express 
factors that promote growth arrest and prevent apoptosis.  ECs exposed to low, 
oscillatory or disturbed flow have only intermittent activation of these pathways 
(Chatzizisis et al., 2007; Dekker et al., 2005).  To maintain the permeability barrier 
ECs form intercellular junctions which mediate intercellular signalling and regulate 
homeostasis (Bazzoni and Dejana, 2004; Mehta and Malik, 2006).  In the advent of 
endothelial damage, growth factors and chemokines are released which increase EC 
proliferation and motility in an attempt to reduce neointima formation, caused by 
deposition in the denuded area.  Recent studies have also identified that endothelial 
precursor cells (EPCs), which circulate in the blood, may target and repair damaged 
endothelial regions (Xu, 2008; Xu et al., 2003).  Endothelial dysfunction is 
hypothesised to be the initial stage in many cardiovascular diseases, such as 
atherosclerosis. 
 
1.1.3 Endothelial cell development 
 
 ECs and SMCs were initially thought to derive from distinct precursor cells 
through multiple rounds of cell division and specialisation.  ECs were thought to 
derive from the angioblast, (an exclusively endothelial prescursor) or the 
haemangioblast (both EC and blood cell precursor) during embryonic development 
(Carmeliet, 2003).  In addition to these precursors, in both embryos and adults, new 
ECs can also derive from circulating EPCs (Asahara et al., 1997).  Adult EPCs have 
also been postulated to play a role in vascular repair as well as disease progression.  
Recent reports have demonstrated the existence of a common, vascular endothelial 
growth factor receptor-2 (VEGFR-2)
+
, precursor from which both ECs and SMCs can 
be derived (Yamashita et al., 2000).  EC or SMC differentiation from the common 
VEGFR-2
+
 precursor has been demonstrated to occur after vascular endothelial 
growth factor (VEGF) and platelet derived growth factor-BB treatment, respectively 
(Xiao et al., 2007; Xiao et al., 2006). 
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 The isolation and characterisation of EPCs has proved very difficult and is 
therefore a controversial subject, with many differences in the methods of isolation, 
culture and characterisation.  However, despite these issues EPCs have the potential to 
be extremely important in vasculogenesis, angiogenesis (both therapeutic and 
pathologic) and as an agent of repair for damaged endothelium (Zampetaki et al., 
2008).  EC precursors are initially characterised by VEGFR-2 expression.  
Stimulation of VEGFR-2 and downstream signalling initiates cell migration and 
division.  For the initiation of the majority of differentiation events towards ECs 
VEGF is the stimulus.  VEGF is produced in close proximity to regions of newly 
forming vessels allowing progenitor cells to create the vascular plexus which forms a 
template for vascular development.  Further development and differentiation produces 
mature ECs.  Mature ECs can be characterised through the expression of von 
Willebrand Factor (vWF), platelet endothelial cell adhesion molecule (PECAM-1 or 
CD31), VEGFR1, VEGFR2, Tie2, endothelial nitric oxide (eNOS) and many other 
factors.  Although some of these factors are not limited to ECs, detection of multiple 
factors is considered sufficient to identify ECs.  There is an additional level of 
regulation during EC differentiation which involves formation of arterial and venous 
endothelium. 
 
1.1.4 Endothelial cell function 
 
 The endothelium is a semi-permeable barrier that lines the vasculature and 
regulates the conduction of blood and the passage of fluids and solutes between the 
blood and the interstitial space.  The permeability of the barrier is tightly regulated.  
There are two pathways that allow the passage of solutes: the paracellular pathway, 
involving passage between adjacent ECs through the intercellular junctions; and the 
transcellular pathway, involving passage through the cell via uptake and export 
machinery.  The intercellular junctions are crucial for the correct formation of blood 
vessels.  The most important intercellular junctions are adherens junctions and tight 
junctions.  Adherens junctions are formed by vascular endothelial (VE)-cadherin, 
which is a calcium dependent transmembrane receptor.  Tight junctions are formed by 
occludin and members of the claudin family and function as a size barrier to prevent 
the passage of solutes larger than 3nm in diameter, but allow passive diffusion of 
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smaller solutes.  Adherens junctions are also involved in signalling events and can 
regulate specific gene transcription (Bazzoni and Dejana, 2004).  The intercellular 
junction is a dynamic structure and can respond to agonists which alter permeability.  
Dynamic regulation allows infiltration of cells, such as leukocytes, through the 
endothelium and can alter the flow of solutes between the blood and the interstitial 
space during specific events (Mehta and Malik, 2006; Vandenbroucke et al., 2008).  
Intercellular junctions are even more important in the formation and maintenance of 
the blood-brain barrier.  The blood-brain barrier contains multiple adenosine tri-
phosphate (ATP)-binding cassette (ABC) transporters, preventing the accumulation of 
harmful anionic compounds within the brain. 
 
 ECs also have an anti-thrombotic role, which prevents / slows the progression 
of the thrombotic response after endothelial damage.  Coagulation is prevented 
through the release of tissue factor pathway inhibitor, which binds activated 
coagulation pathways and inhibits the activation of tissue factor.  Platelet aggregation 
is prevented by nitric oxide (NO), prostacyclin and prostaglandin-E2 synthesis, which 
also induce vasodilation.  Fibrinolysis is stimulated by synthesis of plasminogen 
activators, which lyse the developing thrombus before the advent of damage (van 
Hinsbergh, 2001).  The endothelium is also responsible for inhibiting leukocyte 
adhesion, inhibiting SMC proliferation and regulating vascular tone. 
 
 The balanced production of vasodilation and vasoconstriction factors by the 
endothelium maintains the basal vascular tone.  The vasodilatory factors produced by 
the endothelium include NO, prostacyclin and endothelium derived hyperpolarising 
factor.  The vasoconstrictive factors include TXA2.  NO production in ECs occurs 
through the action of the enzyme nitric oxide synthase (NOS), of which there are three 
isoforms; neuronal, inducible and endothelial.  The ability of a blood vessel to dilate 
is mainly dependent upon the activity of eNOS.  Agonists of eNOS (bradykinin, 
acetylcholine, ATP, ADP, substance P and thrombin) increase the cytosolic 
concentration of Ca
2+
 inducing the association of Ca
2+
 with calmodulin, which binds 
to and activates eNOS.  Phosphorylation, by kinases, and acetylation of eNOS can 
also increase its activity (Butt et al., 2000; Jung et al., 2010).  NO diffuses from the 
EC into the adjacent vascular SMCs, where it reduces their contraction. 
 
 23 
1.1.5 Endothelial cell dysfunction 
 
 Endothelial dysfunction is thought to be the initiation point for many diseases.  
The healthy endothelium may be considered ‘a defender’ and through expression and 
release of NO, prostacyclin, bradykinin, carbon monoxide (CO) and others reduce 
inflammation and thrombosis.  Endothelial dysfunction results in the cell becoming 
‘an offender’, increasing superoxide, prostaglandin-D2, cytokine, chemokines and 
adhesion molecule production.  Formation of this state increases inflammation and 
thrombosis which ultimately leads to disease formation and progression.  Endothelial 
dysfunction can be initiated by low density lipoprotein (LDL) levels, smoking, 
diabetes, hypertension, infection and haemodynamic forces.  Perturbation of EC 
function leads to EC dysfunction, which often precedes vascular disease, such as 
atherosclerosis. 
 
1.1.6 Endothelial cells and atherosclerosis 
 
 Cardiovascular diseases are a major contributor to mortality, especially in 
North America and Europe.  The most recent statistics demonstrate that 
cardiovascular disease is the main cause of death in Europe, contributing to over four 
million deaths per year, equivalent to 48% of total deaths.  In North America, the 
2009 statistics released by the Centres for Disease Control and Prevention, state that 
over 33% from a total of 2.5 million deaths were as a result of heart disease or stroke.  
Cardiovascular diseases include, but are not limited to aneurysms, arteriosclerosis, 
cerebrovascular disease, coronary heart disease, heart failure, hypertension, 
myocardial infarction and stroke.  Atherosclerosis is the most common form of 
arteriosclerosis and is the primary cause of coronary heart disease and cerebrovascular 
disease. 
 
 Atherosclerosis is the generic term to describe pathologies which cause a 
hardening of the arterial wall and a reduction in elasticity.  Atherosclerosis is 
considered a chronic inflammatory disease, associated with endothelial dysfunction 
and other profound changes to the vascular system (Sandoo et al., 2010; Sima et al., 
 24 
2009).  ECs are involved at all stages of atherogenesis and their dysfunction is a key 
early event in atherosclerotic plaque formation.  Atherosclerosis predominantly 
manifests in specific regions of the vasculature and develops due to interactions 
between modified lipoproteins, macrophages, endogenous SMCs and ECs and 
immune cells.  The aetiology of atherosclerosis is extremely complex and its 
acquisition is not attributable to any single factor, rather it results from and requires 
multiple risk factors.  It is difficult to classify atherosclerosis as a single disease 
process, as at various stages different processes such as endothelial dysfunction, 
inflammation and autoimmune responses are activated and predominate.  Only 
elevated levels of cholesterol have been demonstrated to be sufficient to drive the 
formation of atherosclerotic lesions in mice in the absence of other risk factor.  
Multiple risk factors have been characterised by epidemiologic and animal studies 
(table 1).   
 
The exposure of the endothelial wall to these risk factors triggers changes in 
endothelial cell functions.  In atheroprone regions, ECs have increased permeability, 
secretory function, hyperplasia of the basement membrane, transcytosis of 
lipoproteins and increased expression of cell adhesion molecules on their surface and 
increased cytokine production (Sima et al., 2009).   Atheroprone regions of the 
vasculature occur where there is disturbed flow.  ECs are sensitive to changes in blood 
flow, which can change their morphology and signalling cascade activation (World et 
al., 2006).  There is also a positive correlation between areas of disturbed flow and 
sites of LDL accumulation and lesion formation (Ross, 1999; Zand et al., 1999). 
 
Atherosclerosis can lead to an acute clinical event by occlusion of the lumen 
of a vessel, usually through thrombosis after plaque rupture.  The progression of 
atherosclerosis, although incompletely understood, can be classified into several 
stages (figure 1).  Briefly, formation of a fatty streak through retention and oxidation 
of low density lipoprotein (LDL) within the endothelium activates ECs at the 
atheroprone region.  This leads to the activation of an inflammatory response by 
inducing the exposure of adhesion molecules on the apical surface of the endothelium.  
Monocytes are subsequently recruited and penetrate into the subendothelial space.  
Oxidised LDL is engulfed by macrophages, through recognition by scavenger 
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receptors.  The excessive uptake of oxidised LDL and reduced clearance by 
macrophages results in a morphological change into a foam cell. 
 















Increased accumulation of LDL in the vasculature results in LDL 
accumulation in the subendothelial space and leads to increased oxLDL 
production (Tamminen et al., 1999).  Circulating LDL levels can increase 
due to abrogated expression of ApoE or LDL receptors. 
 
 
Reduced levels of HDL 
 
 
Decreased removal of LDL from peripheral tissues leads to increased 
accumulation of oxLDL in macrophages.  ABCA1 is a cholesterol 








Increased blood pressure and the rennin – angiotensin – aldosterone 
pathway are implicated in atherosclerotic lesion formation.  Angiotensin II 
induced hypertension resulted in increased lesion formation (Assmann et 
al., 1999; Weiss et al., 2001). 
 
 
Diabetes and Obesity 
 
Aberrant ratio of cholesterol molecules increases the risk of cardiovascular 





Increased activation of the inflammatory response leads to faster 
progression of fatty streaks into lesions.  Elevated levels of inflammatory 









Increased circulating LDL levels, increases LDL accumulation in 






Reduction in endothelial integrity.  Smoking is a risk factor for 
atherosclerosis and other cardiovascular diseases (Assmann et al., 1999). 
 
 
Lack of exercise 
 
Increased ratio of LDL to HDL levels (Assmann et al., 1999). 
 
. 
 The foam cells have high intracellular levels of cholesterol which after time 
induces apoptosis releasing the fatty contents into the subendothelial space and 
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driving the formation of the atherosclerotic lesion.  The lesion progresses through 
growth of a fibrous cap, formed from SMC-produced extracellular matrix proteins.  
The cap fills around the core and continued expansion of the lipid-filled interior leads 
to the formation of a lipid-filled necrotic core (Glass and Witztum, 2001; Rader and 
Daugherty, 2008).  Atherosclerotic plaques can either be stable or unstable, a status 
that is dependent on their composition and location.  Stable plaques can continue to 
grow until the lumen is completely occluded or unstable plaques can rupture, which is 
usually precipitated by proteolytic degradation at the edges of the fibrous cap, 
resulting in thrombogenesis and the occlusion of the lumen at the site of rupture.  
Atherosclerosis has primarily been studied through the use of knockout animals and 
epigenetic studies.  Although mice are naturally resistant to atherosclerosis, lesions 
can be induced through a combination of ApoE knockdown and a high fat diet.  
However, atherosclerotic lesions in mice are different from human lesions as they take 
weeks rather than years to form and are much more cellular in structure.  These 
differences must be taken into account when extrapolating data from studies on 
atherosclerosis in mice. 
 
 
Figure 1: The initial stages of atherosclerotic lesion formation. 
A. Formation of the fatty streak and initiation of the inflammatory response.  LDL infiltrates the 
subendothelial space where oxidation occurs.  Oxidised LDL stimulates adhesion molecule production 
by ECs and monocyte recruitment.  Macrophages engulf oxidised LDL after recognition by scavenger 
receptors leading to foam cell formation.  B. Progression of the atherosclerotic lesion and formation of 
the necrotic core.  The accumulation and apoptosis of foam cells leading to exposure of modified self-
antigens such as oxLDL activates an immune response.  Th1 cells are activated which increase local 
inflammation, initially in a beneficial manner.  Progression of the lesion involves SMC migration, 




 The formation of the initial fatty streak is considered to be the initiating event 
in the formation of an atherosclerotic lesion and is also the atherosclerotic event 
towards which EC activity and function is most important.  Although it is important to 
note that fatty streak formation has been observed from the first decade of life and 
does not necessarily lead to atherosclerosis.  This stage is characterised by the 
accumulation of LDL within the subendothelial space and macrophage recruitment 
(figure 1A).  The increased transcytosis of lipoproteins leads to their accumulation 
and retention in the intimal space by modification through oxidation, glycation and 
other enzymatic reactions.  LDL is able to passively diffuse through intercellular 
junctions; however, the oxidation of these molecules in the permissive subendothelial 
environment prevents retrograde transfer due the formation of more stable interactions 
with extracellular matrix proteins.  These modified lipoproteins have been identified 
in early thickenings of the human aorta (Tirziu et al., 1995).  Oxidised LDL stimulates 
ECs, in part through the activation of signalling through the LOX-1 endothelial LOX-
1 receptor.  This leads to NADPH oxidase activation and the production of superoxide 
radicals (Xu et al., 2007).  Endothelial activation involves the synthesis and secretion 
of cytokines such as monocyte chemotractant protein-1, interleukins, vascular 
endothelial growth factor (VEGF) and the expression of cell adhesion molecules; 
vascular cell adhesion molecule 1, intercellular cell adhesion molecule  1 and E- and 
P- selectins (Nakashima et al., 1998).  The expression of these proteins is specifically 
activated in response to oxidised LDL (Khan et al., 1995).  The expression of 
adhesion molecules and chemokines recruits and activates monocytes to the intimal 
space.  Oxidised LDL is a high affinity substrate for the macrophage scavenger 
receptors; SR-1 and CD36.  Therefore macrophage recruitment by activated 
endothelial cells initially works to reduce the presence of oxidised LDL in the 
subendothelial space.  However, there is no negative feedback regulation of the 
scavenger receptor-mediated uptake and therefore if there are large quantities of 
oxidised LDL present then the macrophages will eventually overload and form foam 
cells.  Foam cells have a dramatically reduced ability to migrate and are retained in 
the subendothelial space where they eventually undergo apoptosis and the start of the 
atherosclerotic lipid-filled core is formed.   
 
 The progression of atherosclerosis is characterised by fibrous plaque formation 
(figure 1B), which involves an accumulation in extracellular lipid, infiltration of 
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SMCs into the intima and activation of an immune response.  Th1 and Th2 cells are 
activated by macrophage foam cells and dendritic cells presenting modified self 
antigens, such as oxLDL.  Published studies suggest that Th1 cells, which initiate a 
pro-inflammatory response, predominate in atherosclerosis, with the role of Th2 cells 
suggested to be anti-inflammatory (Nilsson and Hansson, 2008).  Therapeutic 
modulation of the Th1 and Th2 response and ration may be beneficial in patients 
suffering from atherosclerosis.  Activated Th1 cells release cytokines which increase 
the level of local inflammation.   
 
SMCs pass through the basal lamina, proliferate and secrete extracellular 
matrix proteins that form a fibrous plaque.  The lesion continues to grow as more 
macrophages are recruited and more cholesterol is deposited in the core.  Initially the 
lesion grows towards the basal lamina, however after a threshold is passed the lesion 
extends into the lumen of the vessel.  During the early growth phase the lumen of the 
vessel remains constant as the vessel is remodelled through expansion of the local 
artery wall.  Although complete occlusion of the lumen is possible, most 
complications of atherosclerosis are caused by plaque rupture and resulting 
thrombosis.  Plaque rupture exposes thrombotic factors present in the lesion core.  
The stability of the lesion is influenced by many factors such as cellular composition 
of the necrotic core, macrophage activation and expression of metalloproteinase’s 
(Newby, 2007, 2008).  Metalloproteinase’s have been demonstrated to be particularly 
active in the edge regions of atherosclerotic lesions, which are the regions most likely 
to rupture. 
  
There are several therapeutic targets for the treatment of atherosclerosis (table 
2).  Atherosclerosis has also been targeted as an autoimmune disease initiated by the 
immune response to oxLDL.  Studies have been performed that demonstrate the 
incidence of atherosclerosis is reduced after immunisation of ApoE knockout mice 
with peptide fragments generated from ApoB100, which is conserved in all LDL 
molecules (Nilsson et al., 2007).  Much of the information obtained on atherosclerosis 
derives from studies on animal models.  The usefulness of these models is subject to 
much debate.  In the ApoE mice atherosclerotic lesions develop, however they have a 
much more cellular content than lesions formed in humans.  These lesions take only 
weeks to form compared to years, even decades in humans.  The incidence of plaque 
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rupture is also very different in mice lesions, as plaque rupture is thought to depend 
on the composition of the lesion and not the size.  Finally, lipoprotein metabolism and 
inflammatory responses differ greatly between mice and humans suggesting that the 
therapeutic response observed in mice may not be conserved in humans. 
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clearance of LDL from macrophages into HDL molecules. 
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Involved in degradation of the extracellular matrix proteins in 
the fibrous cap leading to plaque rupture. 
 
 
1.1.7 Endothelial cell migration, angiogenesis and focal adhesion kinase 
 
 The growth of new blood vessels occurs through a process termed 
neovascularisation.  This process is critical during development and growth and for 
wound healing and tissue repair.  Angiogenesis, a form of neovascularisation involves 
the migration, recruitment and connection of ECs.  Unwanted angiogenesis has been 
associated with the development of atherosclerosis (Carmeliet, 2003).  The early 
vascular tree occurs through the sprouting of ECs from angioblasts.  This process 
requires the activation of VEGFR, cell-cell and cell-matrix signalling.  The cells will 
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then migrate, interconnect and divide before eventually forming tube-like structures 
(Risau, 1997).  There are three main forms of angiogenesis vasculogenesis, 
arteriogenesis and angiogenesis. Vasculogenesis is the formation of new blood vessels 
from circulating or tissue-resident EC stem cells, which proliferate to form new 
vessels.  This predominantly occurs during development.  Arteriogenesis is the 
formation of larger blood vessels, possessing an intima, media and adventitial layer.  
Angiogenesis is the formation of thin-walled EC-lined structures, which extensively 
occur during the repair of damaged tissues.  The new growth of blood vessels 
supports tissue growth and organ function during development and disease. If a lack 
of nutrients or oxygen is detected then angiogenic sprouting occurs, which is the 
growth of new vessels from an existing vessel.  The signals that activate angiogenic 
sprouting include growth factors and chemokines that are released by hypoxic tissue 
(Phng and Gerhardt, 2009).  EC migration during angiogenesis involves several major 
stages.  The EC senses a pro-migratory signal, such as VEGF and filopodia are 
formed through the activation of Cdc42 and WASP signalling.  PI-3-kinase 
phosphorylation and activation of focal adhesion kinase signalling result in the 
extension of lamellipodia.  The extended region of the EC then reattaches to the 
surrounding matrix through focal adhesion assembly.  The cell then contracts through 
stress-fibre mediated contractions and the rear end of the cell is released from its 
attachments by degradation of focal adhesions.  These steps require the precise 
remodelling of the EC in response to a hypoxic signal (Lamalice et al., 2007).  One 
particular mechanism through which EC migration can be abrogated is through ROS-
dependent signalling.  ROS produced via the activation of NADPH oxidase, 
subsequent to VEGF stimulus has been hypothesised to activate several protein 
tyrosine phosphatases, including SHP-1 and SHP-2.  These dephosphorylate VEGFR2 
and attenuate the effects of VEGF signalling (Ushio-Fukai, 2006). 
 
 There are multiple pro and antiangiogenic signals that originate within the 
body. These contribute to and control blood vessel density and function.  The 
insufficient supply of nutrients and oxygen in any tissue results in the formation of 
new vessels from the walls of existing vessels.  Angiogenic sprouting occurs after 
quiescent ECs receive signals from growth factors and cytokines released by 
surrounding hypoxic tissue.  These signals enhance the migratory capacity of ECs and 
a new network of vasculature is formed, until the hypoxic signalling is reduced by 
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correct blood flow to the affected area.  VEGF, VEGFR2 and focal adhesion kinase 
(FAK) are crucial during the formation of blood vessels.  Activation of VEGFR2 
expression promotes EC elongation, motility and proliferation.  The detection of 
VEGF by ECs results in delta-like ligand 4 (Dll4) expression which is a crucial 
protein of ‘tip cells’, which are ECs with a highly motile phenotype thought to form at 
the migrating end of newly forming vessels.  Activation of Dll4 signals to the 
proceeding ECs to induce a phenotypic change into ‘stalk cells’ to promote new 
vessel formation (Jakobsson et al., 2010).  The migration of all ECs does not occur in 
the same manner.  The migration of ECs is spearheaded by the ‘tip cells’ which exude 
long filopodia composed of multiple tyrosine kinase receptors to sense the 
surrounding environment (Gerhardt and Betsholtz, 2003; Gerhardt et al., 2003).  
These cells have a reduced interaction with surrounding cells, which is necessary to 
increase their ability to migrate.  Stalk cells produce fewer filopodia and proliferate 
when stimulated with VEGF-A.  These cells also contribute to lumenal formation 
through form intercellular interactions via adherens and tight junctions (Dejana et al., 
2009).  The specification of these ECs and the signals that are required to produce tip 
and stalk cells are highly regulated and elucidating not only these signals but the way 
in which they interact will contribute toward our understanding of the angiogenic 
process which is so important during so many disease processes. 
 
 One of the crucial components during EC migration is the formation and 
degradation of focal adhesions.  FAK is widely expressed in ECs and its signalling 
regulates fundamental aspects of neovascularisation and is involved in EC adhesion 
and migration (Wary et al., 2012).  FAK signalling can be initiated by both integrins 
and through VEGF / VEGFR2 signalling, thus implicating FAK as a signal 
component of EC migration and survival pathways (Zhao and Guan, 2009).  FAK is 
ubiquitously expressed and the promoter has been demonstrated to contain AP-2, NF-
κB and p53 regulatory sites (Golubovskaya et al., 2004). 
 
In the adult vasculature, ECs form a quiescent monolayer, where the cells are 
no longer dividing and form a network of intercellular attachments.  Upon stimuli, 
such as a loss of shear stress a subset will respond and form tip cells, which are 
responsible for new vessel formation (figure 4).  Tip cells have reduced 
interconnections with surrounding ECs and extracellular matrix, and the cells are 
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therefore able to proliferate, elongate and migrate (Wary et al., 2012).  Stalk cells 
have also been identified which proliferate to increase the length of the blood vessel.  
The formation of both of these cell types is regulated through the activation of VEGF 
signalling on VEGFR2 receptors (Gerhardt et al., 2003). 
 
 
Figure 2: Tip cell formation during angiogenesis. 
The formation of a new blood vessel due to a loss of shear stress and VEGF signalling.  Tip cells form 
filopodia and ‘push’ the new vessel forwards.  Stalk cells are in a proliferative state and maintain EC-
cell contacts.  Phalanx cells are in a quiescent anti-proliferative, anti-migratory state.  This figure has 
been adapted from (Zhuang et al., 2011). 
 
FAK can regulate the migratory process and the formation of tip cells through 
several mechanisms.  Firstly in FAK-null cells there are increased numbers of focal 
adhesions and FAK was also shown to regulate cell survival (Ilic et al., 2003).  
Secondly FAK-deficient cells cannot form functional vascular networks, whilst 
overexpression of FAK increased angiogenesis in a transgenic mouse model (Ilic et al., 
2003; Zhao and Guan, 2009).  These results indicate a key role for FAK in 
angiogenesis and EC migration.  During EC migration it is necessary for ECs to 
partially detach from the extracellular matrix, which increases the likelihood of the 
cell undergoing apoptosis.  Previous studies have shown that FAK acts to prevent EC 
apoptosis through the recruitment and activation of PI-3-Kinase and its subsequent 




1.1.8 Endothelial cells and shear stress 
 
 Despite the systematic nature of atherosclerotic risk factors, atherosclerosis 
lesions only occur at predisposed sites.  The propensity for atherosclerotic lesion 
development therefore differs between regions of the vasculature.  A higher incidence 
of atherosclerosis was observed in curved regions and lateral walls of branch points 
than in linear segments of vessels (Ku et al., 1985).  Atherosclerotic lesions 
predominantly formed in regions of the vasculature which have low time-averaged 
shear stress (the amplitude of the total flow observed over time in a single direction) 
and high spatial shear stress (the total force of the shear stress observed at a single 
location in multiple directions).  These different forces are caused by the non-uniform 
flow of blood through the vascular system.  In regions of the vasculature that are 
straight and around the outer curves of bends the laminar blood flow sensed by the 
endothelium is unidirectional and pulsatile.  In humans the shear stress sensed by the 
endothelium in these regions is between 15 – 70 dynes / cm2.  Regions of the 
vasculature predisposed to atherosclerotic lesion formation, such as the insides of 
arterial curves and bifurcation points continue to sense pulsatile flow, however it is 
highly turbulent and bidirectional.  The endothelium in these regions senses an 
oscillatory shear stress of 0 - 10 dynes / cm
2
.  High shear stress induces an 
atheroprotective and anticoagulant endothelial phenotype.  Studies into the rate of EC 
apoptosis on visible (laminar shear stress) and occluded (disturbed shear stress) 
sections of atherosclerotic lesions demonstrated an 85% decrease in EC apoptosis in 
regions with elevated shear stress (Tricot et al., 2000).  Meanwhile, disturbed shear 
stress is associated with endothelial dysfunction and atherosclerosis development.  
The inside walls of arterial curves and lateral branch points demonstrated increased 
monocyte adhesion and EC apoptosis (Boon and Horrevoets, 2009).   
 
1.1.8.1 Protective Cell Signalling 
 
 Steady laminar shear stress activates mechanosensitive, atheroprotective 
signalling pathways, responsible for maintaining endothelial integrity.  
Atheroprotective flow patterns limit oxidative stress, inflammation and apoptosis.  In 
regions of disturbed flow these pathways may only be transiently activated (Berk, 
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2008; Chatzizisis et al., 2007).  In healthy regions of the vasculature mechanical 
forces and chemical ligands are sensed by receptors on the apical surface of ECs.  
This initiates a signalling cascade that ultimately resolves in altered gene expression.  
These result in altered cell function; in this case increasing the protection of ECs 
against apoptosis and reducing the expression of monocyte attachment proteins.  
There are several crucial signalling pathways that are activated through mechanical 
force; including redox-mediated inhibition of ASK1 / jun-terminal kinase signalling 
and activation of KLF2 and Nrf2 signalling. 
 
  Kruppel-like transcription factor 2 (KLF2) is specifically induced by laminar 
shear stress in ECs (Dekker et al., 2002).  KLF2 expression promotes anti-
inflammatory and pro-survival signalling through suppressing the activation of the 
apoptotic molecule TGF-β, by inducing Smad7 expression and reducing baseline 
expression levels of AP-1 (Boon et al., 2007).  Global expression studies showed that 
KLF2 is also important for the integration of multiple endothelial functions associated 
with vascular regions that are resistant to atherogenesis such as inflammation, 
thrombosis/haemostasis, vascular tone and blood vessel development (Parmar et al., 
2006).  Shear stress induces KLF2 expression through both transcriptional activation 
and stabilisation of KLF2 mRNA (Dekker et al., 2002; van Thienen et al., 2006).  
Shear stress leads to the induction of MEK5-ERK5-MEF2C signalling, leading to 
MEF2C binding to the KLF2 promoter (Parmar et al., 2006).  Histone deacetylases 
have been linked to the regulation of MEF2 activity at the KLF2 promoter (Kumar et 
al., 2005). 
 
 Nuclear factor erythroid 2-like 2 (Nrf2) is a shear induced transcription factor 
responsible for antioxidant gene expression.  Nrf2 binds directly to the antioxidant 
response element (ARE) of antioxidant enzymes like haem oxygenase 1 (HO-1) and 
NAD(P)H dehydrogenase quinone 1.  Activation of these enzymes reduces the 
oxidative burden on the endothelium (Chen et al., 2003b).  Nrf2 is activated by shear 
stress through activation of PI-3-Kinase and Akt signalling, which increases the 
nuclear localisation of Nrf2 (Dai et al., 2007). 
 
 Laminar flow also promotes a reducing state in ECs due to the presence of 
glutathione.  Glutathione is a substrate for glutathione peroxidase to allow the 
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elimination of hydrogen peroxide and lipid hydroperoxides.  Steady laminar flow has 
been shown to inhibit hydrogen peroxide-induced jun-terminal kinase activation by 
increasing the reduced glutathione levels in a glutathione reductase-dependent manner 
(Hojo et al., 2002).   
 
1.1.8.2 Atherogenic cell signalling 
 
 In contrast to endothelium subjected to laminar flow, regions of the 
vasculature exposed to disturbed flow have very different gene expression patterns.  
Disturbed flow attenuates NO and prostacyclin production, reducing the vasodilatory 
and atheroprotective role of these molecules (Chien, 2008a).  Disturbed flow also 
promotes oxidative stress by increasing the transcription and activity of nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase and downregulating the expression 
of reactive oxygen species (ROS) scavengers.  Disturbed flow has also been shown to 
enhance inflammation by upregulating NF-κB-mediated VCAM and monocyte 
chemoattractant protein expression.  Disturbed flow also promotes SMC migration, 
differentiation and proliferation; extracellular matrix degradation and synthesis in 
fibrous plaques; and has potential roles in neovascularisation, calcification and 
thrombogenecity (Chatzizisis et al., 2007; Cunningham and Gotlieb, 2005).   
 
1.2 Oxidative stress in the vasculature 
 
 Oxidative stress has been implicated in cardiovascular dysfunction and many 
cardiovascular diseases, including atherosclerosis.  Oxidative stress is a state in which 
ROS overwhelm the endogenous antioxidant capabilities of cells and tissues.  ROS 
play an important role in endothelial dysfunction.  ROS molecules include hydrogen 
peroxide, superoxide radical, hydroxyl radicals and reactive nitrogen species, such as 
peroxynitrate and nitrogen oxide radicals.  ROS are oxygen molecules capable of 
easily reacting with other molecules to produce further detrimental products and 
reactions.  Superoxide is formed from the univalent reduction of oxygen, which can 
be performed by NADPH oxidases and xanthine oxidases.  Superoxide is itself 
functional within the cell; however it is also required to generate the more harmful 
peroxynitrate, the nitrogen oxide radicals and the less harmful hydrogen peroxide 
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molecules.  Hydrogen peroxide can be converted into water or into the highly reactive 
hydroxyl radical.  All of these species initiate signalling responses in the vasculature 
(Taniyama and Griendling, 2003).  ROS can be generated endogenously or in 
response to environmental stress and are involved in initiating apoptotic signalling.  
HO-1 has been a major focal point of research due to its ability to counter 
proapoptotic stimuli and thereby prevent apoptosis (Ryter et al., 2007). 
 
1.2.1 Apoptotic signalling through oxidative stress 
 
 Maintaining the correct balance of ROS levels is crucial in preserving 
endothelial function.  For example nitrogen oxide is required for arterial vasodilation 
and a reduction in nitrogen oxide levels resulting from increased interactions with 
superoxide radicals impairs vasodilation.  ROS are of particular importance in 
maintaining EC integrity.  The incubation of ECs with superoxide or hydrogen 
peroxide induces apoptosis, which damages the endothelial wall and initiating a 
proatherogenic state.  The overproduction of hydrogen peroxide in mice was also 
demonstrated to increase atherogenesis (Cai, 2005).  ROS are also involved in 
promoting adhesion molecule production and the subsequent attachment of 
monocytes to the endothelial wall.  In humans, the higher expression of NADPH 
subunit proteins is associated with increased superoxide production and severity of 
atherosclerosis (Sorescu et al., 2002).  NADPH oxidase deficient ApoE -/- mice also 
have significantly less atherosclerotic lesions formation than their wild type 
counterparts (Barry-Lane et al., 2001).  Furthermore interleukin-1 beta activation of 
VCAM-1 expression was almost completely abolished by co-incubation with 
antioxidants, suggesting that VCAM-1 expression can be induced by ROS (Marui et 
al., 1993).  Shear stress, apoptotic signalling through TNFα, VEGF and cellular injury 
can all result in the activation of ROS producing enzymes.  These activate ECs and 
lead to impaired vessel relaxation, an increase in apoptosis and increased monocyte 
adhesion.  This primes regions of the vasculature and makes them more sensitive to 




1.2.2 ROS, atherosclerosis and shear stress 
 
 Shear stress plays a critical role in the production of ROS in the vasculature.  
Shear stress has been shown to activate NADPH oxidase resulting in the production 
of superoxide (De Keulenaer et al., 1998; Hwang et al., 2003a; Hwang et al., 2003b).  
This increases the ability of monocytes to adhere to the endothelium thereby 
increasing the likelihood of atherosclerotic lesion formation (Hwang et al., 2003b).  
Xanthine oxidoreductase is also activated in response to disturbed flow and promotes 
the production of superoxide molecules (McNally et al., 2003).  NO is also a key 
molecule in the vascular system and can result in increased oxidative stress.  eNOS is 
induced in ECs by pulsatile and laminar shear stress (Metaxa et al., 2008).  The 
production of NO can be beneficial and result in vasodilation of the vasculature; 
however it is also able to interact with superoxide molecules to form the highly 
reactive peroxynitrate molecule.  Peroxynitrate induces oxidative damage and 
enhances adhesion molecule expression inducing a pro-atherogenic EC phenotype 
(Shelton et al., 2008).  The expression of these molecules is heavily influenced by the 
type of flow that ECs are subjected to.  High laminar shear stress enhances the NO 
production and reduces superoxide molecule production, whereas oscillatory shear 
stress enhances superoxide expression to a greater extent than laminar flow (De 
Keulenaer et al., 1998; Takabe et al., 2011).  These studies demonstrate a clear link 
between shear stress, the production of ROS and the development of atherosclerotic 
lesions. 
 
1.2.3 Haem oxygenase 1 
 
 Haem oxygenase is the rate limiting enzyme in the degradation of haem.  HO-
1 is inducible whilst the expression of HO-2 is constitutive in certain cell types.  HO 
catalyses the conversion of haem into carbon monoxide (CO), biliverdin and iron 
(Fe
2+
).  HO-1 plays a central role in the response of cells to stress, particularly 
oxidative stress.  The expression of HO-1 has been associated with anti-inflammatory 
effects and the suppression of proliferation, apoptosis and inflammation (Ryter et al., 
2007).  The various contributions of HO-1 towards preventing apoptosis are 
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demonstrated in figure 3.  Although iron is pro-oxidative, HO-1 induces the export of 
iron from the cell and the formation of ferritin.  Ferritin neutralises the reactive iron 
and reduces apoptosis.  Iron has also been shown to activate NF-κB which initiates an 
anti-apoptotic signalling cascade (Choi et al., 2004).  Biliverdin and bilirubin also 
prevent apoptosis by scavenging ROS molecules.  Bilirubin and biliverdin may also 
initiate anti-inflammatory and anti-proliferative signalling (Ryter et al., 2006).  CO is 
the most interesting and therefore most studied product of the HO-1-mediated 
degradation of haem.  Initially thoughts towards the function of CO were heavily 
influenced by the perception generated by CO poisoning leading to death due to its 
ability to permanently displace oxygen from haemoglobin.  However, recent studies 
have demonstrated a role for CO in many signalling events (Kaczorowski and 
Zuckerbraun, 2007).  CO was demonstrated to inhibit TNFα-mediated apoptosis in 
mouse ECs.  The activation of MKK3 and p38 MAPK were necessary for this 
function (Brouard et al., 2000).  CO was also determined to have a direct anti-
inflammatory effect by inhibiting cytokine-mediated apoptosis.  HO-1 is therefore a 
potent inhibitor of oxidant mediated apoptosis and inflammation in cells. 
 
1.2.3.1 Induction of haem oxygenase 1 gene expression 
 
 HO-1 can be highly induced by haem, heavy metals, TGFβ, PDGF, VEGF, 
NO, peroxynitrate, modified lipids, hypoxia and cytokines (Ryter et al., 2006).  HO-1 
can also be induced in response to many atherosclerotic risk factors such as high 
blood pressure, shear stress, smoking and oxidised lipids (Chen et al., 2003a; Favatier 
and Polla, 2001; Ishikawa et al., 2001; Ishizaka et al., 1997).  It has been suggested 
that HO-1 is a relevant target in pharmacologic intervention in atherosclerosis 
(Stocker and Perrella, 2006).  There are several critical regulatory domains present in 
the 10kb proximal promoter region, upstream of the HO-1 initiation site.  This region 
contains multiple confirmed and putative enhancer sites of which E1 and E2 are the 
most studied.  These regions contain stress response elements that are able to bind 
proteins belonging to the bZIP superfamily of transcription factors.  HO-1 gene 
transcription can be induced by a wide-range of stimuli and therefore its regulation is 





Figure 3: Anti-apoptotic signalling pathways initiated by haem oxygenase-1. 
HO-1 catalyses the conversion of haem into biliverdin, Fe
2+
 and CO.  Haem and ROS are inducers of 
oxidative stress which leads to apoptosis and inflammatory responses.  Biliverdin is converted into 
bilirubin by biliverdin reductase.  Both bilirubin and biliverdin function as antioxidant molecules and 
scavenge free ROS.  Fe
2+
 is an inducer of ROS, however, HO-1 induced Fe
2+
 is either exported from 





also be involved in suppressing apoptosis through activating transcription of anti-apoptotic proteins 
mediated by NF-κB.  CO has been demonstrated to indirectly inhibit pro-inflammatory cytokine 
production as well as inhibitng apoptosis through an MKK3, p38 MAP kinase signalling cascade.  
Adapted from (Ryter et al., 2007). 
 
1.3 X-box binding protein 1 
 
 The human X-box binding protein (XBP1) belongs to the basic region / 
leucine zipper (bZIP) superfamily of transcription factors.  Members of the bZIP 
transcription superfamily contain a basic peptide region, responsible for non-covalent 
interactions with the major groove of DNA molecules and a leucine zipper region, 
containing a leucine residue every seven amino acid residues, responsible for protein 
dimerisation and necessary for gene transcription.  XBP1 was initially characterised 
through its ability to bind the HLA DRα promoter in B cells.  Early studies into XBP1 
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demonstrated that guanine residues in the X-box motif and the interspace element, the 
nucleotides located between the X and Y boxes, contributed towards the interaction of 
XBP1 with the DNA molecule (Liou et al., 1990).  These early studies only identified 
a single 261 amino acid structure of XBP1, containing a basic domain in which 45% 
of the residues are arginine or lysine and a leucine zipper region, containing six 
leucine residues spaced seven amino acid residues apart (figure 4).  The consensus 
target DNA sequence for XBP1 was identified as 5’-TGCGTCA-3’.  XBP1 also 
contains an acid-rich domain, a glutamine-rich domain and a serine-threonine-rich 
domain.  XBP1 retains a high degree of sequence homology with other members of 
the bZIP transcription family, in particular c-jun (Liou et al., 1990). 
 
 Subsequent studies identified two isoforms of XBP1, which arise due to 
unconventional splicing.  The region of the genome encoding XBP1 has coding 
sequences present in two distinct reading frames (figure 4).  Both of these reading 
frames are transcribed and are incorporated into a single XBP1 mRNA molecule.  
Under normal physiologic conditions the first reading frame is translated and the 
unspliced XBP1 (XBP1u) protein is synthesised.  Unconventional splicing of XBP1 
mRNA, which is mediated by IRE-1α homodimerisation and activation, results in the 
removal of a 26 nucleotide fragment from the central section of XBP1 mRNA.  This 
splicing event results in the translational machinery bypassing the first stop codon, 
allowing the synthesis of a second, spliced XBP1 protein (XBP1s).  XBP1s has a 
unique C-terminal domain (figure 4B).  Unconventional splicing occurs in the 
cytoplasm and does not require the nuclear spliceosome machinery.  Unconventional 
splicing has been more fully described via experimentation on the yeast homologue of 
XBP1 (Yoshida, 2007).  In order for the splicing of XBP1 to occur IRE-1α, a resident 
endoplasmic reticulum membrane protein, undergoes homodimerisation in response 
to endoplasmic reticulum (ER) stress.  Conformational changes in the IRE-1α 
cytoplasmic region result in the formation of an active endoribonuclease site.  IRE-1α 
catalyses the removal of a 26 nucleotide fragment from XBP1u mRNA.  The 
remaining RNA sequence is subsequently ligated through an as yet undetermined 
mechanism in humans, or by Rlg1p in yeast cells to produce XBP1s mRNA.  The 
mature XBP1u protein is a 261 amino acid peptide and contains an N-terminal DNA-
binding domain, a nuclear import and export signal and a motif that targets the protein 
for proteosome-mediated degradation.  The mature XBP1s protein contains a 376 
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amino acid sequence and contains the identical N-terminal domains (the DNA-
binding site and the nuclear localisation signal), but has an altered C-terminal domain.  
This region contains an activation domain responsible for inducing the transcription 
of ER stress response genes, such as endoplasmic reticulum associated protein 
degradation (ERAD) and chaperone proteins (figure 4B).  The mature XBP1u protein 
is predicted to be 35 kDa in size, whilst the spliced isoform produces a protein of 56 
kDa, allowing identification of the expression of each individual isoform. 
 
1.3.1 ER stress 
 
 The accumulation of unfolded proteins within the ER results in the induction 
of ER stress.  Activation of ER stress results in an intracellular signalling cascade 
called the unfolded protein response (UPR).  There are three mechanistically distinct 
pathways involved in the correct signal transduction of the UPR (figure 5).  These 
pathways are mediated by activating transcription factor 6 (ATF6); inositol requiring 
enzyme 1α (IRE-1α); and double-stranded RNA-activated protein kinase (PKR)-like 
endoplasmic reticulum kinase (Reimold et al.) (Reimold et al.).  The activation of the 
UPR alters gene expression, including the induction of genes involved in lipid 
synthesis, ERAD and protein folding.  The specific functional and gene expression 
changes generate an adaptation to normal cell physiology which allows cells to 
compensate and then overcome the demands imposed by ER stress (Schroder and 
Kaufman, 2005).  ER stress can be defined as a consequence of an imbalance between 
the load of unfolded proteins in the ER and the capacity of the unfolded protein 
machinery to deal with that load (Ron and Walter, 2007).  Once an increase in the 
load of unfolded proteins is detected within the lumen of the ER, three discrete 
pathways are activated which initiate signal transduction events.  Activation of the 
unfolded protein response results in a transient reduction in normal protein production, 
a medium-term upregulation of the protein folding machinery and an increase in the 
degradation machinery and if unfolded protein response stimulation is long-term 
initiate apoptosis.  These three pathways are controlled by the integral ER membrane 
proteins, ATF6, PERK and IRE-1α, which can assess the folding state in the ER 
lumen through interactions with BiP and initiate a co-ordinated response (Ron and 




Figure 4: XBP1u and XBP1s mRNA and protein structure. 
A. The mRNA structure of XBP1u and XBP1s.  B. The protein domain structure of XBP1u and XBP1s.  
C. The predicted mechanism of XBP1u splicing through IRE-1α.  The removal of the 26 nucleotide 





 Transient activation of the ER stress response abrogates the derogatory effects 
of an increase in protein load.  However, chronic ER stress results in cell death by 
apoptosis (Ferri and Kroemer, 2001; Rodriguez et al., 2011). 
 
 
Figure 5: The unfolded protein response signalling cascade. 
A. Under normal physiological conditions proteins fold normally and the association of BiP with 
PERK, IRE-1α and ATF6 prevents their dimerisation (PERK and IRE-1α) and their transport to the 
golgi (ATF6).  B. When the unfolded protein load exceeds the capability of the protein folding 
machinery the level of unfolded proteins is increased.  BiP preferentially associates with the unfolded 
proteins, liberating the oligomerisation domains of IRE-1α and PERK and allowing the transfer of 
ATF6 from the ER membrane to the golgi.  ATF6 is then spliced in the golgi by S1P and S2P, releasing 
activated ATF6, which translocates to the nucleus and induces gene transcription.  PERK 
oligomerisation induces autophosphorylation exposing its endogenous kinase activity.  PERK 
phosphorylates eIF2, which inhibits eIF2B, which is an activator of translation.  IRE-1α 
oligomerisation exposes its endogenous endoribonuclease activity.  XBP1u is spliced allowing the 
translation of XBP1s protein.  XBP1s is targeted to the nucleus and inducing gene transcription.  There 
are several points where cross talk between the three pathways occurs.  The mechanism of BiP activity 





1.3.2 IRE-1α activation 
 
 IRE-1α initiates the most conserved signalling pathway of the UPR, although 
very little is known about its biochemical regulation.  IRE-1α is a serine / threonine 
kinase that catalyses the unconventional splicing of XBP1.  A 26 nucleotide intron of 
XBP1 mRNA is spliced out by IRE-1α.  There have been several models suggested to 
explain the activation of IRE-1α by ER stress.  The initial model suggested that BiP 
binds to the lumenal domain of IRE-1α and maintains it in an inactive state.  BiP 
release during ER stress results in IRE-1α dimerisation and subsequent activation 
(Bertolotti et al., 2000).  Mutagenesis analysis of the IRE-1α lumenal domain 
indicated that unfolded proteins may bind directly to IRE-1α and promote its 
aggregation (Credle et al., 2005).  Further mechanisms suggested two other 
mechanisms through which BiP and IRE-1α may interact.  BiP could potentially 
recruit unfolded proteins and target them towards IRE-1α to promote dimerisation, or 
BiP, when not associated with unfolded proteins can interact with IRE-1α to prevent 
its dimerisation (Hetz et al., 2011).  Recent studies have indicated that IRE-1α may 
form oligomers instead of dimmers and that the formation of these oligomers is 
crucial for XBP1 splicing (Li et al., 2010). 
 
 Only two groups have looked at the mechanisms involved in targeting XBP1 
mRNA to IRE-1α.  It has been shown that the XBP1u protein itself may be involved 
in mediating the interaction between XBP1 mRNA and IRE-1α (Yanagitani et al., 
2009).  It has been shown that XBP1u mRNA localises to the ER membrane and it is 
released to the cytosol after splicing.  The membrane localisation of XBP1u mRNA 
required a hydrophobic region within the XBP1u protein, as demonstrated by 
biochemical mutation analysis.  These data served to demonstrate that the nascent 
XBP1u polypeptide serves to recruit its own mRNA to the membrane for subsequent 
splicing and translation events.  During searches to identify other IRE-1α substrates it 
was noticed that a subset of genes were downregulated during ER stress in an XBP1-
independent, IRE-1α-dependent manner.  It was suggested that IRE-1α was involved 
in the selective degradation of mRNA molecules (Hollien et al., 2009; Hollien and 
Weissman, 2006).  The reports describing IRE-1α-dependent mRNA decay indicate 
that mRNA decay is cell specific and no consensus target sequence was identified. 
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1.3.3 XBP1s and ER stress 
 
 The translation of XBP1s in response to ER stress induces physiologic 
changes to the cell which decrease the build up of ER stress (Yoshida et al., 2001).  
XBP1s can bind to cis-acting response elements in promoter regions such as the 
ERSE, ERSE-II and UPRE elements (Figure 6).  The targets of XBP1s include the ER 
chaperones: BiP, ERdj4, ERdj5, HEDJ, GRP58 and PDI-P5.  Induction of expression 
of these genes increases the ability of the protein folding machinery in the ER to bind, 
process and fold misfolded proteins.  The ERAD components EDEM and OS9 are 
transcribed increasing the degradation of misfolded proteins.  Finally components of 
the secretory pathway are increased by XBP1s activation which increases the speed of 
protein transport from the ER to target compartments.  XBP1u was initially 
demonstrated to be a precursor molecule to allow fast transcription of XBP1s in 
response to ER stress.  Recent studies demonstrated that XBP1u could bind to XBP1s, 
translocate from the nucleus to the cytoplasm and target XBP1s for degradation 
(Yoshida et al., 2006). 
 
1.3.4 Functional roles of XBP1u 
 
 Previous studies have identified a role for XBP1 in antibody production, lipid 
synthesis, liver function, cancer and inflammation.  XBP1 was initially identified 
through its ability to bind to the promoter region of MHC class II genes.  XBP1 was 
subsequently demonstrated to be required for the differentiation of plasma cells 
(Brunsing et al., 2008; Schebesta et al., 2002).  XBP1 was linked with cancer through 
its similarity to hepatocarcinogenesis-related transcription factor.  XBP1 splicing was 
also detected in hepatocellular carcinoma.  The interior of the cancer is predicted to be 
hypoxic which can induce the unfolded protein response and XBP1 splicing.  XBP1 
has been speculated as a therapeutic target for the treatment of cancer (Koong et al., 
2006).  XBP1 has also been linked to atherosclerosis through its role in ER stress 




Figure 6: The IRE1 / XBP1 pathway in response to ER stress. 
ER stress is initiated after the accumulation of unfolded proteins in the ER.  BiP dissociates from IRE1 
exposing an oligomerisation domain.  Homodimerisation of IRE1 leads to conformational changes in 
the cytosolic domain of IRE1 exposing the endogenous endoribonuclease activity.  A 26 nucleotide 
fragment of XBP1 pre-mRNA, which is constitutively expressed as XBP1u, is cleaved resulting in an 
altered reading frame.  XBP1s is encoded by the mature mRNA and when expressed results in gene 
transcription via binding to ER stress response elements in the promoter regions of enzymes and 
proteins involved in ER membrane lipid synthesis, chaperone proteins, ERAD proteins and the 
promoter of XBP1.  When ER stress has been reduced XBP1 pre-mRNA is no longer spliced and the 
XBP1u isoform binds to XBP1s and targets it for degradation. 
 
 Two recent studies have identified very important roles for XBP1 in hepatic 
lipogenesis and intestinal inflammation.  XBP1 was identified to have a central role in 
normal fatty acid synthesis in the liver, distinct from its role in augmenting lipid 
synthesis for ER expansion.  XBP1 synthesis was elevated after feeding mice with 
carbohydrates.  This corresponded with an XBP1-dependant induction of genes 
involved in fatty acid synthesis.  This study demonstrated that XBP1 is able to 
regulate a subset of genes involved in fatty acid synthesis (Lee et al., 2008).  A second 
study identified the role of XBP1 and ER stress in intestinal inflammation.  The 
authors demonstrate that induction of cell-specific ER stress through activation of 
XBP1 can lead to organ inflammation, a process requiring XBP1 (Kaser et al., 2008).  
Both of these studies involve processes that occur during progression of 
atherosclerosis.  Further study on the role of XBP1 in EC and during atherosclerosis is 
necessary, perhaps to identify a novel therapeutic target for the disease. 
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 Interestingly, a study published in the last few years has identified a novel role 
for XBP1u in preventing oxidative stress (Liu et al., 2009).  XBP1-deficient mouse 
embryonic fibroblasts were exposed to hydrogen peroxide to promote oxidative stress.  
It was determined that XBP1-null cells were more susceptible to oxidative stress than 
their wild type counterparts, as demonstrated by assessing mitochondrial membrane 
potential and apoptosis.  ROS generation in XBP1-null cells was also enhanced.  The 
expression of catalase was strongly linked to XBP1u expression and indeed XBP1u 
was shown to bind to the catalase promoter via CCAAT boxes.  These studies are 
very similar in nature to the ones performed in our studies and therefore support the 
principle that XBP1u prevents oxidative stress. 
 
1.4 Akt and cell survival signalling 
 
 Akt is a serine / threonine kinase that has an amino-terminal PH domain, a 
central catalytic domain and a carboxyl-terminal regulatory domain.  There are three 
members of the Akt family; Akt1, Akt2 and Akt3.  Akt is activated via a dual 
regulatory mechanism (Vivanco and Sawyers, 2002).  Firstly Akt must be 
translocated to the plasma membrane.  Secondly activation of Akt requires the 
phosphorylation of serine-473 and threonine-308 (Bellacosa et al., 1998) (figure 7).  
Akt is recruited to the plasma membrane through the activation of PI-3-Kinase.  PI-3-
Kinase catalyses the conversion of phosphatidylinositol-4,5-bisphophate (PIP2) into 
phosphatidylinositol-3,4,5-trisphosphate (PIP3).  PIP3 recruits Akt to the plasma 
membrane through its ability to interact with its PH domain.  Once Akt has been 
recruited to the plasma membrane kinases are able to induce the phosphorylation of 
Akt at S473 and T308.  3-phosphoinositide-dependent protein kinase-1 (PDK1) 
catalyses the phosphorylation of Akt at T308, which is sufficient to induce its 
activation (Stokoe et al., 1997).  In order for Akt to be fully activated the 
phosphorylation of S473 by a second protein kinase is required (Alessi et al., 1997).  
The MTORC2 complex, that consists of multiple proteins including mTOR, rictor, 
mLST8, DEPTOR and Sin1, has been demonstrated to induce phosphorylation of this 
site (Oh and Jacinto, 2011). 
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 The activation of Akt results in increased cell survival, proliferation and 
growth.  Akt is also important during VEGF-mediated endothelial cell migration 
during angiogenesis.  Akt promotes cell survival through a multi-factorial manner, by 
phosphorylating several components of the cell death machinery.  For example, Akt 
has been shown to inhibit the pro-apoptotic action of caspase-9 through 
phosphorylation of serine-196 (Cardone et al., 1998).  Akt also promotes cell survival 
through its indirect ability to alter the functionality of NF-κB and p53.  Akt enhances 
the anti-apoptotic activity of NF-κB through phosphorylation and activation of IκB 
Kinase, which induces the degradation of the NF-κB inhibitor IκB.  NF-κB is 
subsequently released and translocates to the nucleus to induce the transcription of 
target genes (Romashkova and Makarov, 1999).  Activated Akt can also 
phosphorylate MDM2, which is a negative regulator of p53 function, thereby 
reducing pro-apoptotic signalling through p53 (Mayo and Donner, 2001).  Akt is also 
highly important in regulating proliferation signals.  One of the targets of Akt is 
glycogen synthase kinase 3β (GSK3β).  Phosphorylation of GSK3β by Akt, blocks its 
kinase activity and prevents the phosphorylation of cyclin D1 kinase, thereby 
preventing its degradation and ensuring progression through the G1 to S-phase 
transition (Diehl et al., 1998). 
 
 Interestingly, several studies have implicated redox regulation of Akt 
activation.  The phosphorylation of Akt has been demonstrated to be both positively 
and negatively influenced by ROS signalling.  In the same study, hydrogen peroxide 
increases Akt activity at low concentrations and acts in an inhibitory manner at higher 
concentrations (Antico Arciuch et al., 2009).  Furthermore, direct redox regulation of 
Akt is suggested to regulate its function.  Oxidation of Akt and the subsequent 
disulphide bond formation between cysteine 293 and cysteine 311 in cardiac H9C2 
cells exposed to hydrogen peroxide led to an increased association with the inhibitory 
phosphatase PP2A and a reduction in serine 473 phosphorylation and Akt signalling 





Figure 7: Akt activation and downstream signalling cascades. 
Pi-3-Kinase induces the phosphorylation of PIP2 into PIP3.  Akt binds to PIP3 at the cell membrane 
through its PH domain.  This allows the phosphorylation of Akt at T308 and S473 leading to Akt 
activation and downstream signalling cascades to induce cell survival and proliferation. 
 
1.4.2 Akt induced activation of HO-1 
 
 The PI-3-Kinase / Akt pathway has been reported to activate HO-1 expression 
and enhance cell survival.  Previous reports have demonstrated that the activation of 
Akt is required for HO-1-mediated protection against carnosol-induced oxidative 
stress (Martin et al., 2004).  The levels of the ARE-binding transcription factor Nrf2 
are also raised during the protective response against carnosol.  Akt has also been 
demonstrated to directly phosphorylate HO-1 at serine-188.  Point mutations of HO-1 
at this site to represent the effect of phosphorylation result in enhance enzymatic 
activity of HO-1 both in vitro and in vivo (Salinas et al., 2004).  Recent studies have 
also shown that HO-1 expression is mediated by activation of Akt signalling by a 
mitochondrial redox-dependent pathway in ECs.  Celecoxib, a cyclooxygenase-2 
selective inhibitor, activates HO-1 expression through an Akt-dependent manner 
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(Hamdulay et al., 2010).  These results indicate that activation of Akt is a key event in 
regulating the induction of HO-1 in response to cytokines and growth factors. 
 
1.5 Histone deacetylases 
 
 Histone deacetylases (HDACs) are protein lysine deacetylases with pivotal 
roles in numerous biological processes; largely through their repressive influence on 
transcription.  There are four classes of HDACs; I, IIa, IIb and IV, which separate 
HDACs according to phylogenetic analysis and sequence homology.  The activity of 
HDACs is zinc-dependent and they can all be inhibited by pan HDAC inhibitors. 
 
 Human cells show distinct gene expression profiles which are modulated in 
response to physiological and pathological signalling.  This requires multiple levels of 
transcriptional control and occurs through transcriptional regulators that bind specific 
DNA sequences.  These modify the chromatin structure allowing DNA transcriptional 
machinery to access the genome.  The main factor influencing chromatin structure is 
the state of the histone amino acid tails that serve as targets for many reversible post-
translational modifications.  The acetylation status of the lysine residues at the 
protruding N-termini of histones acts to regulate, both positively and negatively, gene 
transcription (Shahbazian and Grunstein, 2007).  HDACs are responsible for the 
removal of acetyl groups from these residues.  The loss of the acetyl group increases 
the positive charge of the histone N-terminal domain and tightens its interaction with 
the negatively charged DNA, thus compacting the DNA and reducing the access of 
the transcriptional machinery (Shahbazian and Grunstein, 2007). 
 
 HDACs can also promote the upregulation of gene expression (Nusinzon and 
Horvath, 2005).  HDACs are predicted to exert this function through the utilisation of 
their deacetylase activity on non-histone proteins, such as heat shock and structural 
proteins.  HDACs are often found in multi-protein complexes associated with specific 




1.5.1 HDAC3 structure 
 
 The class I HDAC3 family, of which HDAC3 is a member, are ubiquitously 
expressed, predominantly found in the nucleus and display a high enzymatic activity 
towards histone substrates.  They have a conserved C-terminal deacetylase domain 
and short C- and N-terminal extensions. 
 
 HDAC3 is a 428 amino acid protein with a predicted molecular weight of 
49kDa (Yang et al., 1997).  HDAC3 has a variable C-terminal domain that 
differentiates it from other class I HDACs.  HDAC3 is present in the both the nucleus 
and the cytoplasm and is located at the cell membrane (Longworth and Laimins, 2006; 
Takami and Nakayama, 2000).  The nuclear export signal responsible for this ability 
is present within the amino acid sequence 180-313.  HDAC3 is also reported to 
contain domains responsible for: deacetylase activity, which requires the C-terminal 
region; transcriptional repression, encoded by amino acids 421-428; nuclear 
localisation signal, present in amino acids 313-428; protein-protein interactions, 
which requires the N-terminal 1-122 amino acids (figure 8) (Yang et al., 2002). 
 
 HDAC3 does not exist in isolation within the cell and can form large multi-
protein complexes through protein-protein interactions.  One of these complexes is the 
NCoR SMRT repression complex.  The formation of this complex alongside the 
recruitment of other proteins, such as GSP2 stabilises and potentiates HDAC3 
enzymatic activity (Oberoi et al., 2011).   The activity of HDAC3 is also regulated by 
protein-protein interactions, phosphorylation status and cellular localisation.  CK2 
kinase and PP4 phosphatase mediate antagonistic effects on S424 of HDAC3.  
Phosphorylation at this site increases HDAC3 activity (Zhang et al., 2005).  HDAC3 
is also able to localise to the plasma membrane through interactions with the 
membrane bound tyrosine kinase, c-Src (Longworth and Laimins, 2006).  Through 
these different interactions HDAC3 is able to mediate signalling pathways promoting 




Figure 8: HDAC3 structural domains. 
HDAC3 is a 428 amino acid protein containing a protein-protein interaction domain, a nuclear export 
and nuclear import signal, deacetylase activity and a domain responsible for transcriptional repression. 
 
1.5.2 HDAC3 function in endothelial cells 
 
 HDAC3-null mice die before embryonic day 9.5 owing to defects in 
gastrulation; possibly due to the loss of DNA double-stranded break repair (Bhaskara 
et al., 2008).  Several studies into cardiac specific deletion of HDAC3 have also been 
performed.  Cardiac-specific HDAC3 deletion resulted in increased expression of 
genes associated with fatty acid uptake, fatty acid oxidation and oxidative 
phosphorylation.  This induced myocardial accumulation of lipids and triglycerides, 
leading to the mice dying 3-4 months after birth from cardiac hypertrophy 
(Montgomery et al., 2008).  Transgenic overexpression of HDAC3 in the heart also 
leads to severe defects.  Overexpression of HDAC3 led to increased myocardium 
thickness and reduced ventricular cavity space (Trivedi et al., 2008).  These studies 
indicate that the role of HDAC3 is tightly regulated in cardiomyocytes to promote 
normal development and function. 
 
 Several studies have also demonstrated a crucial role for HDAC3 in 
maintaining endothelial integrity.  Our lab has shown that HDAC3 can mediate the 
differentiation of embryonic stem cells (ESCs) to endothelial-like cells that are 
capable of vascular repair.  VEGF and shear stress induced differentiation requires 
p53 deacetylation and activation of p21 (Xiao et al., 2006; Zeng et al., 2006).  
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Furthermore, knockdown of HDAC3 in ECs inhibits TNFα-induced VCAM1 
expression and reduced the adhesion of monocytes to ECs (Inoue et al., 2006).  
Increased leukocyte adhesion is one of the initiating steps during atherogenesis.  
Therefore inhibition of HDAC3 has been suggested as a potential mechanism to 
attenuate the inflammatory response in ECs and thereby reduce atherosclerotic lesion 
formation.  HDAC3 can also regulate blood coagulation.  Inhibition of HDAC3 
abolished TNFα-induced tissue factor expression in ECs (Wang et al., 2007).  
HDAC3 has also been demonstrated to transcriptionally and post-translationally 
regulate eNOS expression and activity.  The recruitment of HDAC3 and subsequent 
deacetylation of the eNOS promoter histone tails leads to the repression of eNOS 
transcription (Zhang et al., 2008).  Recently, acetylation of lysine 609 of eNOS was 
shown to stimulate NO production.  Overexpression of HDAC3 inhibited the 
acetylation event and reduced eNOS activity and NO production.  Knockdown of 
HDAC3 resulted in increased lysine 609 acetylation and thereby increased the 
generation of NO (Jung et al., 2010).  These studies demonstrate the important role of 
HDAC3 in the vasculature and suggest that its regulation is crucial to maintain EC 
function and integrity. 
 
 There is therefore clearly an important role for HDAC3 in mediating various 
endothelial functions.  Recently, and crucial to this study, our lab has demonstrated 
that the correct regulation of HDAC3 function aids in the maintenance of endothelial 
integrity and prevents atherosclerosis formation (Zampetaki et al., 2010).  The 
expression of HDAC3 is enhanced in regions of the vasculature subjected to disturbed 
flow, whilst knockdown of HDAC3 led to reduced EC survival in both in vitro and ex 
vivo experiments.  Disturbed flow-mediated stabilisation of HDAC3 was shown to be 
impaired in the presence of vascular endothelial growth factor receptor (VEGFR2) 
and phosphatidyl inositol-3-kinase (PI-3-K) inhibitors.  Akt, a downstream mediator 
of PI-3-K signalling is also enhanced by disturbed flow and interacts with HDAC3 to 
form a complex.  This interaction is enhanced in the presence of disturbed flow, as 
well as increased phosphorylation of HDAC3 serine and threonine residues, although 
HDAC3 is not a target for Akt-mediated phosphorylation.  HDAC3 deletion 
constructs identified that residues 136-206 of HDAC3 mediate the interaction with 
Akt.  Further experiments suggested that reduced NO levels, which occur in regions 
of the vasculature subjected to disturbed flow, are crucial in increasing the binding of 
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Akt to HDAC3.  Furthermore, overexpression of HDAC3 enhances the 
phosphorylation, and therefore activation, of Akt at serine 473 and threonine 308.  
Overexpression of constitutively active Akt can partially rescue the apoptotic 
response observed after HDAC3 knockdown.  Finally, knockdown of HDAC3 in 
aortic isografts experiments led to significant increases in neointima formation.  These 
studies provide evidence that HDAC3 acts as a prosurvival factor in the vasculature 
and that its interaction with Akt is critical for EC survival (Zampetaki et al., 2010). 
 
1.6 Project Aims 
 
 XBP1 is a key signal transducer in the ER stress response yet its potential role 
in endothelial cell function and atherosclerosis development is unknown.  This study 
aimed to investigate the role of XBP1 in the endothelium.  To explore the role of 
XBP1 in the vascular system the expression of XBP1 was determined in linear and 
bifurcation regions of mice aortas.  It was previously known that XBP1 is expressed 
in ECs, however it was unknown if XBP1 expression correlated with the 
microenvironment of particular vascular locations.  The expression of XBP1 protein 
was detected in the linear and bifurcation regions of ApoE
-/-
 / Tie2-LacZ mice aorta by 
en face staining (figure 9).  Staining of mice aortic segments with an anti-XBP1 
antibody that binds to both isoforms of XBP1 revealed that XBP1 was highly 
expressed in vascular regions exposed to disturbed blood flow.  There was very little 
XBP1 protein detected in linear regions of the vasculature.  Linear and bifurcation 
segments were also stained with X-gal to demonstrate the morphology of ECs in 
linear and bifurcation regions.  ECs in linear vasculature regions demonstrate a 
smooth ‘wave-like’ pattern, whilst those near bifurcation regions have a disorganised 
morphology. 
 
Furthermore the expression of XBP1 in atherosclerotic lesions of ApoE
-/-
 / 
Tie2-LacZ mice was examined.  Staining of mouse aortic segments containing 







Figure 9: XBP1 is highly expressed in bifurcation regions and atherosclerotic lesions. 
Aortas from Tie2-LacZ / ApoE
-/-
 were harvested and prepared for en face staining.  Aorta sections from 
linear and bifurcation regions (OB) were developed with X-gal to demonstrate the morphology of ECs 
in these regions.  En face immunostaining for XBP1 showed that XBP1 was highly expressed in the 
branch points and regions of atherosclerotic lesion development in mice arteries.  Minimal XBP1 
staining was observed in linear regions of the vasculature.  Scale bar: 100μm.  The data is 
representative of three independent experiments.  This is data is reproduced with permission from Dr. 






Laminar flow induces EC quiescence and survival, whilst disturbed flow has 
been linked to EC proliferation and apoptosis.  Having observed that XBP1 is 
upregulated in bifurcation regions of the vasculature, which are prone to increased EC 
turnover we hypothesised that shear stress-induced modulation of XBP1 could push 
ECs towards an atheroprone or atheroprotective phenotype.  In order to differentiate 
the role of XBP1u from XBP1s two separate expression vectors were constructed and 
their roles in EC integrity were examined individually.  In order to observe the role of 
XBP1s on EC survival, XBP1s was overexpressed in ex vivo aorta sections from Tie2-
LacZ mice (figure 10A) and in in vivo aortic isograft experiments with ApoE
-/-
 mice 
(figure 10B).   Overexpression of XBP1s in ex vivo aorta sections dramatically 
reduced EC survival.  Similarly, the overexpression of XBP1s in aortic isograft 
experiments significantly increased the size of atherosclerotic lesion formation. These 
results, alongside further studies performed in our laboratory, demonstrate that XBP1s 
promotes a pro-apoptotic, pro-atherogenic EC phenotype.  Further studies into the 
role of XBP1s demonstrated that EC apoptosis is promoted by XBP1s via caspase 
activation and down-regulation of VE-cadherin through transcriptional suppression 
















Figure 10: XBP1s promotes EC apoptosis and atherosclerotic lesion formation. 
A. Overexpression of XBP1s induced EC loss from the vessel wall.  Artery segments from Tie2-LacZ / 
ApoE
-/-
 mice were infected with Ad-Null or Ad-XBP1s adenovirus at 5 x 10
7
 pfu/mL and cultured for 4 
days.  The surviving ECs were revealed by X-gal staining.  The images are representative of six 
independent experiments.  B. Overexpression of XBP1s induced atherosclerosis development.  
Thoracic aortas were isolated from donor ApoE
-/-
 mice and infected with Ad-Null or Ad-XBP1s 
adenovirus at 1 x 10
6
 pfu/mL in vitro.  The aortas were then grafted into the same background recipient 
ApoE
-/-
 mice.  Neointima formation was checked on the grafts four weeks later.  The images are 
representative of six independent experiments.  There were significant differences observed after 
quantification of the data between Ad-Null and Ad-XBP1s treated samples.  This figure has been 
reproduced with permission from Dr. Lingfang Zeng and has been adapted from (Zeng et al., 2009). 
 
Under normal conditions, XBP1 exists as a 29 kDa unspliced isoform.  
Although XBP1u is reported to modulate the level of XBP1s via proteosome-
mediated degradation, other functions are predicted (Nekrutenko and He, 2006).  The 




study, it was shown that XBP1u was the main isoforms present in cultured HUVECs 
and could be upregulated by disturbed flow.  XBP1u was also revealed to be 
expressed in regions prone to atherosclerosis and the expression correlated with the 
severity of lesion formation in ApoE-/- mice.  ECs in regions prone to atherosclerosis 
or under disturbed flow are believed to be undergoing proliferation and apoptosis.  
Considering that XBP1u contains an intact N-terminal domain and DNA binding 
domain, it may bind to DNA sequences and recruit other co-activators or co-
repressors via interactions with its N-terminal domain, modulating gene transcription.  
Indeed, we found that XBP1u bound to the promoter of VE-cadherin in living cells.  
Thus, our hypothesis is that besides antagonising XBP1s, XBP1u may exert its own 
function in the modulation of cell proliferation and apoptosis. 
 
To facilitate our study, unspliced XBP1 has been cloned and an adenoviral 
expression vector (Ad-XBP1u) has been created.  Overexpression of XBP1u will be 
mediated via adenoviral gene transfer.  On the other hand, knockdown of XBP1 will 
be mediated through shRNA lentiviral vectors.  In this study, we aim to decipher the 
potential role of XBP1u in EC survival under oxidative stress and the underlying 
mechanism.  We will investigate the effect of overexpression and knockdown of 
XBP1u on ECs under hydrogen peroxide challenge and the signalling pathways 
involved.  We will also screen XBP1u regulated survival genes by microarray assay 
and explore how XBP1u regulates the expression of these genes. 
 
Importantly, this study focuses on the role of XBP1u.  The physiological 
switch between the production of XBP1u and XBP1s can happen very quickly as 
unconventional splicing of XBP1u occurs in the cytoplasm.  Therefore, upon ER 
stress the production of XBP1s protein occurs very rapidly.  To aid our study we use 
Ad-XBP1u to produce large exogenous quantities of XBP1u.  However, when we 
knock down XBP1 using shRNA this is targeted to both isoforms of XBP1 and 
therefore the role that each isoforms play in the cell is more difficult to establish.  
Under normal conditions very little XBP1s is produced and therefore the XBP1u 
isoforms predominates.  During ER stress the activation of IRE-1α results in a large 
induction of XBP1u pre-mRNA splicing and the expression of the XBP1s protein.  
Our study aims to elucidate the contribution of the XBP1u isoforms towards EC 
function.  However, the role of XBP1s cannot be ignored due to their close interaction. 
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2.1.1 Chemicals and Reagents 
 
2-Mercaptoethanol 
β-EC growth factor 
Bovine serum albumin (BSA) 
Collagen-1 
Collagenase, type 2 (Worthington Biochemical Corporation) 
Dulbecco’s modified eagle media (DMEM) (Gibco) 
EC growth supplement from bovine neural tissue 
Fibronectin 
Foetal bovine serum (FBS) 
Gelatin 
Glucose 
Hanks’ balanced salt solution (HBSS) 
Heparin 
Hydrocortisone 




Murine epidermal growth factor 








2.1.2 ELISAs, Assays and Kits 
 
Qiaprep Miniprep Kit (Qiagen) 
Qiaquick Gel Extraction Kit (Qiagen) 
RNeasy Mini Kit (Qiagen) 
CellTiter 96 Aqueous One Solution Cell Proliferation Assay (Promega) 
Nitric Oxide Biometric Assay Kit (BioVision) 
Apo-Direct Flow Cytometry Kit for Apoptosis (Chemicon) 
Cell Surface Protein Isolation Kit (Pierce) 
 
2.1.3 Buffers and Solutions 
 
HUVEC media M199 media 
3ng/mL β-EC growth factor 
3μg/mL EC growth supplement from bovine neural tissue 
10U/mL heparin 
1.25μg/mL thymidine 




HBSS + additions HBSS 
2mg/mL glucose 
2.5mg/mL taurine 
1% (w/v) BSA 
1.4mM magnesium chloride 
HBSS + collagenase HBSS + additions 
0.8mg/mL collagenase, type 2 
HBSS + trypsin HBSS 
0.05% trypsin 
2mg/mL glucose 
CMEC media DMEM 









10ng/mL murine epidermal growth factor 
1μg/mL ascorbic acid 
0.5ng/mL VEGF 
10ng/mL insulin-like growth factor 1 
Fixation Solution 37% Formaldehyde 
25% Gluteraldehyde 
in PBS 
X-gal staining solution 1 mg/mL X-gal solution 
5mM Potassium ferricyanate 
5mM Potassium ferrocyanate 
2mM Magnesium chloride 
in PBS 
HEK 293 media Dulbecco’s modified eagle medium (DMEM) 




5X SDS loading buffer 10% SDS 
50% glycerol 
0.05% bromophenol blue 
10mM β-mercaptoethanol 
500mM Tris-hydrochloride (pH 6.8) 
6X DNA loading buffer 30% glycerol 
0.3% bromophenol blue 
Distilled water 
Protein lysis buffer 1mM EDTA 
50mM tris-hydrochloride (pH7.4) 
150mM NaCl 
1% Triton X 






10% methanol in distilled water 
Tris buffered saline 0.9% sodium chloride 
500mM Tris base (pH8.4) 
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Phosphate buffered saline 137mM sodium chloride 
2.7mM potassium chloride 
8.1mM Na2HPO4 
1.76mM KH2PO4 to pH7.4 
Buffer 1 25 mM Tris-HCL (pH8.0) 
10mM EDTA 
50mM glucose 
Buffer 2 0.2M NaOH 
1% SDS 
Buffer 3 5M KOAc 
Buffer 4 10 mM Tris-HCL (pH8.0) 
1mM EDTA 
20 μg/mL RNASE 
 








































































































































































































2.1.5 Semi-quantitative PCR primers 
 
 Primers specific to our PCR template were designed from human mRNA 












































































































































































































Sequence 5’ – 3’ 
 



















































































2.2.1 Cell Culture 
 
All cell culture techniques were performed in sterile conditions in a tissue 
culture class II safety cabinet.  Cell cultures were maintained in a humidified 
atmosphere of 5% CO2 and 95% air at 37°C.  Cell centrifugation steps were 
performed using a Thermo Scientific Sorvall Legend RT centrifuge with the 
75006445 rotor, unless stated otherwise. 
 
2.2.1.1 Human Umbilical Vein Endothelial Cell (HUVEC) Culture 
 
Primary ECs were isolated from postnatal human umbilical vein and were 
kindly donated by Dr. Gillian Cockerill.  HUVECs were isolated on three distinct 
occasions and were named HUVEC-A, HUVEC-B and HUVEC-C.  Primary 
HUVECs are labelled when used during experiments.  Pre-screened HUVECs were 
also obtained from PromoCell (C-12205).  HUVECs from all sources were 
maintained under identical conditions and used up to passage 8.  HUVECs were 
cultured on flasks pre-incubated with 10μg/mL collagen-1 for 1hr at 37°C.  HUVECs 
were cultured in HUVEC media and sub-cultured when 70-80% confluent, usually 
every three days, at a ratio of 1:4.  The media was changed every one to two days. 
 
HUVECs were sub-cultured through the addition of trypsin and incubated in a 
humidified incubator for 90 seconds until cell detachment was observed.  HUVEC 
growth media was added to the flask to prevent over-trypsinisation and the cell 
solution was transferred to a falcon tube and the cells were centrifuged at 400 x g for 
5 minutes, before resuspension and transfer to fresh collagen-coated flasks. 
 
2.2.1.2 Human embryonic kidney 293 cell culture 
 
 HEK 293 (ATCC, CRL-1573) and 293T (ATCC, CRL-11268) cells were 
maintained in HEK 293 media in a humidified incubator with 5% CO2.  The cells 
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were passaged at a ratio of 1:6 every three days.  Trypsin-mediated detachment was 
used to subculture the cells 
 
2.2.1.3 Mouse coronary microvascular EC (CMEC) isolation and culture 
 
CMECs were isolated and characterised using a method adapted from Li et al 
(Li et al., 2001).  Each batch of CMECs was isolated from at least 4 hearts that were 
harvested from mice between 6 and 10 weeks old.  The isolation process does not 
involve selection; instead cardiomyocytes are removed by treatment with collagenase.  
CMECs are removed with trypsin and then separated from SMCs due to the different 




1. Prepare a 15mL falcon tube containing 10mL PBS for each batch of hearts 
2. The mice were sacrificed by cervical dislocation and the hearts were removed 
whilst still beating and placed in PBS 
3. Briefly dip the hearts into 70% ethanol to devitalise the epicardial mesothelial 
cells 
4. Wash in PBS and trim all the fat and connective tissue.  Remove the atria and 
valve tissue from the heart and remove all clots 
5. Cut open the ventricles and repeat the wash in PBS 
6. Chop the remaining tissue into 1mm2 pieces and suspend in 20mL HBSS + 
additions 
7. Centrifuge at 500rpm for 1 minute 
8. Resuspend in 6mL HBSS + collagenase, digest for 5 minutes (shear for the 
first 3 minutes by passing through a 10mL pipette at least 10 times, leave for 
the final 2 minutes to settle (no centrifugation)) 
9. Discard the supernatant and repeat a further three times 
10. Resuspend the pellet in 6mL HBSS + trypsin and digest for 3 minutes (shear 
for the first 2 minutes by passing through a 10mL pipette at least 10 times, 
leave for the final minute to settle (no centrifugation)) 
11. Remove the supernatant and mix with 1mL FBS 
12. Repeat a further three times 
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13. Combine the four trypsin digestions with 22mL complete media and 
centrifuge at 1200rpm for 8 minutes. 
14. Resuspend in 10mL CMEC media and plate on a 75cm2 flask pre-coated with 
1% (v/v) gelatin for 1hr 




CMECs were characterised by CD31, CD144 and vWF immunocytochemistry 
staining.  Vimentin and SM22were used as controls for fibroblast and muscle cell 
contamination.  Acetylated-LDL uptake was also assessed.  CMECs were cultured 
and used until passage 3, whilst the media was changed daily during culture.  Shear 
and immunocytochemistry experiments were performed with CMECs plated on flasks 
and slides pre-coated with 10ng/mL fibronectin. 
 
2.2.1.4 Cell Subculture 
 
1. Remove and discard culture medium 
2. Briefly rinse the cell layer with PBS and discard 
3. Add 3mL of 0.05% Trypsin-EDTA per 75cm2 of cell layer for 3 minutes 
4. Add 7mL of complete growth medium and aspirate the cells 
5. Centrifuge at 400 x g for 5 minutes 
6. Resuspend and aliquot appropriate cell numbers to new flasks 
 
2.2.1.5 Cell Counting 
 
Cell numbers were determined using a haemocytometer.  Cells were 
resuspended in complete media and 10μL of the cell suspension was mixed with 10μL 
0.4% Trypan blue.  10μL of this mixture was used to assess cell number in the 






2.2.1.6 Harvesting cells 
 
 Cells were scraped off the culture flasks with the medium present and 
decanted into 15 mL centrifuge tubes.  The cells were pelleted by centrifugation at 
600 x g for 5 minutes.  The medium was decanted and the cell pellet was resuspended 
in 1 mL of cold (4°C) PBS.  The PBS-cell solution was then used to extract RNA or 
protein. 
 
2.2.2 Viral Gene Transfer 
 
The adenoviruses used for this project were constructed using the Adeno-X 
expression system (BD Biosciences). 
 
2.2.2.1 XBP1u-FLAG Adenoviral Gene Construction 
 
 Unspliced XBP1 cDNA was cloned by RT-PCR from untreated HepG2 cell 
mRNA using the primer set: 5’-GGA GCT GGT ACC CTG GTG GTG GTG GCA 
GCC-3’ and 5’-TCT GAG TCT AGA ACA GTA TTG GAT CAT TCC-3’.  The 
insert was cloned into Kpn I / Xba I sites of the modified pShuttle 2 vector, in which 
the FLAG tag is fused to the N-terminal of the target protein.  The resulting plasmid 
was designated as pShuttle2-XBP1u-FLAG and verified by DNA sequencing.  The 
adenoviral vector Ad-XBP1u was created using the pShuttle2-XBP1u plasmid and a 
commercial kit (Clontech).  The initial step was to construct the recombinant 
adenoviral-XBP1u-FLAG DNA by subcloning from the pShuttle2-XBP1u-FLAG 
vector.  A double digestion of the pShuttle2-XBP1u-FLAG vector with the restriction 
endonucleases PI-Sce I / I-Ceu I was carried out to provide the XBP1u-FLAG 
expression cassette.  This expression cassette was purified with the Qiagen Gel 
extraction kit after running on a 1% agarose gel.  The XBP1u-FLAG expression 
cassette was then ligated into the Adeno-X genome by an in vitro ligation reaction at 
16°C overnight in a microcentrifuge tube.  The ligated adenoviral XBP1u-FLAG 
DNA was then purified using the phenol : chloroform : isoamyl alcohol method.  
90μL of 1X TE buffer (pH8.0) was added to 100 μL of phenol : chloroform : isoamyl 
alcohol (24:25:1) and the ligation mixture and mixed by vortexing gently.  The phases 
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were separated by centrifugation at 10,000 x g for 5 minutes at 4°C.  The aqueous 
phase was transferred to a new tube and 1 / 10 volume of 3M NaOAc and 1 μL 
glycogen (20 mg/mL) was added and vortexed gently.  The supernatant was discarded 
after centrifuging at 10,000 x g for 5 minutes at 4°C.  The pellet was overlayed with 
300 μL of 70% ethanol and centrifuged at 10,000 x g for 2 minutes and the 
supernatant carefully removed.  The pellet was air dried for 15 minutes at room 
temperature and the DNA precipitate was resuspended in 15 μL of 1X TE buffer 
(pH8.0). 
 
 The ligated Adeno-XBP1u-FLAG vector was then propagated and purified.  
Adeno-XBP1u-FLAG was transformed into JM109 competent cells and ampicillin 
resistant positive colonies were identified by PCR screening with the primer sets 
provided in the kit.  Positive colonies were amplified overnight in LB medium (100 
μg / mL ampicillin) with shaking at 37°C.  Purification of the adeno-XBP1u-FLAG 
plasmid was then carried out using the mini scale purification kit provided.  The 
bacterial cell pellet was resuspended in 150 μL of buffer 1 by gently pipetting up and 
down.  150 μL of buffer 2 was then added to the suspension and mixed gently by 
inversion several times.  After 5 minutes of incubation at room temperature, 150 μL 
of buffer 3 was added to the chilled suspension and mixed gently by inverting the tube 
several times and placing on ice for 5 minutes.  The suspension was centrifuged at 
10,000 x g for 5 minutes at 4°C and the supernatant was transferred to a clean 
microcentrifuge tube.  An equal volume of phenol : chloroform : isoamyl (25:24:1) 
was added to the supernatant and mixed by inversion.  The suspension was 
centrifuged for 5 minutes at 4°C to separate the phases and the top aqueous layer was 
transferred to a clean 1.5 mL microcentrifuge tube.  After thorough mixing with 1 mL 
of 95% ethanol through inversion, the mix was centrifuged at 10,000 x g for 10 
minutes at 4°C and the supernatant was discarded.  1 mL of 70% ethanol was added to 
the mix and centrifuged for 2 minutes at room temperature.  The supernatant was 
discarded and the pellet was air dried at room temperature.  The DNA precipitate was 
then dissolved in 15 μL of buffer 4 and vortexed gently.  PCR screening was 
performed to check that XBP1u-FLAG was correctly inserted, using the primers 
provided with the Adeno-X kit. 
 
 71 
 For the production of recombinant Adenovirus, the adeno-XBP1u-FLAG 
DNA was first linearised by Pacl, before transfection into HEK 293 cells.  Post 
digestion with Pacl, 60 μL 1X TE buffer (pH8.0) and 100 μL phenol : chloroform : 
isoamyl alcohol (25:24:1) was added to the mix and vortexed gently.  The tubes were 
centrifuged at 10,000 x g for 5 minutes at 4°C to separate the phases.  The top 
aqueous layer was transferred to a new microcentrifuge tube.  Subsequently 400 μL of 
95% ethanol, 1/10 volume of 3M NaOAc and 1 μL glycogen (20mg/mL) was added 
and vortexed gently.  The tubes were then centrifuged at 10,000 x g at 4°C for 5 
minutes and the supernatant was removed and discarded.  The pellet was washed with 
300 μL of 70% ethanol and centrifuged at 10,000 x g for 2 minutes.  The supernatant 
was carefully aspirated and the pellet was airdried for 15 minutes at room temperature.  
The DNA precipitate was dissolved with 10 μL of 1 X TE buffer (pH 8.0). 
 
 One T75 flask of subconfluent HEK 293 cells was transfected with 10 μL of 
the linearised DNA using Fugene 6 transfection reagent according to the 
manufacturer’s protocol.  When the cytopathic effect (CPE) was observed, 
approximately 1 week post-transfection, the cells were dislodged by pipetting and 
transferred to a 15 mL conical tube and centrifuged at 1,500 x g for 5 minutes at room 
temperature.  The cell pellet was resuspended in 500 μL PBS and lysed with three 
consecutive freeze-thaw cycles (-80°C to room temperature).  250 μL of this viral 
solution was used to transfect a second T75 of HEK 293 cells.  When 50% CPE was 
observed the virus was harvested as previously mentioned.  The concentration of the 
virus was increased through subsequent infections of large quantities of HEK 293 
cells and resuspension in the same volume of PBS.  The final viral concentration was 
determined through an end-point dilution assay. 
 
 24 hours prior to the titration protocol, 100 HEK 293 cells / well were plated 
into every well of a 96-well plate in 100 μL growth medium.  Serial dilutions of the 
virus stock were done as follows: 1:100 dilution by adding 10 μL virus stock to 990 





.  100 μL of each dilution was added to 10 wells, with the remaining 
wells left with 100 μL growth medium to act as negative control wells to demonstrate 
the viability of non-transfected cells.  The cells were then incubated in a humidified 
5% CO2 incubator for 10 days at 37°C.  Using a microscope the cells in each well 
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were checked for CPE.  A well is scored as showing CPE even if only a few cells 
show CPE.  The number of wells demonstrating CPE was calculated (as a fraction of 
1 for each viral dilution) and the viral titre was calculated using the formula:  Titre 
(pfu/mL) = 10 (x + 0.8) based on the Apearman-Karber method where x is the sum of 




 are assumed to all show 
CPE and therefore contribute 1.0 and 1.0 to the final value for x. 
 
2.2.2.2 Adenoviral XBP1u gene transfer 
 
 For adenoviral gene transfer, ECs were cultured as described and transduced 
with the adenoviral vector for 24 hours.  The cells were then harvested at the stated 
timepoints post-infection.  The cells were transduced with different multiplicity of 
infections (MOI) indicating the number of viral particles per cell used for each 
experiment.  An adenoviral tetracycline-controlled transactivator (Ad-Null) was used 
as the control virus.  This adenovirus expresses tTa, a regulatory protein that switches 
on genes expressed under the control of a tetracycline response element promoter.  No 
such genes under this control were used under our current system and this adenovirus 
thus served as the control virus.  Ad-Null was used to compensate for MOI, to ensure 
that all cells were treated with adenoviral vectors to compensate for the effect of 
infection on cell attributes. 
 
2.2.2.3 Constitutively active and dominant-negative AKT gene transfer 
 
 The adenovirus encoding the constitutively active myrAkt cDNA (Ad-Akt)  
and the dominant-negative (Ad-Akt(d/n)) was a generous gift from Professor Justin 
Mason at the Bywaters Centre for Vascular Inflammation, Imperial College, 
Hammersmith Hospital, London, W12 0NN, UK.  Ad-Akt expresses a constitutively 
active Akt mutant in which point mutations of threonine 308 and serine 473 are 
substituted with aspartic acid (T308D / S473D) and has the c-Src myrisolytion 
sequence for membrane targeting fused in frame to the N terminus.  For adenoviral 
gene transfer, ECs were seeded the day before transfection and transfected at the 
stated MOI for 24 hours with the virus and harvested at the stated time points.  Ad-
Null was used as the infection control. 
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2.2.2.4 XBP1 lentiviral particle production 
 
 Knockdown of XBP1 was achieved through lentiviral infection in HUVECs 
with small hairpin RNA (shRNA) complementary to XBP1.  Lentiviral particles were 
produced using MISION shXBP1 lentiviral pLKO.1 plasmid according to the 
protocol provided by the RNA consortium.  The shRNA non-targeting pLKO.1 
plasmid was used as a negative control.  Fugene 6 is a lipid-based transfection reagent 
allowing nucleic acid delivery into the host cell.  This method was employed for the 
transfection of lentiviral plasmids and the packaging plasmids, required to make a 
functional lentivirus, into HEK 293T cells.  24 hours prior to transfection 1.5 x 10
6
 
HEK 293T cells / T75 flask were seeded to achieve 70 % confluency after 24 hours 
growth.  A ratio of 3:1 (Fugene: μg plasmid) was used during the transfection.  Co-
transfection was performed using 4 μg shRNA-XBP1 (or HDAC3, IRE-1α or NT), 
3.5 μg pCMV-dR8.2 packaging plasmid and 0.5 μg pCMV-VSV-G envelope plasmid 
(both Addgene).  24 μL Fugene 6 was added directly to 46 μL Opti-MEM serum free 
media in a microcentrifuge tube for 5 minutes at room temperature.  8 μg of plasmids 
were then added to 30 μL of serum-free Opti-MEM in a separate tube.  The plasmids 
were then added to the Fugene mixture and incubated at room temperature for 30 
minutes to allow the lipid – plasmid complex to form.  This complex was then added 
drop wise to the HEK 293T cells in serum-free media.  The media was changed 4-6 
hours later and the supernatant, containing the lentivirus particles was harvested 24, 
48 and 72 hours after transfection, pooled and then filtered through a 0.45 μm filter 
and then the concentration was detected via p24 antigen ELISA. 
 
 The p24 antigen ELISA (Zeptometrix) was used to determine the viral titre.  
The microwells are coated with a monoclonal antibody specific for the p24 gag gene 
product of HIV-1.  The viral antigen present in our lentivirus particles is specifically 
captured onto this immobilised antibody during specimen incubation.  The shRNA-
XBP1 sample was diluted 1:1000 and 200 μL of this dilution was added to the 
microwells in duplicate.  Simultaneous addition of the inactivated p24 antigen 
standard was added to the microwells with 8 dose points (0-125 pg/mL) and incubated 
overnight at 37°C.  The captured antigen was then reacted with a high titred human 
anti-HIV-1 antibody conjugated with biotin for 1 hour at 37°C.  Subsequent 
incubation at 37°C for 30 minutes with streptavidin conjugated to horseradish 
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peroxidase binds it to biotin, a blue colour is developed as the bound enzyme reacts 
with the addition of the substrate, tetramethylbenzidine/H2O2 in citrate buffer, for a 
further 30 minutes at room temperature.  The reaction was halted and a yellow colour 
develops.  The optical density was observed at 450 nm and this is proportional to the 
amount of HIV-1 p24 antigen present in the specimen.  The transducing unit (TU) 
was calculated using the conversion factor recommended by the manufacturer (10
4
 
physical particles per pg of p24 and 1 TU per 10
3
 physical particle for a VSV-G 
pseudotyped lentiviral vector), with 1pg of p24 antigen converted to 10TU. 
 
2.2.2.5 XBP1 shRNA lentivirus particle transduction 
 
 For lentiviral transduction, 1.5 x 106 HUVECs were seeded on Collagen I-
coated plates and left to adhere overnight.  The following day the cells were incubated 
with 100 TU/cell shRNA-XBP1 (HDAC3, IRE-1α or NT) in complete growth media 
with 10 mg/mL polybrene for 16 hours.  Subsequently fresh medium was added to the 
cells and the plates were harvested at the stated time points after transduction.  
shRNA-NT was used as a transduction control. 
 
2.2.3 Cell Treatments 
 
2.2.3.1 MTT-Cell Proliferation Assay 
 
HUVECs were grown until 60% confluent.  The media was replaced and the 
HUVECs were incubated for 16 hours with the stated multiplicity of infection (MOI) 
of control adenovirus (Ad-Null; tetracycline controlled transactivator) and Flag-
tagged XBP1u containing adenovirus (Ad-XBP1u).  24 hours after infection the 
HUVECs were subcultured into 96 well plates at a density of 1 x 10
4
 HUVECs per 
well.  The HUVECs were grown for a further 42 hours before cell proliferation was 
assessed using the CellTiter 96 Aqueous One Solution Cell Proliferation assay kit 
(Promega).  HUVECs were treated with 50 μM hydrogen peroxide or 50 μM SnPPIX 
where stated.  The MTS tetrazolium compound is bioreduced by cells to form a 
coloured formazan product that is detectable using a luminometer at 490 nm.  Only 
metabolically active cells produce the NADPH (NADH) dehydrogenase enzymes 
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necessary to carry out this conversion.  The absorbance was observed 2 hours after the 
application of the MTS compound using a luminometer.  The induction or reduction 
in proliferation was assessed relative to the rate of proliferation of untreated HUVECs 
which was set to 1.0. 
 
2.2.3.2 Hydrogen peroxide treatment 
 
 Hydrogen peroxide treatment was used to induce cell death as a model of 
oxidative stress.  HUVECs and aorta sections were treated with 50 μM (or in some 
cases 20 μM) hydrogen peroxide.  All hydrogen peroxide treatments took place for 24 
hour time periods.  Hydrogen peroxide was stored at 4°C and fresh dilution aliquots 
were prepared before each experiment. 
 
2.2.3.3 Flow cytometry detection of apoptosis 
 
 Apoptosis was determined using the Apo-Direct flow cytometry kit 
(Chemicon).  This is a single step staining method that detects apoptotic cells through 
labelling DNA breaks.  Wild type and XBP1-null embryonic cells were isolated as 
stated previously.  The cells were left untreated or treated with hydrogen peroxide to 
induce apoptosis, followed by fixation through suspension in 1% paraformaldehyde 
on ice for 1 hour.  The cell suspension was then centrifuged at 300 x g and the 
supernatant was discarded, before washing in 5 mL PBS and subsequent 
centrifugation.  This wash step was repeated 3 times.  The pellet was resuspended in 
the residual PBS by gentle vortexing.  DNA breaks were detected by staining with 50 
μL of staining solution (TdT reaction buffer, TdT enzyme, Fluorescin-dUTP) and 
incubated for 60 minutes at 37°C, with shaking every 15 minutes.  The reaction was 
stopped through the addition of 1 mL rinse buffer and the cells were pelleted through 
centrifugation at 300 x g for 5 minutes.  The supernatant was removed and discarded.  
This rinse stage was repeated 3 times.  The cell pellet was resuspended in 500 μL of 
propidium iodide/RNase A solution and incubated in the dark at room temperature for 
30 minutes. 
 
 Apoptosis was observed by flow cytometry.  As fluorescein fluoresces at 520 
nm, using the positive and negative apoptotic cells and a 488 nm Argon Laser as a 
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light source it was possible to identify apoptotic cells.  The number of detected 
fluorescein events was recorded and as the cell numbers in the samples were kept 
constant it was possible to determine the level of apoptosis for all the different cell 
samples. 
 
2.2.3.4 Actinomycin D and cyclohexamide treatment 
 
 To determine if changes in gene expression are transcriptionally and 
translationally dependent Actinomycin D and cyclohexamide treatment can be used to 
inhibit transcription and translation, respectively.  Actinomycin D binds DNA at the 
transcription initiation complex and prevents elongation of the RNA chain by RNA 
polymerase.  Cyclohexamide blocks translation by preventing the correct 
translocation of tRNA and mRNA molecules and thereby preventing peptide 
elongation.  HUVECs were pre-treated with DMSO (as a control), 25 nM 
Actinomycin D and 50 μg / mL cyclohexamide for 6 hours prior to subsequent 
experimentation. 
 
2.2.3.5 Tin protoporphyrin treatment 
 
 The effect of HO-1 on cell survival was determined using an inhibitor of HO-1.  
Tin protoporphyrin (SnPPIX) is a competitive inhibitor of HO-1.  HUVECs were 
treated with DMSO as a control and 50 μM SnPPIX 6 hours prior to any subsequent 
treatments. 
 
2.2.3.6 Inhibition of VEGFR2, PI-3-Kinase and MEK 
 
 To determine if changes in cell function require VEGFR2, PI-3-Kinase or 
MEK activation inhibitors of these proteins were used.  HUVECs were pre-treated 
with 5μM LY294002 (an inhibitor of PI-3-Kinase), 5μM SU1498 (an inhibitor of 
VEGFR2) and 10μM PD98059 (an inhibitor of MEK1) or DMSO controls 6 hours 





2.2.3.7 Disturbed flow 
 
 HUVECs were plated at stated quantities in 25 cm
2
 collagen-1 coated flasks 
and grown overnight.  Disturbed flow was created by placing flasks longitudinally on 
a platform shaker (Labnet, model Rocker 25).  A measurable and constant parameter 
for disturbed flow was maintained by ensuring a conserved 2.0 mm depth in culture 
medium, a 10 cm flask length, a ± 7° rotating angle and a frequency of 0.5 Hz (2 
seconds per cycle).  The magnitude of the shear stress experienced by the cells is 
approximately 4.5 dyn/cm
2
.  However, during each cycle the magnitude of the shear 
stress perceived by the cells is subjected to spatial and temporal variability.  In each 
rotating cycle the spatial gradient of shear stress ranges between 0 and 20 
(dyn/cm
2
)/cm, whilst the average temporal gradient of the shear stress is 4.5 
(dyn/cm
2
)/sec.  These values have been estimated based on numerical simulation of 
the oscillatory flow system using computational fluid dynamics software.  It is 
important to note that HUVECs are subjected to reduced, oscillatory, disturbed flow 
as opposed to just disturbed flow.  The HUVECs were subjected to disturbed flow for 
the stated time points. 
 
2.2.3.8 HO-1 and ARE luciferase promoter assay 
 
 The HO-1 promoter sequence was identified using the UCSC genome browser 
programme.  Forward and reverse primers were designed to clone the promoter region. 
 
Forward: 1.003kb:  5’-ACTGTG-GGTACC-GAATCATCTGGTCCATTC-3’ 




XhoI and KpnI were not present within the promoter region and were therefore 
introduced into the primer sequence.  The HO-1 promoter was amplified using 
Accuprime Taq via PCR as stated previously.  The sequence was then restriction 
digested with the aforementioned restriction enzymes and inserted into a linearised 
PGL3 basic plasmid.  The sequence was then verified and the plasmid was transfected 
into HUVECs as detailed below. 
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The ARE-promoter luciferase construct was kindly donated by Professor Josef Dulak, 
Jagellonian University, Krakov, Poland. 
 
 HUVECs were plated 24 hours prior to treatment at a density of 100,000 cells 
per 10cm
2
.  Prior to transfection cells were cultured in low serum (2%), additive-free 
media.  Fugene was used at a 3:1 ratio (Fugene : μg DNA).  For 1 x T25 of HUVECs 
2 μg of the promoter plasmid was combined with 0.5 μg of the renilla transfection 
control and 7.5 μL of Fugene 6 reagent.  These are then combined in 100 μL of 
DMEM and left at room temperature for 30 minutes to form a complex.  The DNA-
lipid complex was then added drop wise to cells and incubated for 6 hours, before the 
media was changed.  The cells were then grown for a further 48 hours before 
treatment was initiated. 
 
 The cells were washed with ice-cold PBS and then following the addition of 
RLB buffer were subjected to three rounds of freeze-thaw cycles (-80°C to room 
temperature).  The cell suspension was then centrifuged at 10,000 x g for 5 minutes 
and the supernatant was removed to a fresh tube.  This can then be used to measure 
the luciferase and renilla activity present in the sample.  Renilla and luciferase activity 
is measured by combining 100 μL of the cell supernatant and 30 μL of luciferase and 
renilla substrate (Promega).  Each sample is then normalised to renilla to account for 
transfection efficiency and then compared against the untreated control samples. 
 
2.2.3.9 Wound healing assay 
 
 To perform the wound healing assay HUVECs were plated in 6-well plates 
and allowed to grow until confluent.  A 1 mL pipette tip was then used to create a 
consistently sized scratch across the confluent monolayer.  A permanent marker was 
used to characterise individual sections of the scratch that would be studied over a 
time course experiment.  Images were taken after 0, 4 and 8 hours and the area of the 





2.2.3.10 Induction of migration 
 
 To study the expression of genes at the initial stages of migration, HUVECs 
were grown until confluent.  The confluent monolayer was then subjected to multiple 
scratch wounds so that >75% of the HUVECs would have reduced contacts with 
surrounding cells.  The HUVECs were then allowed to migrate for the stated time 
points before they were harvested for gene expression studies. 
 
2.2.3.11 Determination of nitrate in HUVEC supernatant 
 
 Determination of the nitrate concentration in the supernatant of HUVECs 
allowed a determination of eNOS activity and NO production.  HUVECs were treated 
and then grown until confluent.  They were then incubated in the minimum possible 
media (4 mL for a T75 flask) for 24 hours to increase the detectable concentration of 
nitrate.  Nitrate was detected using a two-step process.  The initial step converts 
nitrate to nitrite using nitrate reductase, whilst the second step uses Greiss reagents to 
convert nitrate to a detectable purple Azo compound (BioVision).  The assay was 
performed according to the manufacturer’s protocol.  The absorbance at 540 nm was 
detected and using the standard curve created by the supplied standards the nitrate 
concentration was calculated using the following formula: nitrate concentration = 
((sample absorbance – blank absorbance) / slope of standard curve) / μL of sample 
measured.  The nitrate was then compared against the amount of nitrate found in the 
control samples. 
 
2.2.3.12 Tube formation assays 
 
 Tube formation assays involve the plating of ECs on matrigel and observing 
the outgrowth and ability of the ECs to form tube-like structures.  For the tube 
formation assays matrigel (Morsi et al.) was removed from -80°C and defrosted 
overnight on ice.  100μL was plated per well of an 8-well chamber slide.  20,000 





2.2.4 In vivo and ex vivo experiments 
 




 The conditional knockout XBP1 mouse was developed through collaboration 
with genOway.  The aim was to develop a floxed mouse line, by inserting a loxP site 
together with an FRT flanked neomycin selection cassette within the intron 2 and a 
single distal loxP site within the upstream of exon 1.  The mouse line was then bred 
with deleter mice, which constitutively express Flp recombinase to remove the 
neomycin selection cassette and thus create a line of floxed mice in which exons 1-2 
are flanked by loxP sites.  The floxed XBP1 mouse is then bred with a mouse line 
expressing Cre recombinase under the control of the Tie2 promoter, so XBP1 is only 
knocked out in cells expressing Tie2.  The specific process and genotyping are 
demonstrated in figure 11. 
 
2.2.4.2 En face X-gal staining 
 
 Mice aortas were removed from the donor animals and cut into 2-4 mm
2
 
sections.  Each section was then washed with PBS and fixed in fixation solution at 
room temperature for 5 minutes.  The sections were then washed in PBS before the 
application of X-gal staining solution overnight at 37°C.  The sections were then 
washed in 3% DMSO and water was added to dissolve any remaining X-gal crystals.  
The sections were then mounted on slides with the inner surface facing upwards and 
the surviving endothelial cells were observed to have a blue colouration when placed 




Figure 11: Creation of Tie2-Cre XBP1f/f mice. 
A.  Schematic diagram of the creation of XBP-conditional knockout mice.  Initially homologous 
recombination of the XBP1 and the targeting vectro occur to introduce two loxP sites and an FRT-
flanked neomycin gene.  FLPe-meditaed excision of the neomycin fragment follow.  Finally after 
brreding with a Tie2-Cre mouse Cre recombinase induced excision results in abrogated XBP1 
expression.  B. C. and D. Genotype analysis of Cre recombinase and XBP1 floxed mice. 
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2.2.4.3 Indirect Immunofluorescence staining of aorta segments 
 
 Mice were anaesthetised and perfused with 4% paraformaldehyde to fix the 
ECs.  The aortas were then harvested from wild type and Tie2-Cre XBP1
f/f 
mice.  
These were cut into approximately 2 mm
2
 sections and mounted lumen side up on 
rubber sections.  The sections were then washed in PBS briefly before a further fixing 
stage at room temperature for 20 minutes in 4% paraformaldehyde.  The sections were 
then washed three times in PBS for 5 minutes.  The cells were then permeabilised 
with 0.1% Triton X-100 for 40 minutes at room temperature.  The sections were again 
washed in PBS for 5 minutes.  The sections were then blocked in 10% swine serum 
for 1 hour at 37°C.  The sections were then incubated with the primary antibody in 
10% swine serum overnight at 4°C.  The primary antibody was removed through 
washing in PBS and the secondary antibody was applied for 1 hour at 37°C.  The 
sections were washed three times in PBS and counterstained with DAPI (1:1000) for 
2 minutes at room temperature.  The cells were then mounted with fluorescent 
mounting media (Dako) and images were taken with the axio imager M2 microscope 
and AxioVision Digital Imaging Sytem (Carl Zeiss). 
 
2.2.4.4 En face staining of aorta segments 
 
 Tie2-LacZ / ApoE
-/-
 mice or Tie2-LacZ / ApoE
+/+
 mice were perfused with 4% 
paraformaldehyde to fix ECs, followed by dissection of the artery vessel.  After 
removing the fatty tissues the artery was mounted on rubber with the lumen opened 
and facing upwards.  The en face staining procedure detailed above was used, using 
rabbit anti-XBP1 antibody.  Images were assessed by Zeiss Axioplan 2 Imaging 
microscope with Plan-NEOPLUAR 10x/0.3 objective lenses, AxioCam camera and 
Axiovision software at room temperature and were processed by Adobe Photoshop 
software.  Scale bars are demonstrated in the images. 
 
2.2.4.5 Isolation of XBP1-null embryonic cells 
 
 XBP1 heterozygous mice were cross bred and the embryos were harvested at 





 embryonic day 13.5 mice were removed from the embryo 
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sac and gently homogenised. The cells were then strained via passage through a cell 
strainer.  The cells were plated on flasks coated with 10μg/mL collagen-1 for 1hr at 
37°C and cells that did not adhere after 2 hours were discarded.  Those cells that 
adhered were maintained for further analysis. 
 
2.2.4.6 Artery graft experiments 
 
 Arteries were isolated from donor ApoE
-/-
 mice.  The ends and main branches 
were banded.  300 μL of virus solution (1 x 106 pfu/mL diluted in M199 + 15% FBS) 
was injected into the lumen and incubated at 37°C for 2 hours with the whole artery 
immersed in M199 medium and 15% FBS.  Each artery was then cut into two pieces 
and grafted into two recipient ApoE
-/-
 mice.  Four weeks later, the recipient mice were 
sacrificed humanely and the grafts were harvested for formalin-fixed sections.  The 
sections were stained with H.E. and neointima formation was observed under a 
microscope. 
 
2.2.4.7 Ring outgrowth 
 
 Arterial sections from wild type and Tie2-Cre / XBP1
f/f 
mice were harvested 
and cut into narrow ring sections.  These were then plated onto low-growth factor 
matrigel (Morsi et al.) and the outgrowth of ECs was assessed after 8 hours by 
microscopy. 
 
2.2.5 Nucleic Acid Analysis 
 
All solutions used in the isolation and manipulation of nucleic acids were 
prepared using molecular biology grade chemicals and distilled water or ethanol.  The 
solutions were sterilised by autoclaving or filtration through a 0.22 μm filter.  RNA 
degradation by contaminating RNases was minimised through the use of diethylamine 
pyrocarbonate (DEPC) treated water (Invitrogen).  All techniques that required the 
handling of RNA were performed with RNA-grade reagents and RNA-free plastic 
ware.  All centrifugation steps using 1.5 mL tubes were performed using an 
Eppendorf Centrifuge 5415R with an FE014 rotor. 
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2.2.5.1 RNA Extraction and Purification 
 
 RNA was extracted from cultured cells to study the expression pattern of 
genes in HUVECs subjected to various treatments.  RNA expression patterns of 
specific genes were analysed using semi-quantitative PCR, real-time PCR and 
microarray analysis. 
 
 The cell medium was removed and the cells were washed briefly with ice-cold 
PBS.  The cells were then mechanically detached, using a cell scraper, into 0.1 mL of 
PBS per cm
2
 cell surface area.  The cell suspension was pelleted in a 15 mL tube 
through centrifugation, in a Thermo Scientific Sorvall Legend RT centrifuge, at 600 x 
g for 5 minutes at 4°C.  The cells were resuspended in 1 mL ice-cold PBS, transferred 
to a 1.5 mL tube and centrifuged at 13,400 rpm for 30 seconds at 4°C.  The 
supernatant was removed and the cells were resuspended in RLT buffer (Qiagen) 
supplemented with 10 μL 14.3 M β-mercaptoethanol per 1 mL (Sigma).  RNA was 
purified using the Qiagen RNeasy mini kit.  Briefly, cell lysis was ensured by 
centrifugation through a QIAshredder column.  The cell lysate was mixed with 1 
volume of 70% ethanol.  RNA was bound to the RNeasy column and several wash 
steps were used to remove contaminants.  Purified RNA was eluted in 30-50 μL 
DEPC-treated water. 
 
 Genomic DNA contamination was prevented by treatment with DNase I 
(Ambion).  0.1 volume of 10X DNase buffer was mixed with RNA and 1 μL DNase I 
at 37°C for 25 minutes.  0.1 volume of DNase inactivation reagent was added to 
inhibit DNase activity and chelate ions which may have interfered with subsequent 
steps.  The solution was centrifuged at 10,000 rpm for 1.5 minutes and the supernatant 
was transferred to a fresh tube.  The RNA concentration (ng/μL) was assessed in 
duplicate using a NanoDrop 1000 (Thermo Scientific).  Only RNA with an A260/A280  







2.2.5.2 Reverse Transcription 
 
RNA was converted into cDNA using reverse transcriptase.  A typical reverse 
transcriptase reaction was performed in 25 μL total volume.  Initially 1 μg RNA was 
made up in 10 μL DEPC-treated water.  Reaction mix A containing RT buffer, dNTPs 
(Invitrogen), random primers and magnesium chloride (all Promega, Southampton, 
UK) was mixed with the RNA, incubated at 70°C for 5 minutes and then cooled to 
4°C.  Reaction mix B containing RNasin plus RNase inhibitor and reverse 
transcriptase was subsequently added (Promega).  The final reaction mix contained: 1 
μg RNA, 1X (v/v) RT buffer, 1 μM dNTP, 4 μg/mL  random primers, 3mM 
magnesium chloride, 1 U/μL RNasin and 0.2 U/μL reverse transcriptase.  This 
mixture was incubated at 25°C for 5 minutes, 42°C for 1.5 hours and finally the 
reverse transcriptase was inactivated by incubating the mixture at 72°C for 5 minutes 
before cooling to 4°C.  The reverse transcription was performed in a Techne thermo 
cycler 512.  Assuming that all the RNA was converted into cDNA the mixture was 
then diluted to create 10 ng/μL cDNA solutions.  Negative control reverse 
transcription experiments were also performed.  These contained the above reagents 
with the exclusion of reverse transcriptase.  The purpose of these was to determine 
that no genomic DNA contamination had occurred. 
 
2.2.5.3 Microarray Analysis 
 
 RNA was purified from HUVECs as detailed above and analysed by the 
genomics group, Oxford.  Briefly, 500 ng total RNA was provided at 45.5 ng / μL and 
the samples were quantified using an Agilent Bioanalyser.  The amplification and 
labelling was performed using the Ambion total prep Illumina Amplification kit, the 
quality was then checked using the Agilent Bioanalyser.  The sample was then 
hybridised to the chip and scanned.  The output consisted of a report file containing 
the intensity data per probe.  This was analysed using BeadStudio software.  500 ng of 
total RNA (45 ng/μL) was quantified by the Agilent Bioanalyser.  Total RNA is 
amplified and labelled with biotin during in vitro transcription with the Ambion 
Illumina TotalPrep RNA Amplification kit.  The amplified RNA is hybridised 
overnight to the array.  The array is then washed and stained with Cy3-streptavidin 
complex which can be seen by the scanner.  The arrays are made up of 
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oligonucleotides probes attached to beads which are randomly introduced to the 
Illumina chip.  Each array will contain up to 30 replicates of the bead type and 
therefore 30 replicates of each probe.  Each oligomer is made up of the 50-base gene-
specific probe and 29-base address sequence used to identify the randomly placed 
bead (www.well.ox.ac.uk/expression-profiling).  Three HUVEC cell lines (A, B and 
commercial (promocell)) were infected with 5 MOI of Ad-Null and Ad-XBP1u 
adenoviral vectors.  Samples were harvested 24 and 72 hours post-infection.  The 
variation in intensity for each gene, as determined through binding to specific probes 
was assessed.  Genes demonstrating a 2-fold change were selected for further study. 
 
 The subsequent analysis was performed by Ingenuity statistical calculations.  
Ingenuity statistical software uses a specific test to determine gene expression profile 
changes that correspond to particular cellular functions.  The genes identified to have 
two-fold changes were entered into the online statistical calculation software.  The 
right-tailed Fishers exact test was used to analyse gene expression profiles as it 
considers: the number of roles that the gene plays in each cell function; the total 
number of genes in the particular cell function analysed known to be associated with 
that cell function; the total number of genes in the data sample; the total number of 
genes in the reference set.  There is then a significance threshold of 0.05 under which 
a particular cell function is deemed to have been significantly altered by the 
overexpression of XBP1u. 
 
2.2.5.4 Semi-quantitative Polymerase Chain Reaction (PCR) 
 
 DNA amplification using the polymerase chain reaction (PCR) was used to 
amplify specific sequences within the genes of interest to analyse gene expression 
changes.  A typical PCR was performed in 25 μL total volume.  Prior to each 
experiment a master mix containing PCR reaction buffer, magnesium chloride, dNTPs, 
Taq DNA polymerase and primers was prepared (all Invitrogen).  50 ng of cDNA is 
used per reaction.  The final concentration of reagents in the reaction mixture is 1X 
PCR reaction buffer, 2 mM magnesium chloride, 0.166 μM dNTP, 0.5 U Taq DNA 
polymerase and 0.666 μM forward and reverse primers all diluted in DEPC-treated 
water.  The generic reaction protocol involved an initial 5 minute incubation at 94°C, 
followed by repeating cycles of 94°C denaturation and annealing for 30 seconds, and 
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72°C extension for 1 minute.  The number of cycles and the annealing temperature is 
stated in Table 4.1.  The reaction was terminated by a final extension of 10 minutes at 
72°C and the mixture was cooled to 4°C.  The PCR was performed in a Techne 
thermo cycler 512.  The specific sequences, cycle numbers and annealing 
temperatures for each primer used are shown in Table 4.1.  Lyophilised primers were 
diluted in 10 mM EDTA to a concentration of 100 μM.  Further dilutions were all 
performed in DEPC-treated water. 
 
2.2.5.5 Agarose Gel Electrophoresis of DNA 
 
DNA was separated by electrophoresis on a 1% (w/v) agarose gel made in 1X TBE 
buffer supplemented with 0.1 μg/mL of ethidium bromide.  DNA samples were mixed 
1:5 with 6X gel loading buffer (50% glycerol, 1% bromophenol blue) and loaded into 
wells.  The samples were electrophoresed in 1X TBE buffer at 195 V for 
approximately 25 minutes.  The DNA bands were visualised using ultraviolet light 
using a UVP biosphere AC imaging system and vision works software.  The size of 
the DNA fragments was estimated by comparison to a 1 kb plus DNA ladder (0.1-
10kb; Invitrogen). 
 
2.2.5.6 Real-time PCR 
 
 Total RNA was isolated as previously described.  Each real-time PCR reaction 
was performed in duplicate.  Real-time PCR primers were designed as stated 
previously.  Each real-time reaction contained 20 ng cDNA, 9 uL DEPC-treated water, 
0.75 uL of 0.3 μM forward and reverse primers and 12.5 uL of sybr green reaction 
mix (Applied Biosystems).  The reaction mixture was placed in one well of a 96-well 
plate and placed into a Sequence Detection System 7000 (Applied Biosystems).  A 
dissociation protocol was run using 60°C as the annealing temperature.  Results were 









 Genotyping of total knockout XBP1-null mice was performed on the mixed 
population of embryonic cells whose isolation has previously been described.  1/40
th
 
of the cell pellet was resuspended in PBS and centrifuged at 500 x g for 5 minutes at 
4 °C.  The cell pellet was resuspended in 200 μL DNA extraction buffer containing 
200 μg / mL proteinase K and incubated overnight at 55°C.  The DNA was extracted 
using 200 μL phenol/chloroform and centrifuged at 10,000 x g for 5 minutes at 4°C.  
The supernatant was then transferred to a fresh tube and 200 μL was added, followed 
by subsequent mixing and centrifugation at 10,000 x g for 5 minutes at 4°C.  The 
supernatant was then transferred to a fresh tube.  1/10 volume NaAc, 2.5 volumes of 
ethanol were added to the supernatant, mixed and incubated at room temperature for 1 
hour.  The sample was then centrifuged at 10,000 x g for 5 minutes at 4°C.  The 
supernatant was discarded and the DNA was resuspended in 50 μL water.  Semi-
quantitive PCR was performed using three primer sets (XBP1-gen-1/2/3) with a 55°C 
annealing temperature for 35 cycles.  The products were then run on a 2% agarose gel.  
XBP1
-/-
 = 365bp, XBP1
+/-
 = 365bp and 265bp, XBP1
+/+
 = 265bp. 
 
 To genotype the conditional XBP1-null mice (Tie2-Cre / XBP1
f/f
) the DNA 
was extracted from tail sections as previously stated above.  However the semi-
quantitative PCR reaction utilises 4 primer sets, (XBP1-gen-1/4/5/6).  These will 
identify the presence of both XBP1
f/f 
and Tie2-Cre.  Cre
+
 = 500bp, XBP1
+/+
 = 270bp, 
XBP1
f/+
 = 270bp + 388bp, XBP1
f/f
 = 388bp. 
  
2.2.6 Protein Analysis 
 
2.2.6.1 Whole Lysate Protein Extraction and Purification 
 
 Cells were washed with PBS to remove cell debris.  The cells were 
mechanically removed using a cell scraperand centrifuged to form a cell pellet.  The 
cell pellet was resuspended in the appropriate volume of lysis buffer (50mM Tris-HCl 
pH 7.5, 150mM NaCl, 1mM EDTA pH 8), supplemented with protease inhibitors 
(Roche) and 0.5% triton (all others Sigma).  The samples were incubated at 4°C for 
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15 minutes before sonication for 10 seconds.  The samples were incubated for a 
further 30 minutes at 4°C.  The samples were then centrifuged at 13,000rpm for 10 
minutes at 4°C and the supernatant was removed to a clean tube.  The protein 
concentration was calculated using BSA of known concentrations to form a standard 
curve and Bradford reagent (BioRAD) to determine protein concentrations of the 
samples. 
 
2.2.6.2 Western Blot Protein Analysis 
 
 Western blots were run using 25 μg of protein samples and the Precision Plus 
protein ladder (BioRAD).  SDS-PAGE was performed using 4-12% Bis-Tris gels 
(Invitrogen) using 1 L running buffer (Invitrogen).  The gels were run for 1 hour at 
180 V.  Proteins were transferred onto a nitrocellulose membrane (Whatman) and 
transferred at 25 V for 2.5 hours.  The membrane was blocked for two hours in 5% 
Milk diluted with PBS-T.  Primary antibody incubation was performed overnight at 
4°C.  Primary antibodies are listed in Table 2.4.  The blot was washed 3 times for 10 
minutes with PBS and then incubated with secondary antibody for 1 hour (Dako).  
The blot was washed as stated previously, incubated with ECL reaction mixture for 3 
minutes and exposed to Hyperfilm (GE Healthcare) and developed.  The blots were 
analysed using Adobe Photoshop software. 
 
2.2.6.3 Cell membrane protein isolation 
 
Membrane protein isolation was carried out using Pierce Cell Surface Protein 
Isolation Kit (Thermo Scientific) according to the manufacturer’s instructions.  
HUVEC treated in T175 flasks were washed twice with ice cold PBS.  The membrane 
proteins were first biotinylated with the membrane impermeable EZ-link Sulfo-NHS-
SS-Biotin, a thiol-cleavable amine-reactive biotinylation reagent with gentle agitation 
on a rocker for 30 minutes at 4°C.  The Sulfo-NHS-SS-Biotin reagent forms a stable 
covalent linkage with an extended spacer arm for avidin binding.  500 μL of 
quenching solution was then added to stop the reaction and cells were centrifuged at 
500 x g for 3 minutes and the cell pellet was subsequently lysed via sonication in 500 
μL lysis buffer in a microcentrifuge tube at 4°C.  After incubation on ice for 30 
minutes the cell lysate was centrifuged at 10,000 x g for 2 minutes at 4°C and the 
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supernatant was transferred to a new microcentrifuge tube.  The following step 
isolates the labelled proteins with NeutrAvidin Agarose.  500 μL of the NeutrAvidin 
slurry was added to the columns provided and centrifuged for 1 minute at 1,000 x g 
and the flow-through was discarded.  500 μL of wash buffer was then added to the gel 
and centrifuged for 1 minute at 1,000 x g and the flow-through was again discarded.  
The washing process was repeated 3 times.  The cell lysate was then added to the gel 
and incubated for 60 minutes on a rotator at room temperature.  The column was then 
added to a collection tube and centrifuged for 1 minute at 1,000 x g and the flow-
through discarded.  500 μL wash buffer was added and mixed by inverting the column 
and centrifuged for 1 minute at 1,000 x g.  This wash was repeated 3 times.  The final 
step was carried out to release the bound proteins by incubating them with 200 μL 
SDS-PAGE sample buffer containing 50 mM DTT with rotation at room temperature.  
The columns were then centrifuged for 2 minutes at 1,000 x g and the protein 
concentration of the eluted sample was then measured as previously stated.  50 μg of 
the eluted protein was then analysed by Western blotting. 
 
2.2.6.4 Isolation of nuclear and cytosolic fractions 
 
 HUVECs were treated in T175 flasks and then washed in ice-cold PBS, before 
they were scraped and pelleted into a microcentrifuge tube at 500 x g for 2 minutes.  
The supernatant was removed and 400 μL of hypotension buffer (10 mM Tris 
hydrochloride (pH7.4), 10 mM potassium chloride and 10 mM EDTA) was used to 
resuspend the cell pellet.  12 μL of NP40 was added to disrupt the outer cell 
membrane and the solution was vortexed for 10 seconds.  The solution was then 
centrifuged at 10,000 x g for 10 seconds.  The supernatant was recovered and then 
designated as the cytoplasmic fraction.  The pellet was the resuspended and washed 
with PBS three times before being resuspended in 200 μL buffer C.  The solution was 
then sonicated for 3 seconds and was designated as the nuclear fraction.  50 μg of 




 For immunoprecipitation studies HUVECs in T175 flasks were transfected 
with the adenoviral vectors for 48 hours.  The cells were then harvested as previously 
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stated and the cell pellet was resuspended in 400 μL immunoprecipitation buffer-A 
(IP-A) in a microcentrifuge tube.  After incubation on ice for 45 minutes the cell 
suspension was centrifuged at 8,000 x g for 5 minutes and the lysate was transferred 
to a new microcentrifuge tube.  The cell pellet was resuspended in 100 μL IP-A and 
sonicated with a Branson Sonifier 150 at the lowest setting for 5 seconds.  The 
solution was then incubated on ice for a further 30 minutes.  The cell lysate was then 
centrifuged at 8,000 x g for 5 minutes and the supernatant was pooled with the 
previous lysate.  The protein concentration was determined as stated previously and 1 
mg of protein was transferred to fresh microcentrifuge tubes.  3 times the volume of 
IP-B was added to the lysate which was then incubated overnight with 40 μL of the 
agarose conjugated antibody on a rotator at 4°C.  The mix was then centrifuged at 
5000 x g and the supernatant carefully removed and discarded with a narrow pipette 
tip.  The resin was then washed 3 times with 500 μL TBS.  The bound proteins were 
then eluted with 20 μL 2 x SDS-sample elution buffer by boiling for 3 minutes.  The 
samples were then centrifuged at 5,000 x g for 30 seconds to pellet any undisolved 
agarose and the supernatant was transferred to a new microcentrifuge tube.  The 
samples were then loaded simultaneously with 50 μg of the total lysate sample and 
analysed by Western blotting. 
 
2.2.7 Data and statistical analysis 
 
 Data was expressed as mean and standard deviation of three individual 
experiments.  Statistical analysis was carried out using the unpaired Student’s t test.  
All statistical analysis was carried out using the Prism GraphPad 4.0 software.  A P 








Chapter 3 - Results 
 
The X-box binding protein-1 (XBP1) is a key signal transducer in the 
endoplasmic reticulum stress response yet its potential role in endothelial cell (EC) 
function and atherosclerosis development is unknown.  This study aims to explore the 
impact of XBP1 on maintaining EC integrity related to atherosclerosis and to 
delineate the underlying mechanisms.  Under normal conditions, XBP1 exists as a 29 
kDa unspliced isoform (XBP1u).  Although XBP1u is reported to modulate the level 
of spliced XBP1 (XBP1s) via proteosome-mediated degradation, other functions are 
predicted (Nekrutenko and He, 2006; Yoshida et al., 2006).  The physiological 
function of the unspliced isoform remains unclear.  In our previous study, it was 
shown that XBP1u was the main isoforms present in cultured HUVECs and could be 
upregulated by disturbed flow.  XBP1u was also revealed to be expressed in regions 
prone to atherosclerosis and the expression correlated with the severity of lesion 
formation in ApoE-/- mice (Zeng et al., 2009).  ECs in regions prone to 
atherosclerosis or under disturbed flow undergo increased proliferation and apoptosis.  
Considering that XBP1u contains an intact N-terminal domain and DNA binding 
domain, it may bind to DNA sequences and recruit other co-activators or co-
repressors via interactions with its N-terminal domain, thereby modulating gene 
transcription.  Indeed, we have found that XBP1u binds to the promoter of VE-
cadherin in living cells (data not shown).  Thus, our hypothesis is that besides 
antagonising XBP1s, XBP1u may exert its own function in the modulation of cell 
proliferation and apoptosis. 
 
To facilitate our study, XBP1u has been cloned and an adenoviral expression 
vector (Ad-XBP1u) has been created.  Overexpression of XBP1u will be mediated via 
adenoviral gene transfer.  On the other hand, knockdown of XBP1 will be mediated 
through shRNA lentiviral vectors (shRNA-XBP1).  In this study, we aim to decipher 
the potential role of XBP1u in EC survival under oxidative stress and the underlying 
mechanism.  We will investigate the effect of overexpression and knockdown of 
XBP1u on ECs under hydrogen peroxide challenge and the signalling pathways 
involved.  We will also screen XBP1u regulated survival genes by microarray assay 
and explore how XBP1u regulates the expression of these genes. 
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3.1 XBP1u Enhances EC Survival in Response to Oxidative Stress 
 
3.1.1 Disturbed flow enhances XBP1 expression 
 
The bifurcation regions of the vasculature are subjected to lower, more 
turbulent, oscillatory or even reversed shear stress (commonly termed disturbed flow) 
caused by the non linear flow of blood.  Linear regions of the vasculature are 
subjected to higher, unidirectional haemodynamic forces (laminar flow).  Due to the 
nature of blood flow bifurcation regions are more susceptible to the formation of 
atherosclerotic lesions caused by alterations in the phenotype of local ECs (Malek et 
al., 1999).  Due to the differences in the shear stress exerted by blood flow between 
linear and bifurcation regions we speculated that the expression of either XBP1 
isoform could be driven by differences in shear stress and that these could act to 
induce an atheroprotective or atheroprone EC phenotype.  Disturbed flow was applied 
to HUVECs in vitro and the expression of XBP1u and XBP1s was assessed at the 
mRNA and protein level (figure 12).  The expression of XBP1s protein is transiently 
and significantly upregulated by 1 and 2 hours of disturbed flow in comparison to 
static controls.  The increased expression of XBP1s protein is quickly reduced after 2 
hours (figure 12A, 12C).  The expression of XBP1u is differently modulated by 
disturbed flow.  The expression of XBP1u at the protein level is consistently 
upregulated by 1 to 8 hours of disturbed flow, with the observed expression dropping 
slightly, although remaining above that of the static control, after 24 hours (figure 
12A, 12B).  These studies show that disturbed flow induces a prolonged increase in 




















































































Figure 12: Disturbed flow upregulates XBP1 expression at the protein level. 
HUVECs were subjected to disturbed flow for 0, 1, 2, 4, 8 and 24 hours.  A. The expression of XBP1u 
and XBP1s at the protein level was detected by Western blotting.  The images are representative of 
three independent experiments.  B. and C. The expression changes in XBP1u and XBP1s at the protein 





3.1.2 Overexpression of XBP1u increases HUVEC proliferation 
 
 Overexpression of XBP1s ‘pushes’ ECs towards an apoptotic phenotype, 
however, XBP1s is only expressed under certain conditions and the expression of 
XBP1u predominates in ECs.  The expression of the spliced isoforms of XBP1 is 
minimal under quiescent conditions. However, during ER stress and in response to 
redox fluctuations the activity of IRE-1α and therefore the expression of XBP1s is 
dramatically upregulated (Yoshida, 2007; Yoshida et al., 2001; Zeng et al., 2009).  
Therefore determining the role of XBP1u in ECs is crucial to a more complete 
understanding of vascular integrity.  Previous reports show that XBP1u can function 
through antagonistic interactions with XBP1s (Yoshida et al., 2006).  XBP1u binds to 
XBP1s, sequesters it in the cytosol and targets it for proteosome-mediated degradation.  
Due to its antagonistic effects on XBP1s, XBP1u could promote EC survival. 
 
Additionally, other XBP1u functions have been predicted, yet remain 
unexplored (Nekrutenko and He, 2006).  Furthermore, the mature XBP1u protein 
contains an intact N-terminal domain, comprising a DNA-binding element and 
therefore has the potential to act as a co-activator or co-repressor during gene 
transcription.  Indeed, previous work in our lab has demonstrated that XBP1u binds to 
the VE-cadherin promoter (data not shown).  Similarly to XBP1s, XBP1u is also 
upregulated in bifurcation regions of the vasculature.  We hypothesised that XBP1u is 
upregulated in ECs to promote survival and protect against mechanical stress induced 
apoptosis and that this occurs separately to its role in antagonising XBP1s. 
 
 Overexpression of XBP1u was achieved by cloning the XBP1u gene fused to a 
FLAG tag into an adenoviral expression vector (Ad-XBP1u).  The adenoviral vector 
was produced and HUVECs were transduced with Ad-XBP1u alongside Ad-Null, 
which contains a tTa gene as a control for transduction.  The infection of HUVECs 
with Ad-XBP1u adenovirus augmented the expression of XBP1u at the mRNA and 
protein level (figure 13A-B). 
 
The overexpression of XBP1u also altered HUVEC morphology in 
comparison to Ad-Null transduced cells (figure 13C-D).  Overexpression of XBP1u 
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induced HUVECs to acquire an elongated and unidirectional appearance, similar to 
that observed when healthy ECs are subjected to laminar shear stress.  HUVECs 
subjected to the overexpression of XBP1u also demonstrated a more quiescent 
morphology. 
 
ECs subjected to laminar shear stress demonstrate increased cell survival and 
are less likely to undergo apoptosis.  We hypothesised that XBP1u enhances EC 
growth and survival.  To determine if XBP1u is involved in EC survival XBP1u was 
overexpressed via adenoviral gene transfer and the proliferation of HUVECs was 
determined via an MTS tetrazolium assay.  The overexpression of XBP1u in 
HUVECs significantly increased HUVEC proliferation (figure 13E).  These data 
indicate that the overexpression of XBP1u in ECs contributes to changes in EC 
morphology and an enhancement in EC survival. 
 
3.1.3 XBP1u protects ECs against oxidative stress 
 
 Disturbed flow promotes oxidative stress leading to EC apoptosis (Chatzizisis 
et al., 2007).  Disturbed flow also increases ROS production by enhancing gene 
expression and post-transcriptional activity of NADPH and xanthine oxidase at the 
endothelial membrane (Hwang et al., 2003b; McNally et al., 2003).  Disturbed flow 
also downregulates ROS scavengers and degrades the atheroprotective NO molecule 
and its cofactors further enhancing the production of ROS (Harrison et al., 2006).  We 
have demonstrated that XBP1u is upregulated in regions of disturbed flow, which are 
prone to increased oxidative stress and EC apoptosis.  Secondly, we have 
demonstrated that the overexpression of XBP1u enhances EC proliferation.  Therefore, 
we hypothesised that XBP1u is upregulated by disturbed flow to mediate against 










































Figure 13: XBP1u enhances HUVEC proliferation. 
A. and B. HUVECs were left untreated or transduced with 10 MOI of Ad-Null or Ad-XBP1u 
adenoviruses.  The mRNA and protein was harvested 48 hours post-transduction and the expression of 
XBP1u at the (A) mRNA and (B) protein level was detected by semi-quantitative PCR and Western 
blotting respectively.  C. and D. The morphology of HUVECs transduced with (C) Ad-Null and (D) 
Ad-XBP1u adenoviruses was observed by imaging 72 hours post-infection.  E. HUVECs were 
transduced with 10 MOI of Ad-Null or Ad-XBP1u adenoviruses.  The proliferation was detected via an 
MTS tetrazolium assay 72 hours after transduction.  The images are representative and histogram 
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The balance of hydrogen peroxide production and degradation is tightly 
controlled within a cell.  Excess hydrogen peroxide induces oxidative stress and leads 
to apoptosis.  Hydrogen peroxide treatment of cells can be used as a model to study 
the effects of oxidative stress of cell survival.  In order to test this hypothesis 
HUVECs were treated with Ad-Null and Ad-XBP1u adenoviruses.  The HUVECs 
were subsequently treated with 50μM hydrogen peroxide for 24 hours, a dose that has 
previously been shown to promote HUVEC apoptosis.  The proliferation of HUVECs 
was observed via an MTS tetrazolium assay subsequent to hydrogen peroxide 
treatment (figure 14).  HUVECs under control conditions demonstrated significant 
cell loss after hydrogen peroxide treatment.  However, the overexpression of XBP1u 
significantly suppresses hydrogen peroxide-induced cell loss.  There is a two-fold 
increase in HUVEC proliferation in cells expressing exogenous XBP1u after 
treatment with hydrogen peroxide.  This data implicates XBP1u has a protective role 

































Figure 14: XBP1u protects ECs against oxidative stress. 
HUVECs were left uninfected, infected with 10 MOI Ad-Null or 10 MOI Ad-XBP1u adenoviral 
vectors.  48 hours after transduction the cells were left untreated or treated with 50μM hydrogen 
peroxide for 24 hours.  HUVEC proliferation was assessed using an MTS tetrazolium compound assay. 




The regions of the vasculature subjected to disturbed flow and at increased 
risk of atherosclerotic lesion formation are exclusively found in the arterial system.  
Our in vitro cell model, HUVECs, are part of the venous system, therefore it was 
necessary to determine that XBP1u retains this protective effect in arterial ECs.  To 
this end, aortas from Tie2-LacZ mice were harvested and cut into 1-2 mm
2
 sections.  
These were then immediately treated with Ad-Null or Ad-XBP1u adenovirus.  The 
sections were subsequently treated with 50μM hydrogen peroxide for 24 hours.  
Surviving ECs were detected by X-gal staining (figure 15).  Hydrogen peroxide 
treatment of uninfected or Ad-null infected aortic sections resulted in significant EC 
death.  The overexpression of XBP1u in aortic ECs significantly protected ECs from 
hydrogen peroxide mediated apoptosis.  In fact a two-fold increase in EC survival was 
observed after exogenous overexpression of XBP1u and hydrogen peroxide treatment. 
 
3.1.4 Knockdown of XBP1 increases EC apoptosis 
 
 XBP1u increases EC survival during oxidative stress; therefore a loss of 
XBP1u could decrease the ability of ECs to survive stimulation with oxidative stress.  
Total XBP1 was knocked down through the creation and application of a lentiviral 
construct containing a short-hairpin RNA (shRNA) directed at the mature XBP1 
mRNA molecule (shRNA-XBP1).  To control for the effects of lentiviral infection a 
lentivirus containing a randomly generated non-targeting RNA sequence was used 
(shRNA-NT).  HUVECs were transduced with shRNA-NT or shRNA-XBP1 lentiviral 
vectors.  After 72 hours, HUVECs were treated with 20μM hydrogen peroxide and the 
proliferation was observed via an MTS tetrazolium assay (figure 16C).  shRNA-
mediated knockdown of total XBP1 resulted in an 80% reduction in XBP1u detection 
at the mRNA level (figure 16A) and a 70% reduction in XBP1u at the protein level 
(figure 16B).  The treatment of the control cells with hydrogen peroxide resulted in a 
significant (50%) reduction in EC proliferation.  Knockdown of XBP1 had no effect 
on the level of HUVEC proliferation after hydrogen peroxide treatment.  We also 
observed that knockdown of XBP1 had no effect on HUVEC proliferation in the 
absence of hydrogen peroxide treatment.  This data implies that the knockdown of 
XBP1 does not further enhance oxidative stress-mediated apoptosis and that XBP1u is 





























Figure 15: XBP1u protects ECs from hydrogen peroxide-induced apoptosis in ex vivo aorta 
sections. 
Aortic sections from 8-10 week old Tie2-LacZ mice were left untreated or treated with 1x10
7
 pfu/mL of 
Ad-Null or Ad-XBP1u adenoviral vectors.  The aortic sections were treated with 50μM hydrogen 
peroxide for 24 hours, 48 hours after transduction.  A. Surviving ECs were observed by X-gal staining. 
B. Surviving ECs were counted from 10 random segments of the aortic sections.  The number of 
surviving ECs was calculated relative to the number of surviving ECs in the uninfected, untreated 





 We had anticipated that knockdown of XBP1 would enhance the susceptibility 
of HUVECs to oxidative stress; however the previous data does not confirm this.  We 
wished to confirm this data using a different cell population.  XBP1-null mice are 
embryonic lethal after day 15.5 due to hypoplastic liver formation, which results in 
reduced haematopoiesis and death from anaemia (Reimold et al., 2000).  Therefore, to 
examine XBP1-null cells from these embryos it is necessary to harvest them at an 
earlier time point.  Heterozygous XBP1
+/-
 mice were crossbred and harvested as 
embryos at day 13.5.  At this time point the wild type and heterozygous embryos are 
significantly larger when compared to homozygous XBP1-null embryos.  An adherent 
XBP1-null cell population was extracted from these embryos. 
 
 The heterozygous XBP1
+/-
 mice were generated by Dr. Lingfang Zeng and Dr. 
Yanhua Hu through the insertion of a stop codon in exon 2.  The wild type, 
heterozygous and XBP1-null mice were genotyped and the presence of XBP1 in these 
animals has been demonstrated by semi-quantitative PCR (figure 17A).  The adherent 
cell population was generated according to the protocol stated in the methods section 
and the morphology of these cells is demonstrated in Figure 17B.  These cells have 
not been further characterised, therefore they represent a population of cells isolated 
from wild type, heterozygous and XBP1-null animals that have been selected for 
based on their adherence to collagen after 1 hour of incubation. 
 
Wild type and XBP1-null cells were treated with 20μM hydrogen peroxide to 
induce apoptosis.  The cells were stained with dUTP-fluorescein to identify DNA 
breaks.  The number of DNA breaks as compared to total cell number for XBP1 and 
XBP1-null cells was determined by FACS analysis (figure 17A-B).  The percentage 
of apoptotic cells from each sample was quantified (figure 17C).  There was very little 
apoptosis observed in the untreated wild type cell population.  The treatment of wild 
type cells with 20μM hydrogen peroxide increased the observed apoptosis from 0.3% 
of the cell population to 3% of the cell population.  XBP1-null cells, under normal 
conditions, exhibited a higher level of apoptosis than untreated wild type cells (4.5% 
to 0.3% respectively).  Significantly the treatment of XBP1-null cells with hydrogen 
peroxide significantly increased the observed apoptosis when compared to XBP1-null 
untreated cells and wild type cells treated with hydrogen peroxide.  This data 
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counteracts the previous experiment and implies that XBP1 is required to promote EC 














Figure 16: Knockdown of XBP1 does not enhance oxidative stress-mediated survival. 
HUVECs were left untreated or transduced with 100 TU/cell of lentivirus containing a non-targeting 
(shRNA NT) or XBP1 targeting (shRNA XBP1) shRNA particle.  The (A) mRNA and (B) protein was 
harvested and the expression of XBP1u, XBP1s, GAPDH and β-actin was assessed by RT-PCR and 
Western blotting respectively.  C. 48 hours after transduction HUVECs were treated with 20 μM 
hydrogen peroxide for 24 hours and the proliferation was assessed using an MTS tetrazolium 
compound assay.  The images are representative and the histogram depicts mean and standard 
deviation of four independent experiments.  * p < 0.05. 
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Figure 17: XBP1 knockdown increases hydrogen peroxide-induced apoptosis in XBP1-null 
mouse embryonic cells. 
Wild type and XBP1-null Embryos from E13.5 were harvested and an adherent cell population was 
isolated.  A. Wild type, heterozygous and XBP1-null embryos were genotyped and the presence of 
XBP1 was demonstrated by PCR.  B. The morphology of the isolated population was demonstrated 
through imaging.  Wild type and XBP1-null cells were treated with 20μM hydrogen peroxide.  
Apoptosis was determined via detection of dUTP-fluorescein by FACS.  Cell populations of wild type 
(Oberoi et al.) and XBP1-null (blue) in (C) untreated and (D) 20μM hydrogen peroxide treated samples.  
The XBP1-null cell population positive for apoptosis is highlighted in red.  E. Histogram depicting the 
changes in apoptotic cells present in wild type and XBP1-null cell populations.  The data is 































 We have demonstrated that XBP1 is highly expressed in bifurcation regions 
and atherosclerotic lesions.  Disturbed flow is able to transiently upregulate the 
expression of XBP1s and more permanently upregulate the expression of XBP1u.  
Our previous studies have demonstrated that XBP1s enhances EC apoptosis and 
atherosclerotic lesion formation.  This data demonstrates that the overexpression of 
XBP1u in ECs significantly enhances their ability to proliferate and to survive after 
stimulation with oxidative stress.  The importance of XBP1 in survival was further 
demonstrated as XBP1-null cells undergo increased apoptosis after hydrogen peroxide 
treatment.  Our future studies focused on the signalling pathways initiated by XBP1u 
during disturbed flow that would lead to increased EC survival. 
 
3.2 XBP1u Promotes EC Survival through the expression of HO-1 
 
3.2.1 Identification of XBP1u-influenced candidate genes 
 
 As previously stated XBP1u contains a functional DNA-binding domain and is 
capable of binding to genomic DNA.  We hypothesised that XBP1u responds to 
disturbed flow and increases EC proliferation through the activation or repression of 
gene expression.  Specifically, we hypothesised that this occurs through the regulation 
of anti-oxidant and oxidising molecules.  We identified potential candidate genes via 
microarray analysis.  XBP1u was overexpressed in HUVECs from three independent 
human umbilical cord isolations.  These were kindly provided by Gillian Cockerill.  
Adenoviral transduction was used to overexpress XBP1u for 24 and 72 hours.  Any 
gene expression changes were identified via external microarray analysis.  All genes 
demonstrating an up- or downregulated of more than 2-fold were selected for further 
analysis.  The overexpression of XBP1u for 24 hours resulted in the upregulation of 
121 genes and the downregulation of 1263 genes.  The overexpression of XBP1u for 
72 hours resulted in the upregulation of 699 and the downregulation of 52 genes.   
  
The microarray data was performed only once due to budgetary reasons, there is 
therefore no heat-map distribution; however the main purpose of the microarray was 
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to identify candidate genes for further study, a library of 23,000 genes were screened 




















































































Figure 18: Overexpression of XBP1u influences the expression of genes involved in proliferation, 
death and cardiovascular disease. 
Overexpression of XBP1u for 24 (A and B) and 48 (C and D) hours resulted in increased (A and C) 
and decreased (B and D) expression of genes responsible for specific cellular functions.  Statistical 
analysis is calculated using a right-tailed Fishers exact test.  The threshold demonstrates the point 
above which the likelihood of XBP1u influencing these processes is significant.  E. Schematic diagram 
depicting the upregulation and downregulation of genes by XBP1u overexpression after 24 and 72 
hours. 
 
Potential candidate genes for regulation by XBP1u were identified via three 
mechanisms.  Firstly, the Ingenuity programme was used to determine the cellular 
processes, such as proliferation, metabolism, transport, etc. most influenced by 
XBP1u (figure 18).  Overexpression of XBP1u significantly influenced the expression 
of genes involved in cell growth and proliferation, cell death, cardiovascular system 
development and function and cell function and maintenance (figure 18A, 18C).  This 
result supports our previous data linking XBP1u to EC proliferation and survival.  
Secondly, we identified the genes that were consistently regulated at both 24 and 72 
hours of exogenous XBP1u overexpression.  Thirdly, a manual analysis of the 
remaining genes identified several candidates for further study (table 3). 
E 
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Haem oxygenase 1 (HO-1) 
 
 
The products of haem oxygenase; CO, biliverdin and iron(II) have 
been extensively characterised (Ryter et al., 2007).  HO-1 was also 




factor 3 (ATF3) 
 
 
ATF3 can be induced by NO in response to stress and represses p53 to 
protect against TNF-mediated apoptosis (Kawauchi et al., 2002). 
 
Adrenomedullin 2 (ADM2) 
 
 
ADM2 protects cells against hydrogen peroxide-induced damage 




activated receptor γ (PPAR γ) 
 
 
PPARγ agonists were demonstrated to prevent atherosclerosis through 
a reduction in inflammation; however the role of PPARγ is 







CRLR acts as a receptor for ADM2 and therefore mediates the 




One of the key candidate genes induced by XBP1u was haem oxygenase 1 
(HO-1).  HO-1 is an extensively studied antioxidant molecule and was therefore of 
further interest to us.  Of the remaining candidate genes only ATF3 was selected for 
further study due to its induction by stress and ability to protect HUVECs against 
apoptosis (Kawauchi et al., 2002). 
 
3.2.2 Confirmation of XBP1u candidate genes  
 
To further confirm the microarray data the regulation of HO-1, ATF3, PPARγ, 
CRLR, COX-1, COX-2 and p53 gene expression by XBP1u was confirmed by real-
time PCR and Western (figure 19).  Overexpression of XBP1u for 24 hours caused a 
5-fold increase in the level of HO-1 mRNA when compared to Ad-Null infected 
control cells.  The overexpression of XBP1u also caused a significant 2-fold increase 
in ATF3 and COX-1 expression at the mRNA level.  Western blotting confirmed that 
overexpression of XBP1u enhances the expression of HO-1, ATF3 and PPARγ.  HO-
1 and ATF3 have been linked to cell survival and therefore they were selected for 





































































Figure 19: Overexpression of XBP1u enhances the expression of HO-1, ATF3, PPARγ, CRLR, 
COX-1 and COX-2. 
HUVECs were transduced with 10 MOI Ad-Null or Ad-XBP1u adenoviral vectors.  The (A) mRNA 
and (B) protein was harvested 24 hours post-transduction and the relative expression of XBP1 (total), 
XBP1u, HO-1, ATF3, PPARγ, CRLR, COX-1, COX-2 and p53 was determined by real-time PCR and 
Western blotting respectively.  The histogram depicts the average and standard deviation from three 




3.2.3 ATF3 is regulated by disturbed flow, however XBP1u is not crucial for its 
expression 
 
Activating transcription factor 3 (ATF3) is a member of the ATF/cyclic AMP 
response element-binding (ATF/CREB) family of transcription factors.  ATF3 has 
been shown to bind to other members of the bZIP transcription family, of which 
XBP1 is a member.  However, binding of ATF3 to XBP1 has not yet been detected.  
ATF3 is suggested to regulate the delicate balance between proliferative and apoptotic 
signals that contribute to cell survival.  This effect is cell type and context specific as 
overexpression of ATF3 has also been shown to protect cells from apoptosis and 
enhance cellular apoptosis (Yin et al., 2008).  Specifically, overexpression of ATF3 in 
HUVECs has been demonstrated to protect against TNFα-mediated apoptosis at least 
partially through transcriptional regulation of p53 expression (Kawauchi et al., 2002).  
We hypothesised that XBP1u and ATF3 could interact and promote EC survival.  To 
determine if ATF3 is regulated by disturbed flow in a manner similar to XBP1u, 
HUVECs were subjected to static or disturbed flow for 0.5, 2, 4 and 24 hours and the 
expression of ATF3 was determined by Western blotting (figure 20A-B).  There is a 
non-significant trend towards increased ATF3 expression during disturbed flow. 
 
To determine if the expression of ATF3 requires XBP1u, XBP1u was knocked 
down through the addition of shRNA-XBP1 and the expression of ATF3 was detected 
by Western blotting. (figure 20C).  Lentiviral-mediated knockdown of XBP1u for 72 
hours did not result in any significant changes to ATF3 mRNA expression.  These 
data demonstrate that the expression of ATF3 is linked to XBP1u and may be linked 
to disturbed flow.  Further study into the interaction between XBP1u and ATF3 could 








































Figure 20: Disturbed flow and knockdown of XBP1 do not significantly impact ATF3 expression. 
A. and B. HUVECs were subjected to static or disturbed flow stress for 0.5, 2, 4 and 24 hours.  A. The 
protein was harvested and the expression of ATF3 was determined by Western blotting.  B. Histogram 
depicting densitometry of ATF3 protein expression during disturbed flow.  Relative ATF3 expression 
is calculated in relation to the 0.5 hour static sample and the densitometry is normalised against the 
expression of GAPDH.  The image is representative and the histogram depicts averages and standard 
deviation of three experiments.  C. HUVECs were transduced with 100 TU/cell of shRNA-NT or 
shRNA-XBP1 lentiviral particles.  The mRNA was harvested 72 hours post-transduction and the 






3.2.4 Overexpression of XBP1u enhances HO-1 expression 
 
HO-1 has been widely reported to mediate antioxidant and anti-apoptotic 
responses in diverse cell types.  HO-1 has also been shown to protect against hypoxia-
induced oxidative stress in vivo (Ryter et al., 2006).  The products of HO-1 mediated 
degradation of haem include: biliverdin and bilirubin, which scavenge free ROS; Fe
2+
, 
which acts as a cofactor to induce transcription of several anti-apoptotic proteins 
through NF-κβ; and CO, which inhibits pro-inflammatory cytokine activation (Ryter 
et al., 2007).   
 
Our microarray data demonstrated that XBP1u upregulates HO-1 mRNA 
expression.  To confirm this, exogenous XBP1u was overexpressed by adenoviral 
gene transfer.  The mRNA and protein level of HO-1 was determined 24, 48 and 72 
hours after transduction by semi-quantitative PCR, real-time PCR and Western 
blotting (figure 21A-B and 22A-B).  Overexpression of XBP1u resulted in a 4-fold 
increase in HO-1 mRNA expression after 24 hours and a 3-fold increase after 48 
hours when compared to the Ad-Null transduced control samples.  This was result 
was replicated at the protein level. 
 
XBP1u was also overexpressed in a dose-dependent manner and the 
expression of HO-1 at the mRNA and protein level was determined after 24 hours 
(figure 21C-D and figure 22C-D).  The overexpression of XBP1u results in a step-
wise increase in HO-1 at the mRNA and the protein level.  Overexpression of XBP1u 
resulted in a 4-fold increase in HO-1 mRNA expression.  The effect of XBP1u was 
even more dramatic at the protein level.  Overexpression of XBP1u resulted in a 10-
fold increase in HO-1 protein levels.  These data confirm that XBP1u regulates the 
expression of XBP1u at both the mRNA and protein level.  Furthermore, these 
experiments demonstrate the reciprocal regulation of XBP1s expression by XBP1u.  It 
was previously reported that XBP1u binds to XBP1s and targets it for proteosome-
mediated degradation (Yoshida et al., 2006).  Overexpression of exogenous XBP1u 
promotes the degradation of the XBP1s isoform (figure 21D).  At the highest level of 





















































































Figure 21: Overexpression of XBP1u increases HO-1 at the mRNA level. 
A. and B. HUVECs were transduced with 10 MOI of Ad-Null or Ad-XBP1u adenoviruses.  The 
mRNA was harvested 24, 48 and 72 hours after transduction.  The effect of exogenous XBP1u 
overexpression on HO-1 mRNA levels was determined by (A) semi-quantitative PCR and (B) real-time 
PCR.  C. and D. HUVECs were transduced with 0, 1, 2, 5 and 10 MOI of Ad-XBP1u adenoviruses 
with Ad-Null used to control for infectious particle concentration.  The mRNA was harvested 24 hours 
after transduction.  C. The effect of exogenous overexpression of XBP1u on HO-1 at the mRNA level 
was determined by semi-quantitative PCR.  D. Densitometry analysis was performed on the semi-
quantitative PCR images to assess the expression changes in XBP1u, XBP1s and HO-1 mRNA levels 
as compared to Ad-Null infected control cells.  The images are representative and the histograms depict 













































Figure 22: Overexpression of XBP1u increases HO-1 expression at the protein level. 
A. HUVECs were transduced with 10 MOI of Ad-Null or Ad-XBP1u adenovirus.  The protein was 
harvested 24, 48 and 72 hours post-transduction and the level of HO-1 was determined by Western 
blotting.  B. Densitometry was performed to assess changes in HO-1 protein levels.  The expression 
changes in HO-1 are calculated against the HO-1 expression level in Ad-null transduced cells. C. 
HUVECs were transduced with 0, 1, 2, 5 and 10 MOI of Ad-XBP1u adenoviruses with Ad-Null 
supplemented to ensure the quantity of infectious particles remained constant.  The protein was 
harvested 24 hours post-transduction and the expression of HO-1 was determined by Western blotting.  
D. Densitometry was performed to assess changes in HO-1 protein levels.  The expression changes in 
HO-1 are calculated against the HO-1 expression level in Ad-null transduced cells.  The images are 













































3.2.5 XBP1u regulates HO-1 expression independently of UPR activation 
 
 XBP1s is a known activator of the unfolded protein response (UPR) in cells 
(Yoshida, 2007; Yoshida et al., 2001).  CHOP and BiP are both upregulated by 
XBP1s and are used to demonstrate if UPR signalling is active.  The expression of 
XBP1u has only recently been demonstrated to promote protein expression, 
previously only XBP1s had been identified as an active transcription factor (Liu et al., 
2009).  In order to determine if XBP1u activates the expression of HO-1 
independently of XBP1s and UPR activation we overexpressed exogenous XBP1s in 
HUVECs (figure 23).  The overexpression of XBP1s did not increase HO-1 
expression at the mRNA level (figure 23A).  Secondly, exogenous XBP1u and XBP1s 
were overexpressed in HUVECs and the mRNA level of CHOP, BiP and HO-1 was 
determined by real-time PCR (figure 23B).  Only overexpression of XBP1s was 
sufficient to drive the upregulation of CHOP and BiP, which were upregulated by 5-
fold and 8-fold, respectively.  XBP1u had no effect on CHOP and BiP expression.  In 
contrast, exogenous overexpression of XBP1s could not drive the induction of HO-1 
expression.  The expression of HO-1 was solely induced by XBP1u.  This data 
indicates that XBP1u drives the expression of HO-1 independently to the production 
of XBP1s.  Furthermore, the upregulation of HO-1 expression occurs independently 
of UPR activation.  Through the tandem overexpression of XBP1u and XBP1s we 
have demonstrated that only the XBP1u isoform is able to activate the expression of 
HO-1.  This implies that XBP1u functions as an activator of transcription distinctly to 
the role of XBP1s in promoting transcription. 
 
3.2.6 XBP1 is required for the expression of HO-1 
 
 We have demonstrated that XBP1u is sufficient to induce the expression of 
HO-1.  However, is XBP1u also necessary for basal HO-1 expression?  HUVECs 
were transduced with 100 TU / cell of shRNA-NT and shRNA-XBP1 lentiviruses for 
72 hours.  The mRNA and protein were harvested and the expression of HO-1 was 
detected by semi-quantitative RT-PCR (figure 24A) real-time PCR (figure 24C) and 
Western blotting (figure 24B).  Knockdown of XBP1 resulted in significantly 
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abrogated HO-1 expression at the mRNA and protein level as detected by both semi-
quantitative and real-time PCR.  Indeed, knockdown of XBP1 resulted in a 40% 
reduction in basal HO-1 mRNA levels in comparison with shRNA-NT transduced 
control cells.  Knockdown of XBP1 had an even more significant impact on the 
protein level of HO-1 as it resulted in a 5-fold reduction in HO-1 protein.  This data 
indicates that XBP1 is required for the basal expression of HO-1 at both the mRNA 
and protein level. 
 
 Overexpression of exogenous XBP1s results in reduced detection of XBP1u at 
the mRNA level.  Exogenous overexpression of XBP1s results in the activation of the 
ER stress response and increased activity of the IRE-1α endoribonuclease (Back et al., 
2005).  IRE-1α endoribonuclease activity cleaves XBP1u pre-mRNA resulting in 
XBP1s pre-mRNA (Lee et al., 2002).  Therefore, the detection of the XBP1u pre-















































































Figure 23: XBP1u increases the expression of HO-1 independently to UPR activation. 
A. HUVECs were transduced with 10 MOI of Ad-Null or Ad-XBP1s adenovirus.  The mRNA was 
harvested 8, 24, 48 and 72 hours after transduction.  The mRNA level of HO-1 was determined by 
semi-quantitative PCR.  The images are representative of three independent experiments.  B. HUVECs 
were transduced with 10 MOI of Ad-Null, Ad-XBP1u or Ad-XBP1s adenoviruses.  The mRNA from 
the HUVECs was harvested 24 hours post-transduction.  The expression of XBP1 (total), XBP1u, 
CHOP, BiP and HO-1 was assessed by real time PCR.  The histogram depicts the mean and standard 















Figure 24: Knockdown of XBP1 reduces basal HO-1 expression. 
HUVECs were transduced with 100 TU / cell of shRNA-NT and shRNA-XBP1 lentivirus.  The mRNA 
and protein was harvested 72 hours post-transduction.  The expression of HO-1 was determined by (A) 
semi-quantitative PCR, (B) real-time PCR and (C) Western blotting.  The relative mRNA expression 
changes in total XBP1, XBP1u and HO-1 were calculated between shRNA-NT and shRNA-XBP1 
infected HUVECs.  The histogram depicts mean and standard deviation of five independent 







































3.2.7 HO-1 levels are normal in XBP1-null ECs 
 
 We have demonstrated that XBP1u is both sufficient and necessary for the 
expression of HO-1 in HUVECs.  To determine if HO-1 levels are reduced in XBP1-
null ECs in vivo, we developed a conditional knockout XBP1 mouse, where the 
expression of XBP1 is abolished in cells expressing the Tie2 protein.  Generation of 
these mice required the crossbreeding of mice containing loxP sites (floxed mice) in 
the XBP1 gene with mice containing a Tie2-Cre recombinase insert.  Therefore, in 
Tie2-Cre / XBP1
f/f
 mice Cre recombinase will be expressed in cells that express Tie2 
and result in abrogated XBP1 expression.  The generation of these mice was 
performed externally and the genotyping has been demonstrated in figure 11.  These 
mice have been characterised by Dr. Lingfang Zeng.  He has demonstrated that there 
are no physiological differences between the wild type and Tie2-Cre / XBP1
f/f
 mice 
(data not shown).  Data on the characterised mice will be published in Margariti, A. et 
al. 2013 and Zeng, L. et al. 2013. 
 
Aorta sections were harvested from 10 week old wild type and Tie2-Cre / 
XBP1
f/f
 mice, fixed and then double-immunostained for HO-1 and CD31.  The 
sections were then analysed by fluorescence microscopy (Figure 25).  Merged images 
are shown as the individual images are not available.  CD31 was detected at the cell 
membranes, whilst HO-1 was present at the cell membranes and within the cytoplasm.  
We observed no significant differences in the expression of HO-1 between wild type 
and Tie2-Cre / XBP1
f/f
 mice.  This data demonstrates that XBP1 is not necessary for 
the basal expression of HO-1 in vivo.  It is possible that other signalling pathways can 
compensate for the lack of XBP1.  When we knockdown XBP1 the effect is 
instantaneous and the cells do not have time to compensate.  In the conditional 
knockout animal the cells have several weeks to adapt and activate several 
compensatory pathways that replicate Akt phosphorylation.  This would explain the 








Figure 25:  HO-1 levels are normal in XBP1-null cells. 
Aorta sections from wild type and Tie2-Cre / XBP1
f/f 
mice were harvested for en face immunostaining.  
ECs were double-immunostained with HO-1 and CD31 antibodies and then stained with DAPI to 
identify the nuclei.  Scale bar = 20 μm.  These images are representative of independent experiments 
performed on three aortic segments taken from three separate mice for each of genotype. 
 
3.2.8 Overexpression of XBP1u does not enhance the activity of the HO-1 or the 
ARE promoter 
 
 Unspliced XBP1 drives the expression of HO-1 at both the mRNA and the 
protein level.  We hypothesised that XBP1u could directly regulate the expression of 
HO-1 through binding to its promoter and activating gene transcription through the 
recruitment of the polymerase complex.  The activation of HO-1 transcription is 
driven by a large variety of transcription factors and co-activator elements.  PPARα, 
PPARγ and the co-activator RXR bind and activate transcription from a region 1.8kb 
upstream of the HO-1 transcription start site (Kronke et al., 2007).  Enhancer elements 
have also been detected in the internal region of the HO-1 gene (Hill-Kapturczak et al., 
2003).  The majority of the identified activation sites are present within 4kb of the 
transcription start site. 
 
To study the activation of HO-1 gene expression by XBP1u the 1kb and 4kb 
upstream promoter regions of HO-1 were cloned into a PGL3-luciferase plasmid.  The 
cloned regions were sequenced externally and compared to the UCSC genome 
browser for sequence verification.  HUVECs were transfected with the HO-1 
promoter reporter plasmids and the relative luciferase activity was used to assess 
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activation of the HO-1 promoter after exogenous overexpression of XBP1u (figure 
26B).  The expression of XBP1u was demonstrated by semi-quantitative PCR (figure 
26A).  However, the activation of the HO-1 promoter by Akt activation or shear stress 
was not demonstrated.  These experiments would have strengthened the conclusions 
that can be drawn from this data.  In this study we demonstrate that overexpression of 
XBP1u could not activate the transcription of HO-1 through the 1kb upstream 
promoter region.  Overexpression of XBP1u slightly increased the activity and 
therefore the expression driven by the 4kb HO-1 promoter; however this result was 
not significant.  This data suggests that XBP1u either does not directly regulate HO-1 
expression, or that the XBP1u binding site is further upstream or is present in the 
internal gene structure, or that the confirmation of the DNA has altered through the 
cloning processes and prevented XBP1u binding.  Further experiments to confirm that 
the cloned transcription site is functional would enhance the robustness of this data. 
 
Nrf2 is a key-regulator of HO-1 expression and binds directly to antioxidant 
response elements (AREs) in conjunction with several bZIP activators.  We 
hypothesised that XBP1u and Nrf2 may interact to activate transcription through 
binding to AREs.  The ARE promoter region was kindly provided by Professor Jozef 
Dulak and its function has previously been demonstrated (Loboda et al., 2009).  
Overexpression of XBP1u in conjunction with cells transfected with an ARE-
containing luciferase reporter plasmid demonstrated no activation by XBP1u (figure 
26B).  These data imply that XBP1u does not directly bind to the HO-1 promoter or 



















































Figure 26: Overexpression of XBP1u and XBP1s does not influence the activity from the HO-1 or 
ARE Promoter. 
A. Overexpression of XBP1u was demonstrated by semi-quantitative PCR.  B. HUVECs were 
transfected with PGL3-HO1-1kb or PGL3-HO1-4kb plasmids alongside pShuttle2-Control or 
pShuttle2-XBP1u plasmids.  PGL3-Renilla was used as a control for transfection efficiency.  The RLU 
for each sample was assessed and normalised to renilla activation.  The RLU detected was then 
normalised to the empty vector control for each promoter construct.  The histogram depicts mean and 
standard deviation of three independent experiments.  C. HUVECs were transfected with PGL3-ARE 
alongside pShuttle2-Control or pShuttle2-XBP1u plasmids.  PGL3-Renilla was used as a control for 
transfection efficiency.  The RLU for each sample was assessed and normalised to the renilla activation 
to control for transfection efficiency.  The RLU detected was then normalised to the empty vector 






3.2.9 Disturbed flow upregulates HO-1 
 
 We have demonstrated that XBP1u is upregulated under disturbed flow and 
leads to enhanced EC survival during oxidative stress.  We hypothesised that XBP1u 
promotes EC survival through the upregulation of HO-1.  HO-1 has previously been 
shown to be upregulated by shear stress; however we wished to confirm this under our 
conditions (Zeng et al., 2009).  HUVECs were subjected to static or disturbed flow 
shear stress for 0, 1, 2, 4, 12 and 24 hours (Figure 27).  The effect of disturbed flow 
on the expression of HO-1 at the mRNA level was determined by real-time PCR.  
HUVECs exposed to disturbed flow showed a trend towards increased HO-1 mRNA 
expression (figure 20A).  Disturbed flow of 2, 4 and 24 hours resulted in significant 
upregulation of HO-1 at the protein level (figure 27B-C).  These data indicate that 
disturbed flow increases the expression of HO-1 in comparison to static controls.  The 
upregulation of HO-1 after 2 and 4 hours correlates with the observed increases in 
XBP1u expression during disturbed flow. 
 
To determine if the induction of XBP1u and HO-1 by disturbed flow is 
dependent on de novo transcription or translation; HUVECs were treated with 
actinomycin D and cyclohexamide to inhibit transcription and translation, respectively 
(Figure 28).  HUVECs were subjected to 8 hours of disturbed flow after pre-treatment 
with the inhibitors.  The inhibition of transcription and translation completely 
abolished de novo production of XBP1u and HO-1 protein.  Indeed the basal levels of 









































































Figure 27: Disturbed flow upregulates HO-1. 
HUVECs were subjected to static or disturbed flow for 0, 0.5, 2, 4 and 24 hours.  A. The mRNA was 
harvested and the expression of HO-1 was determined by real-time PCR.  B. The protein was harvested 
and the expression of HO-1 was determined by Western blotting.  C. Histogram depicting densitometry 
of HO-1 protein expression after disturbed flow.  The data is representative of and the histogram 




























































Figure 28: Disturbed flow-mediated upregulation of HO-1 and XBP1u is dependent on 
transcription and translation. 
A. HUVECs were pre-treated with the relative inhibitors for 6 hours prior to their exposure to disturbed 
flow.  HUVECs were subjected to static or disturbed flow for 8 hours.  The protein was harvested and 
the expression of XBP1u and HO-1 was determined by Western blotting.  The data is representative of 
three independent experiments.  B. and C. Densitometry analysis of XBP1u and HO-1 expression after 
actinomycin D and cyclohexamide treatment.  
 
3.2.10 Knockdown of XBP1 abolishes disturbed flow-induced upregulation of 
HO-1 
 We hypothesised that XBP1u is responsible for the induction of HO-1 by 




















































transduction of shRNA-XBP1 particles using lentiviral vectors.  The HUVECs were 
subjected to 8 hours of static or disturbed flow conditions.  The protein was harvested 
and the expression of XBP1u, XBP1s and HO-1 was determined by Western blotting 
(figure 29).  Knockdown of XBP1 completely abolished the induction of HO-1 by 
disturbed flow when compared to static controls.  This data indicates that XBP1u is 
required for basal and disturbed flow-induced expression of HO-1 at the protein level. 
 
 
Figure 29: Knockdown of XBP1 abolishes disturbed flow-induced upregulation of HO-1. 
A. HUVECs were transduced with 100 TU / cell of shRNA-NT and shRNA-XBP1 lentiviruses.  
HUVECs were then subjected to static or disturbed flow stress for 8 hours.  The protein was harvested 
and the expression of HO-1 was assessed by Western blotting.  The images are representative of three 
independent experiments. B. and C. Densitometry analysis of XBP1u and HO-1 expression after 























































































3.2.11 Inhibition of HO-1 ablates XBP1u-mediated protection of HUVEC 
apoptosis during oxidative stress 
 
 We have demonstrated that XBP1u promotes EC survival in response to 
oxidative stress and is crucial for the expression of HO-1.  We hypothesised that 
XBP1u upregulates HO-1 and that this in turn increases the ability of ECs to mitigate 
oxidative stress.  To determine if the regulation of HO-1 by XBP1 is crucial to its 
ability to promote EC survival, the activity of HO-1 was inhibited by a competitive 
inhibitor, tin protoporphyrin (SnPPIX).  HUVECs were transduced with Ad-Null and 
Ad-XBP1u adenoviruses.  The HUVECs were then pre-treated for 24 hours with 
50μM SnPPIX before the application of 50μM hydrogen peroxide for 24 hours.  The 
proliferation of the surviving ECs was then assessed by an MTS tetrazolium assay 
(Figure 30).  Similarly to our previous experiments the overexpression of XBP1u 
promotes EC survival compared with Ad-Null treated cells.  Additionally the 
overexpression of XBP1u protects ECs against apoptosis after hydrogen peroxide 
treatment as double the proliferation rate observed is double that of the control cells.  
Crucially, after the inhibition of HO-1 and hydrogen peroxide treatment of cells 
overexpressing exogenous XBP1u the survival rate of HUVECs is significantly 
reduced by 30%.  This data demonstrates that inhibition of HO-1 prevents XBP1u-
mediated promotion of HUVEC survival.  The activation of HO-1 by XBP1u is 









































Figure 30: Inhibition of HO-1 abolishes XBP1u-mediated protection of HUVEC survival in 
response to oxidative stress. 
HUVECs were transduced with 10 MOI Ad-Null or Ad-XBP1u adenoviral vectors.  The HUVECs 
were subsequently treated with 50μM hydrogen peroxide for 24 hours, 48 hours after transduction.  
Prior to the application of hydrogen peroxide HUVECs were pre-treated with 50μM tin protoporphyrin 
(SnPPIX) for 24 hours.  HUVEC proliferation was assessed using an MTS tetrazolium compound assay.  
The data is an average of three independent experiments.  * P < 0.05. 
 
 We have demonstrated a clear and crucial connection between XBP1u and 
HO-1 during the EC response to disturbed flow and oxidative stress.  Overexpression 
of XBP1u enhances the expression of HO-1 and this occurs independently of UPR 
activation.  The expression of both XBP1u and HO-1 is augmented by disturbed flow 
and XBP1u is crucial for the disturbed flow mediated upregulation of HO-1.  
Furthermore, the activation of HO-1 by XBP1u is crucial in XBP1u-mediated 
protection of ECs during oxidative stress.  However, we were unable to determine the 
exact mechanisms of HO-1 activation by XBP1u, in terms of transcriptional 
regulation.  Our future studies will focus on elucidating how XBP1u signalling results 
in HO-1 expression and activation. 
3.3 XBP1u promotes the expression of HO-1 by enhancing Akt 
phosphorylation 
 
Akt is a crucial component of an anti-apoptotic survival pathway.  The 
activation of Akt through phosphorylation is regulated by many growth factors and 
cytokines.  Akt is fully functional when phosphorylated at two sites: T308 in the 
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catalytic domain and S473 in the hydrophobic motif.  Akt has previously been shown 
to induce HO-1 expression (Chen et al., 2012; Martin et al., 2004).  Akt has also been 
found to phosphorylate HO-1 directly (Salinas et al., 2004).  Most reports show that 
Akt activates HO-1 expression through phosphorylation of the ARE-binding element 
Nrf2.  Nrf2 dissociates from Keap2, localises to the nucleus and binds to the ARE in 
the HO-1 promoter (Paine et al.).  We hypothesised that XBP1u may promote HO-1 
expression through modulation of Akt expression or phosphorylation.   
 
3.3.1 Overexpression of XBP1u enhances the phosphorylation of Akt on S473 
 
 To determine the effect of XBP1u overexpression on Akt expression and 
phosphorylation exogenous XBP1u was expressed in HUVECs in both a time and 
dose-dependent manner (figure 31).  HUVECs were transduced with 10 MOI Ad-Null 
and Ad-XBP1u adenoviruses and the expression of Akt at the protein level and the 
phosphorylation of S473 and T308 of Akt was determined by Western blotting after 
24 and 48 hours (figure 31A).  Overexpression of XBP1u for 24 hours increased 
phosphorylation of Akt at S473, when compared to HUVECs transduced with Ad-
Null adenovirus.  The overexpression of XBP1u for 48 hours produced an even 
greater increase in the phosphorylation of Akt at S473.  The protein level of Akt and 
phosphorylation of Akt at T308 remained constant throughout the experiment.  
Secondly, HUVECs were transduced with 0, 1, 2, 5 and 10 MOI Ad-XBP1u for 24 
hours and the expression of Akt and the phosphorylation status of S473 of Akt was 
observed by Western blotting (figure 31B).  Overexpression of XBP1u significantly 
increased Akt-S473 phosphorylation (figure 31C).  A 5-fold increase in Akt-S473 
phosphorylation was observed after overexpression of XBP1u for 24 hours.  These 
























































Figure 31: XBP1u increases the phosphorylation of Akt-S473. 
A. HUVECs were transduced with 10 MOI of Ad-Null or Ad-XBP1u adenoviruses.  The protein was 
harvested 24 and 48 hours after transduction and the expression and phosphorylation status of Akt was 
determined by Western blotting.  B. HUVECs were transduced with 0, 1, 2, 5 and 10 MOI of Ad-
XBP1u adenoviruses with Ad-Null supplemented to ensure a constant quantity of infectious particles.  
The protein was harvested 24 hours after transduction for Western blotting.  C. Densitometry analysis 
of changes in Akt phosphorylation.  The images are representative and the histogram depicts means and 





3.3.2 Overexpression of XBP1u increases the presence of phosphorylated Akt at 
the cell membrane 
 
 Most studies report that Akt phosphorylation occurs subsequently to its 
recruitment to the plasma membrane.  PDK1 is responsible for T308 phosphorylation, 
whereas the Akt-kinases responsible for S473 phosphorylation have only been 
extensively studied more recently.  Candidates for this role include mTORC2 and 
DNA-PK.  It has been reported that the subcellular localisation and interacting 
partners of Akt may enhance the activation of particular downstream pathways 
(Bozulic and Hemmings, 2009).  To determine the localisation of phosphorylated Akt 
after the overexpression of exogenous XBP1u we isolated the nuclear and cytoplasmic 
fractions were separated of HUVECs (Figure 32A).  The majority of phosphorylated 
Akt is present in the cytoplasmic fraction.  There was slight contamination of the 
nuclear samples with cytoplasmic markers; therefore it is possible that all the 
phosphorylated Akt is found in the cytoplasm. 
 
To determine if XBP1u enhances Akt phosphorylation at the cell membrane 
we overexpressed exogenous XBP1u in HUVECs and isolated the cell membrane 
proteins (Figure 32B-C).  The cell membrane proteins and any interacting intracellular 
partners were isolated through biotinylation of the cell surface and integral membrane 
proteins.  Overexpression of XBP1u enhanced the quantity of phosphorylated Akt-
S473 at the cell membrane.  We also detected a large increase in phosphorylated Akt-
S473 in the cytoplasm.  However, this would be anticipated because of its other 
functions and due to the instability of its interaction with the integral membrane 
proteins of the plasma membrane.  These data demonstrate that XBP1u 
Overexpression of XBP1u increases the phosphorylation of Akt at S473 and the 


















Figure 32: XBP1u increases the presence of phosphorylated Akt at the cell membrane. 
A. HUVECs were transduced with 10 MOI Ad-Null or Ad-XBP1u adenovirus.  Protein from the 
nuclear and cytoplasmic fractions was isolated 48 hours after transduction and the expression of Akt 
and pAkt-S473 was assessed by Western Blotting.  B. HUVECs were infected with 10MOI of Ad-Null 
or Ad-XBP1u adenoviral vectors.  The proteins associated with the cell membrane were isolated after 
24 and 48 hours and HO-1 and pAkt-S473 at the cell membrane and in the total lysate were detected by 
Western blotting.  C. Densitometry analysis of HO-1 and pS473 at the cell membrane and in the total 
lysate.  The samples were normalised against HUVECs treated with 10MOI ad-Null for 24 hours.  The 
data is representative and depicts means from two independent experiments. 












































3.3.3 XBP1 is required for Akt-S473 phosphorylation 
 
 We have determined that XBP1u is sufficient to induce an increase in Akt 
phosphorylation at S473; however it is also important to know if normal Akt 
phosphorylation can occur without XBP1u present.  To determine if XBP1u is 
necessary for Akt phosphorylation, XBP1 was knocked down through lentiviral 
transfer of XBP1-targeted shRNA.  The protein was harvested 72 hours after 
transduction and the expression of Akt and S473-phosphorylated Akt was determined 
by Western blotting (Figure 33).  The knockdown of XBP1 significantly reduced the 




Figure 33: Knockdown of XBP1 abrogates Akt phosphorylation. 
HUVECs were transduced with 100 TU / cell of shRNA-NT and shRNA-XBP1 lentivirus.  Protein was 
harvested 72 hours post-transduction and the expression of XBP1u, XBP1s, Akt, pS473-Akt and 








3.3.4 XBP1u does not induce Akt phosphorylation through PI-3-Kinase or 
VEGFR2 activity 
 
 In general Akt is phosphorylated through the activation of 
phosphatidylinositol-3-kinase (PI-3-kinase).  When activated PI-3-kinase 
phosphorylates phosphatidylinositol-3,4-bisphosphate to create phosphatidylinositol-
3,4,5-trisphosphate (PIP3) in the cell membrane.  Akt is recruited, through interactions 
between the lipids and the plekstrin homology domain of Akt (Duronio, 2008).  
Downstream kinases are then responsible for phosphorylation of Akt at T308 and 
S473 of which PDK-mediated phosphorylation of T308 is the more widely studied 
(Bozulic and Hemmings, 2009).  It has been reported that VEGF signalling can also 
induce activation of Akt signalling and that this is important in EC angiogenesis 
(Olsson et al., 2006; Somanath et al., 2006). 
 
 In order to determine the mechanism behind the induction of Akt 
phosphorylation by XBP1u we used inhibitors VEGF receptor 2 (VEGFR2) and PI-3-
kinase, both upstream regulators of Akt activation.  HUVECs were treated with 
DMSO, 5μM LY294002 (a PI-3-kinase inhibitor) or 5μM SU1498 (a VEGFR2 
inhibitor).  These inhibitors have previously been demonstrated to inactivate their 
respective targets at these concentrations in HUVECs (Zampetaki et al., 2010).  The 
HUVECs were subsequently transduced with 10 MOI Ad-Null or Ad-XBP1u 
adenoviral vectors and the protein was harvested after 48 hours.  The phosphorylation 
of Akt-S473 was determined by Western blotting (figure 34).  The inhibition of 
VEGFR2 or PI-3-kinase did not reduce XBP1u-mediated induction of Akt-S473 
phosphorylation.  Although PI-3-kinase is the most commonly studied method of 
inducing Akt activation a PI-3-kinase independent method has been suggested 
(Kamimura et al., 2008).  This data demonstrates that XBP1u activates Akt-S473 
phosphorylation independently of VEGFR2 and PI-3-kinase.  This experiment does 
not address the ability of XBP1u to activate Akt phosphorylation at different time 
points and doses.  To conclusively determine that XBP1u activates Akt 
phosphorylation independently of VEGFR2 and PI-3-Kinase it would be necessary to 
perform a time and dose-dependent treatment of the HUVECs with the inhibitors 




Figure 34: Inhibition of PI-3-kinase and VEGFR2 had no effect on XBP1u-induced Akt 
phosphorylation. 
HUVECs were transduced with 10 MOI of Ad-Null or Ad-XBP1u adenoviral vectors.  Six hours prior 
to transduction the HUVECs were treated with DMSO, 5μM LY294002 or 5μM SU1498.  The 
HUVECs were harvested 48 hours after transduction and the protein was isolated.  The 
phosphorylation status of Akt was detected by Western Blotting.  The images are representative of 
three independent experiments. 
 
3.3.5 Phosphorylated Akt-S473 levels are normal in XBP1-null ECs 
 
 We hypothesised that XBP1-null ECs would have a reduction in Akt-S473 
phosphorylation compared to wild type controls.  Arterial sections from wild type and 
Tie2-Cre / XBP1
f/f
 mice were harvested from 10 week old mice.  The aorta segments 
were then fixed and double-immunostained for phosphorylated Akt-S473 and CD31.  
The sections were then analysed by fluorescence microscopy (Figure 35).  CD31 was 
detected at the cell membranes alongside the majority of phosphorylated Akt-S473.  
Pockets of phosphorylated Akt were also present in specific cytoplasmic subcellular 
locations.  There were no significant differences in the phosphorylation of Akt-S473 
between wild type and Tie2-Cre / XBP1
f/f




Figure 35: Phosphorylated Akt levels are normal in XBP1-null cells. 
Aorta sections from wild type and Tie2-Cre / XBP1
f/f 
mice were harvested for en face immunostaining.  
ECs were double-immunostained with phosphorylated S473-Akt and CD31 antibodies and then stained 
with DAPI to identify the nuclei.  Scale bar = 20 μm.  These images are representative of three 
experiments performed on aortic segments taken from three independent mice for each genotype. 
 
3.3.6 Overexpression of constitutively active Akt increases XBP1u, XBP1s and 
HO-1 expression 
 
 We have demonstrated that overexpression of XBP1u enhances the expression 
of HO-1 and we predict that this occurs through the activation of Akt phosphorylation.  
A constitutively active isoform of Akt (donated by Professor Justin Mason, Imperial 
College, London) was used to further our studies.  Exogenous constitutively active 
Akt was overexpressed in a time and dose-dependent manner.  HUVECs were treated 
with 10 MOI Ad-Null and Ad-Akt adenovirus and the protein was harvested after 24 
and 48 hours.  The protein level of HO-1, XBP1u, XBP1s and Akt was determined by 
Western blotting (figure 36).  As has previously been shown the overexpression of 
constitutively active Akt drastically increases HO-1 protein.  The overexpression of 
constitutively active Akt also resulted in increased levels of XBP1u and XBP1s.  
HUVECs were also treated with 0, 5 and 10 MOI Ad-Akt for 24 hours and the protein 
level of HO-1, XBP1u, XBP1s and Akt was determined by Western blotting (figure 
36B).  The overexpression of constitutively active Akt enhanced the expression of 
HO-1, XBP1u and XBP1s at the protein level.  These data indicate that 






Figure 36: Constitutively active Akt increases XBP1u, XBP1s and HO-1 protein. 
A. HUVECs were transduced with 10 MOI Ad-Null or Ad-Akt adenovirus.  Protein was harvested 24 
and 48 hours after transduction.  The expression of HO-1, XBP1u, XBP1s, Akt, pAkt-T308, pAkt-S473 
and GAPDH was assessed by Western blotting.  B. HUVECs were transduced with 0, 5 and 10MOI of 
Ad-Akt adenovirus alongside compensating quantities of Ad-Null adenovirus to control for viral 
transduction.  The expression of HO-1, XBP1u, XBP1s, Akt and GAPDH was assessed by Western 
blotting.  The images are representative of three independent experiments. 
 
3.3.7 Knockdown of XBP1 ablates Akt-mediated induction of HO-1 
 
 To determine if XBP1u is important for Akt-mediated regulation of HO-1, the 
expression of XBP1 was abolished through targeted shRNA transduction prior to 
overexpression of constitutively active Akt (Figure 37).  HUVECs were treated with 
100 TU/cell of shRNA-XBP1 lentivirus.  48 hours after transduction the HUVECs 
were treated with 10 MOI Ad-Akt.  The protein was harvested and the expression of 
HO-1, Akt and XBP1u was determined by Western blotting.  Knockdown of XBP1 
resulted in a significant decrease in HO-1 expression.  Furthermore, transduction of 
B A 
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constitutively active Akt increased the expression of XBP1u and HO-1.  However, 
after knockdown of XBP1, the application of constitutively active Akt was unable to 
continue to increase the expression of HO-1.  This data implies that XBP1u plays a 
crucial role in the activation of HO-1 expression.  The expression of XBP1u is crucial 
for Akt-mediated activation of HO-1 expression. 
 
 
Figure 37: Knockdown of XBP1 ablates Akt-induced upregulation of HO-1. 
HUVECs were transduced with 100 TU / cell of shRNA-NT and shRNA-XBP1 lentivirus.  The 
HUVECs were further transduced with Ad-Null and Ad-Akt adenoviruses 48 hours post-transduction.  
The protein was harvested 48 hours later.  The expression of HO-1, XBP1u, Akt and GAPDH was 
determined by Western blotting.  The images are representative of three independent experiments. 
 
3.3.8 Inhibition of Akt does not prevent XBP1u-induced upregulation of HO-1 
 
 To clarify the role of XBP1u in the upregulation of HO-1 a dominant-negative 
isoform of Akt (Akt(d/n)), which acts as a competitive inhibitor of activated Akt was 
kindly provided by Professor Justin Mason, Imperial College London.  Exogenous 
Akt(d/n) and XBP1u were simultaneously overexpressed and the expression of HO-1 
was determined.  HUVECs were transduced with 10 MOI of Ad-XBP1u and Ad-
Akt(d/n) alongside compensatory quantities of Ad-null adenovirus.  The protein was 
harvested 48 hours after transduction and the level of HO-1 was determined by 
Western blotting (figure 38).  The overexpression of exogenous XBP1u increased the 
level of HO-1 protein.  Individually, the overexpression of the dominant negative 
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isoform of Akt had no effect on the protein level of HO-1 and reduced the quantity of 
Akt phosphorylated at S473.  Overexpression of XBP1u is still able to induce the 
expression of HO-1 in the presence of inactive Akt.  This data demonstrates that 




Figure 38: Inhibition of Akt does not prevent XBP1u-induced upregulation of HO-1. 
HUVECs were transduced with 10 MOI of Ad-XBP1u, Ad-Akt(d/n) and 10 MOI of both Ad-XBP1u 
and Ad-Akt(d/n).  MOI was compensated for with the addition of Ad-Null adenovirus.  The protein 
was harvested 48 hours after transduction.  The protein expression of HO-1, FLAG (XBP1u), pAkt-







3.3.9 Knockdown of XBP1 abolished the induction of Akt phosphorylation by 
disturbed flow 
 
 Our previous experiments with disturbed flow demonstrated that XBP1u and 
HO-1 are both upregulated through the application of disturbed flow onto a confluent 
HUVEC monolayer.  Previously Akt has been shown to respond to shear stress in ECs.  
To confirm this in our model HUVECs were subjected to disturbed flow for 0, 0.25, 
0.5, 1, 2, 4, 8 and 24 hours.  The protein was harvested and the level of 
phosphorylated Akt-S473, phosphorylated Akt-T308 and Akt was determined by 
Western blotting (Figure 39A).  Disturbed flow had very little effect on the 
phosphorylation status of Akt-T308; however, the application of disturbed flow very 
quickly (15 minutes) induced the phosphorylation of Akt-S473.  The phosphorylation 
of Akt-S473 remained increased at all time points, however the intensity had 
decreased after 24 hours. 
 
To determine if XBP1u is required for Akt phosphorylation during disturbed 
flow, XBP1 was knocked down by targeted shRNA prior to stimulation of the 
HUVECs with disturbed flow.  HUVECs were treated with 100 TU / cell shRNA-
XBP1.  Disturbed flow was then applied for 8 hours, as previous experiments 
suggested that this is the optimal time to see upregulation of XBP1u, HO-1 and 
phosphorylated Akt-S473, and the expression of these proteins was detected through 
Western blotting (figure 39B).  Disturbed flow induced the upregulation of XBP1u, 
HO-1 and phosphorylated S473-Akt.  After knockdown of XBP1, no upregulation of 
HO-1, XBP1u or phosphorylated S473-Akt was observed.  These data confirm that 
XBP1u is crucial in disturbed flow mediated upregulation of HO-1 and 












Figure 39: Knockdown of XBP1 abolishes disturbed flow-induced upregulation of pAkt-S473. 
A. HUVECs were subjected to static or disturbed flow for 0.25, 0.5, 1, 2, 4, 8 and 24 hours.  The 
protein was harvested and the expression and phosphorylation status of Akt was assessed by Western 
blotting.  B. and C. Densitometry analysis of XBP1u and pAkt-S473 expression.  D. HUVECs were 
transduced with 100 TU / cell of shRNA-NT and shRNA-XBP1 lentivirus.  HUVECs were then 
subjected to static or disturbed flow for 8 hours.  The protein was harvested and the expression of HO-1 
and pAkt-S473 was assessed by Western blotting.  The images are representative of three independent 
experiments. E. Densitometry analysis of pAkt-S473 expression. 























































































































































Our results demonstrate that disturbed flow upregulates the expression of 
XBP1u and HO-1 and leads to increased phosphorylation of Akt at serine 473.  
Additionally, overexpression of XBP1u results in increased Akt S473 phosphorylation, 
HO-1 expression and EC survival under both normal and oxidative stress conditions.  
Akt has previously been shown to upregulate the expression of HO-1, which we have 
also confirmed.  In addition, we have demonstrated that constitutively active Akt can 
induce the expression of XBP1u.  Interestingly, we have shown that XBP1u is 
required for Akt-mediated augmentation of HO-1 expression.  We hypothesise that 
XBP1u is upregulated in ECs in an attempt to mediate against the damaging effects of 
disturbed flow.  Our experiments also demonstrate that an increase in XBP1u can 
enhance the phosphorylation, and thereby activation, of Akt.  Indicating a potential 
positive feedback loop, whereby activated Akt increases the expression of XBP1u 
which in turns acts to promote the phosphorylation of Akt. 
 
3.4 HDAC3 interacts with XBP1u and is required for XBP1u-
mediated regulation of HO-1 expression and Akt phosphorylation 
 
 Our lab has demonstrated that HDAC3 is critical in EC survival and 
atherosclerosis development in response to disturbed flow (Zampetaki et al.).  En face 
staining of mouse aortas showed that HDAC3 expression is predominantly increased 
in the branching areas in vivo.  HDAC3 was also shown to be upregulated by 
disturbed flow and in turn upregulation of HDAC3 increased the phosphorylation of 
S473 of Akt.  Furthermore, Akt was found to bind HDAC3 and form a complex that 
localises to the cell membrane.  Finally knockdown of HDAC3 resulted in increased 
EC apoptosis in vitro and increased atherosclerotic development in aortic isografts 
(Zampetaki et al., 2010).  These functions were remarkably similar to those we 
determined for XBP1u.  Therefore, due to the similarities we observed between the 
role of XBP1u and HDAC3 in ECs we investigated the relationship between HDAC3 
and XBP1u.   
 
A second microarray experiment was performed by Dr. Anna Zampetaki, on 
samples subjected to the overexpression of HDAC3, through adenoviral transfer, for 
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24 and 72 hours.  A significant overlap (40-50%) in gene regulation was observed 
between in the gene expression pattern after XBP1u and HDAC3 overexpression (the 
HDAC3 microarray data cannot be shown in this thesis).  Due to these studies our 
investigation focused on a potential interaction between XBP1u and HDAC3 
signalling pathways.  We hypothesised that HDAC3 is also crucial in the XBP1u-Akt-
HO-1 signalling pathway. 
 
3.4.1 XBP1u has no impact on the expression of HDAC3 
 
 To determine if XBP1u can regulate the expression of HDAC3 exogenous 
XBP1u was overexpressed in HUVECs through the transduction of 10 MOI of Ad-
XBP1u adenovirus.  The protein was harvested after 24 and 48 hours and the 
expression of HDAC3 was detected by Western blotting (figure 40).  Overexpression 




















































Figure 40: XBP1u has no effect on HDAC3 protein expression. 
HUVECs were transduced with 10 MOI of Ad-Null or Ad-XBP1u adenoviruses.  The protein was 
harvested 24 and 48 hours post-transduction.  A. The expression of HDAC3 was assessed by Western 
blotting.  B. The histogram depicts the effect of exogenous XBP1u overexpression on HDAC3 at the 
protein level. It depicts the mean and standard deviation of. three independent experiments. 
 
 To determine if the expression of XBP1u is required for basal HDAC3 
expression the expression of XBP1 was knocked down by transducing HUVECs with 
100 TU / cell of shRNA-XBP1 alongside a null shRNA-NT control.  The protein was 
harvested after 72 hours and the expression of HDAC3 was determined by Western 
blotting (figure 41).  Knockdown of XBP1 has no significant effect on the expression 
of HDAC3 at the protein level.  These data demonstrate that XBP1u does not 

















































Figure 41: Knockdown of XBP1 has no effect on HDAC3 protein level. 
A. HUVECs were transduced with 100 TU / cell of shRNA-NT and shRNA-XBP1 lentivirus.  The 
protein was harvested 72 hours post-transduction and the expression of HDAC3, XBP1u, XBP1s and 
GAPDH was determined by Western Blotting.  The images are representative of three independent 
experiments.  B. Densitometry analysis of the HDAC3 protein level. 
 
 Furthermore, we examined the expression of HDAC3 in endothelial sections 
of wild type and Tie2-Cre / XBP1
f/f 
mice.  Aortic sections were harvested and 
subjected to immunostaining with CD31 and HDAC3 antibodies (figure 42).  HDAC3 
is expressed in ECs in specific subcellular locations within the cytoplasm; around the 
nucleus and at the cell membrane.  There was no difference observed between the 









Figure 42: HDAC3 levels are normal in XBP1-null ECs. 
Aorta sections from wild type and Tie2-Cre / XBP1
f/f 
mice were harvested for en face immunostaining.  
ECs were double-immunostained with HDAC3 and CD31 antibodies and then stained with DAPI to 
identify the nuclei.  Scale bar = 20 μm.  These images are representative of three experiments 
performed on aortic segments taken from three independent mice for each genotype. 
 
3.4.2 HDAC3 is transiently increased by disturbed flow 
 
 Our data has linked the expression of XBP1u and HO-1 to disturbed flow.  To 
investigate the influence of disturbed flow on HDAC3, HUVECs were exposed to 
disturbed flow for 0, 1, 2, 4, 8 and 24 hours.  The expression of HDAC3 protein was 
determined by Western blotting (figure 43).  The expression of HDAC3 at the protein 
level was transiently increased by disturbed flow between 1 and 8 hours.  This 
confirms the previous experiments performed in our lab demonstrating that a transient 


























































Figure 43: Disturbed flow transiently increases HDAC3 at the protein level. 
A. HUVECs were subjected to static or disturbed flow for 0, 1, 2, 4, 8 and 24 hours.  The protein was 
subsequently harvested and the expression of HDAC3 was assessed by Western blotting.  The images 
are representative of three independent experiments. B. Densitometry analysis of HDAC3 expression. 
** P < 0.01. 
3.4.3 Knockdown of XBP1 prevents the stabilisation of HDAC3 by disturbed 
flow 
 
 The expression of XBP1u and HDAC3 is enhanced by disturbed flow and 
XBP1u has no effect on the basal HDAC3 expression.  We hypothesised that XBP1u 
could stabilise HDAC3 protein during disturbed flow.  To this end, XBP1 was 
knocked down in HUVECs using a lentiviral vector and then subjected to disturbed 
flow.  The protein was harvested and the expression of HDAC3 and XBP1 was 
determined by Western blotting (figure 44).  Disturbed flow enhances XBP1u, XBP1s 
and HDAC3 at the protein level.  However, after knockdown of XBP1, disturbed flow 
is no longer able to induce an increase in HDAC3.  This data demonstrates that XBP1 


















































Figure 44: Knockdown of XBP1 abolishes disturbed flow-induced upregulation of HDAC3. 
A. HUVECs were subjected to static or 4.5dyn/cm
2
 disturbed flow stress for 8 hours.  The protein was 
then harvested and the level of HDAC3, XBP1u, XBP1s and GAPDH was assessed by Western 
blotting.  The images are representative of three independent experiments.  B. Densitometry analysis of 
HDAC3 protein expression. 
 
 
3.4.4 Disturbed flow-mediated upregulation of XBP1u and HDAC3 is abrogated 





 XBP1u and HDAC3 are both upregulated by disturbed flow, but how?  
Having shown that Akt is also activated by disturbed flow we were interesting in 
determining the mechanism of activation.  VEGFR2, PI-3-kinase and MEK1 have all 
been shown to activate, or respond to, Akt phosphorylation in ECs (Bozulic and 
Hemmings, 2009; Duronio, 2008; Olsson et al., 2006).  HUVECs were treated with 
DMSO, 5μM SU4098, 10μM PD98059 (a MEK1 inhibitor) or 5μM LY294002 for 6 
hours, prior to their exposure to disturbed flow for 8 hours.  The protein was 
harvested and the expression of HDAC3 and XBP1u was determined by Western 
blotting (figure 45).  The inhibition of MEK1 has no effect on disturbed flow-
mediated upregulation of HDAC3 and XBP1u.  However, when VEGFR2 and PI-3-
kinase are inhibited, disturbed flow is unable to upregulate the expression of HDAC3 
or XBP1u.  These data demonstrate that disturbed flow must acts through VEGFR2 

























Figure 45: Disturbed flow-mediated upregulation of XBP1u and HDAC3 is abrogated by 
inhibition of VEGFR2 and PI-3-Kinase. 
A. HUVECs were subjected to 8 hours of 4.5 dyn / cm
2
 disturbed flow after a 6 hour pre-treatment with 
DMSO, 5μM SU4098, 10μM PD98059 or 5μM LY294002.  The protein was harvested and the 
expression of HDAC3, XBP1u and GAPDH was assessed by Western blotting.  The images are 
representative of three independent experiments.  B. and C. Densitometry analysis of HDAC3 and 











































































































3.4.5 Knockdown of HDAC3 ablated XBP1u-mediated Akt phosphorylation and 
HO-1 expression 
 
 How do HDAC3 and XBP1u interact?  We hypothesised that HDAC3 was 
necessary for XBP1u-mediated activation of Akt phosphorylation or HO-1 expression.  
HDAC3 was knocked down using an shRNA particle targeted against HDAC3 
mRNA (shRNA-HDAC3).  HUVECs were treated shRNA-HDAC3 alongside a non-
targeting shRNA control.  After 48 hours the HUVECs were transduced with 10 MOI 
of Ad-XBP1u adenovirus and the protein was harvested a further 48 hours later for 
examination by Western blotting (figure 46).  The efficiency of HDAC3 knockdown 
was very effective (approximately 95%).  The overexpression of XBP1u resulted in 
increased phosphorylation of Akt at S473 and HO-1 protein levels, but had no impact 
on Akt or HDAC3 levels.  After knockdown of HDAC3, overexpression of XBP1u 
was only partially able to induce the phosphorylation of Akt-S473 and HO-1 
expression.  In the presence of HDAC3, XBP1u resulted in a 7-fold increase in HO-1 
expression and a 6-fold increase in Akt-S473 phosphorylation.  In the absence of 
HDAC3, XBP1u was only able to induce 2-fold increase in HO-1 expression and a 3-
fold increase in Akt-S473 phosphorylation.  These data demonstrate that HDAC3 is 


























































































Figure 46: XBP1u-mediated induction of HO-1 expression and phosphorylation of Akt-S473 is 
inhibited by knockdown of HDAC3. 
HUVECs were transduced with 100 TU / cell of shRNA-NT and shRNA-HDAC3 lentivirus and then 
again with 10MOI of Ad-Null or Ad-XBP1u adenovirus 48 hours post-transduction.  A. The protein 
was harvested 48 hours after the second transduction for Western Blotting of phosphorylated S473-Akt, 
Akt, HDAC3, HO-1 and XBP1u (FLAG) expression.  Densitometry analysis was performed on the 
protein expression of (B) HO-1 and (C) pAkt-S473 to determine relative protein expression changes.  
The images are representative and the histogram depicts mean and standard deviation of three 





3.4.6 XBP1u and HDAC3 physically interact 
 
 We have demonstrated that XBP1u and HDAC3 play a very similar role in 
ECs.  Firstly, overexpression of both XBP1u and HDAC3 is sufficient to induce Akt-
S473 phosphorylation.  Secondly, overexpression of XBP1u and HDAC3 results in 
very similar changes to gene expression patterns.  Finally, XBP1u and HDAC3 are 
both induced by disturbed flow; however neither protein influences the expression of 
the other.  We hypothesised that HDAC3 and XBP1u physically interact and that this 
interaction might activate signalling pathways involving Akt.  Several XBP1u and 
HDAC3 expression constructs were created to aid these studies (figure 47A, 47C, 
48A and 49A). 
 
 Initially HA-tagged XBP1u and Flag-tagged HDAC3 were overexpressed in 
HUVECs through FUGENE-mediated transfection.  The protein was harvested 72 
hours after transfection and protein was immunoprecipitated with anti-HA agarose 
beads.  The presence of HDAC3 (Flag) and XBP1u (HA) was detected by Western 
blotting (figure 47B).  Flag-tagged HDAC3 was able to bind to XBP1u and interact 
within HUVECs. 
 
This experiment was repeated using Flag-tagged HDAC3, Flag-tagged XBP1u, 
anti-HDAC3 agarose beads and anti-Flag agarose beads.  Both Flag-tagged HDAC3 
and XBP1u were transfected into HUVECs.  The protein was harvested after 72 hours.  
The sample was then incubated with anti-Flag conjugated agarose beads and anti-
HDAC3 conjugated agarose beads.  The control is performed using agarose beads 
conjugated to an anti-IgG antibody.  The proteins were then eluted and the presence of 
HDAC3 and XBP1u (Flag) was detected by Western blotting (figure 47D).  These 







Figure 47: XBP1u interacts with HDAC3. 
The interaction between XBP1u and HDAC3 was assessed through co-immunoprecipitation of the 
protein.  A. Schematic diagram of the transfected XBP1u and HDAC3 proteins with their attached N-
terminal tags.  B. HUVECs were transfected with 1.5μg pShuttle2-HDAC3-FLAG and 1.5μg 
pShuttle2-XBP1u-HA vectors.  The protein was harvested for co-immunoprecipitation 72 hours after 
transfection.  The protein sample was precipitated with anti-HA agarose beads.  The attached proteins 
were then eluted from the beads and XBP1u and HDAC3 were detected by Western blotting.  C. 
Schematic diagram of the transfected XBP1u and HDAC3 proteins with their attached N-terminal tags.  
D. HUVECs were transfected with 1.5μg pShuttle2-HDAC3-FLAG and 1.5μg pShuttle2-XBP1u-
FLAG vectors.  The protein was harvested for co-immunoprecipitation 72 hours after transfection.  The 
protein sample was precipitated with anti-HDAC3 and anti-FLAG agarose beads.  The attached 











Having identified that XBP1u and HDAC3 are able to interact, we attempted 
to determine the HDAC3 domain responsible for the interaction.  Previously our lab 
has demonstrated that HDAC3 interacts with Akt through residues 136-206 of 
HDAC3 (Zampetaki et al., 2010).  We cloned two N-terminal and three C-terminal 
HDAC3 deletion mutations.  These were Flag-tagged at the N-terminus and co-
transfected with HA-tagged XBP1u (figure 48A).  Immunoprecipitation experiments 
were performed using anti-HA conjugated agarose beads to collect XBP1u from the 
sample.  Western blots were then performed with antibodies targeted against the Flag 
tag, to detect the HDAC3 mutations and the HA-tag to detect XBP1u (figure 48B).  
Both HDAC3 N-terminal deletion constructs (HD3C1 and HD3C2) were able to 
interact normally with XBP1u.  Of the C-terminal deletion constructs, only the largest 
C- (HD3N3) was able to interact with XBP1u.  Therefore residues 201-323 are crucial 
in mediating the interaction between HDAC3 and XBP1u.  These results are very 
interesting as XBP1u interacts with HDAC3 through a completely different site on the 
HDAC3 protein.  There is therefore the possibility that XBP1u and Akt can interact 
with HDAC3 at the same time and possibly binding of one may promote or hinder the 
interaction of the other. 
 
3.4.7 HDAC3 interacts with Akt and this occurs in the presence of XBP1u 
 
 HDAC3 has already been identified to interact with Akt (Zampetaki et al., 
2010).  We sought to repeat this experiment and investigate the effect of XBP1u on 
this interaction.  HA-tagged HDAC3 was overexpressed in HUVECs and the protein 
was harvested, purified and incubated with anti-HDAC3 conjugated agarose beads.  
The proteins bound to the anti-HDAC3 antibody were eluted and the presence of 
HDAC3 and Akt was determined by Western blotting (figure 49A).  Akt was pulled 








Figure 48: XBP1u interacts with residues 131-206 of HDAC3. 
A. Schematic diagram of the HDAC3 deletion mutations and XBP1u and the attached N-terminal tags.  
B.  HUVECs were transfected with 1.5μg pShuttle2-HDAC3-FLAG (and mutation variants) and 1.5μg 
pShuttle2-XBP1u-HA vectors.  The protein was harvested for co-immunoprecipitation 72 hours after 
transfection.  The protein sample was precipitated with anti-HA agarose beads.  The attached proteins 
were then eluted from the beads and XBP1u (HA) and HDAC3 mutations (Flag) were detected by 






 To determine the effect of XBP1u on the interaction between HDAC3 and Akt 
we overexpressed XBP1u and looked to see if any differences were observed in the 
ability of Akt to bind HDAC3.  HA-tagged HDAC3 was transfected into HUVECs 
and then HUVECs were transduced with 10 MOI of Ad-XBP1u adenovirus.  After 48 
hours the protein was collected and co-immunoprecipitated with anti-HDAC3 
conjugated agarose beads.  The protein was eluted and the presence of HDAC3, Akt 
and XBP1u (Flag) was detected by Western blotting (figure 49B).  In the presence of 
XBP1u, HDAC3 still interacts with Akt.  We also found that XBP1u binds to HDAC3 
at the same time.  Therefore, HDAC3 is able to bind Akt and XBP1u and the 
overexpression of XBP1u does not inhibit the binding of Akt.  Indeed, there is also a 
slight indication that the presence of XBP1u might enhance the ability of Akt to 
interact with HDAC3, although this cannot be confirmed through this experiment. 
 
Our results have demonstrated that XBP1u is crucial in maintaining EC 
integrity and survival.  During disturbed flow XBP1u is upregulated and plays a 
critical role in stabilising HDAC3.  We demonstrate that XBP1u and HDAC3 enhance 
the phosphorylation, and thereby the activation, of Akt at S473.  Activated Akt 
induces the expression of HO-1 and XBP1u is also crucial for this.  Furthermore, 
XBP1u and Akt interact with HDAC3 and the overexpression of XBP1u does not 
complete with Akt for a binding site.  HDAC3 is crucial in XBP1u-mediated 
activation of Akt phosphorylation and HO-1 expression as this is prevented by 
ablation of HDAC3 expression.  We hypothesise that under disturbed flow conditions 
the expression (transcription and translation) of XBP1u is augmented.  XBP1u can 
then bind to HDAC3 and promote its stabilisation.  Akt is then recruited to HDAC3 
and undergoes phosphorylation activating downstream anti-apoptotic signalling 
pathways.  In particular we have demonstrated that Akt-mediated upregulation of HO-
1 requires XBP1u and that disturbed flow acts through VEGFR2 and PI-3-kinase to 
initiate the stabilisation of HDAC3 and augment the expression of XBP1u.  The blots 
have been modified as they have been performed alongside another experiment which 











Figure 49: HDAC3 interacts with Akt and XBP1u simultaneously. 
A. HUVECs were transfected with pShuttle2-HDAC3-HA plasmid.  The protein from the HUVECs 
was harvested 72 hours post-transfection.  The ability of HDAC3 to bind Akt was assessed by co-
immunoprecipitation using anti-HDAC3 agarose beads and subsequent Western blotting with HDAC3 
and Akt antibodies.  B. HUVECs were transfected with pShuttle2-HDAC3-HA plasmid.  They were 
then transduced with 10 MOI of Ad-XBP1u adenovirus.  The protein from the HUVECs was harvested 
72 hours post-transfection.  The ability of HDAC3 to bind Akt and XBP1u was assessed by co-
immunoprecipitation using anti-HDAC3 agarose beads and subsequent Western blotting with HDAC3, 
Akt and FLAG (XBP1u) antibodies.  The images have been cropped from an original single Western 










3.5 XBP1 promotes EC migration 
 
 Microarray analysis of gene expression pattern alterations after overexpression 
of XBP1u demonstrated that several genes related to cell migration were affected 
(figure 18A, 18C and 18D).  It was also apparent that overexpression of XBP1u 
influences the alignment and morphology of HUVECs under standard conditions 
(figure 13A).  We hypothesised that XBP1u influences cell pathways involved in 
attachment and movement.  Therefore the role of both isoforms of XBP1 in EC 
migration was investigated. 
 
3.5.1 XBP1u influences HUVEC morphology 
 
 We have demonstrated that overexpression of XBP1u results in a ‘healtheir’ 
EC phenotype.  The effect of XBP1 knockdown on HUVEC morphology was 
investigated after treating HUVECs with shRNA-XBP1 lentiviral constructs.  The 
morphology of the cells was determined 72 hours after transduction via light 
microscopy (figure 50B).  Overexpression of XBP1u elongates the appearance of the 
EC monolayer.  After knockdown of XBP1 the ECs again have a more elongated 
morphology.  These cells also appeared to be larger and demonstrated increased 
directionality.  The cell number and size of HUVECs transduced with shRNA-XBP1 
as compared to shRNA-NT transduced control cells was determined (figure 50C-D).  
These data demonstrate that knockdown of XBP1 creates an altered EC morphology 





Figure 50: Overexpression and knockdown of XBP1 influence HUVEC morphology and cell 
number. 
A. HUVECs were transduced with 10 MOI of Ad-Null or Ad-XBP1u adenoviral vectors and observed 
under a light microscope 48 hours post-transduction.  B. HUVECs were transduced with 100 TU / cell 
of shRNA-NT and shRNA-XBP1 lentivirus.  48 hours post-transduction the HUVECs were observed 
and pictures were taken through a light microscope.  The (C) cell number and (D) cell size were 
calculated after knockdown of XBP1.  The images and data are representative of three independent 























































3.5.2 Overexpression of XBP1 increases the rate of HUVEC migration 
 
 To determine if XBP1 influences EC migration we performed wound healing 
assays.  HUVECs were transduced with 10 MOI of Ad-Null, Ad-XBP1u or Ad-
XBP1s adenoviruses.  The ability of HUVECs to migrate was calculated subsequent 
to transduction and wound formation (figure 51A).  The distance migrated was then 
calculated for each time point and treatment as compared against the distance covered 
by Ad-Null transduced cells migrating for 4 hours (figure 51B).  Overexpression of 
XBP1u and XBP1s increased the speed of EC migration by 20% after 4 hours.  A 
similar increase of 20% was observed after the cells were left to migrate for 8 hours.  
These data demonstrate that XBP1u and XBP1s significantly increase the speed of EC 
migration, particularly immediately after the wound has been created.  These 
experiments were repeated in low serum (2%) media to reduce the influence of cell 
proliferation on the results.  The data is not shown, but the same response was 
observed. 
 
3.5.3 Knockdown of XBP1 reduces the speed of EC migration 
 
 Overexpression of exogenous XBP1u and XBP1s increase the rate of EC 
migration.  Does knockdown of XBP1 also reduce the ability of HUVECs to migrate?  
HUVECs were transduced with shRNA-NT and shRNA-XBP1 lentiviruses and the 
ability of HUVECs to migrate was determined via wound healing assay (figure 52A).  
The relative speed of migration was calculated by comparing the area covered by 
HUVECs at the 4 and 8 hour time points with the area migrated by HUVECs 
transduced with shRNA-NT after 4 hours (figure 52B).  Knockdown of XBP1 
resulted in a 30-35% decrease in the speed of HUVEC migration.  This decrease was 
significant and implies that XBP1 promotes normal cell migration.  These 
experiments were repeated in low serum (2%) media to reduce the effects of cell 





















































Figure 51: Overexpression of XBP1u and XBP1s increases HUVEC migration. 
HUVECs were transduced with 10 MOI Ad-Null, Ad-XBP1u and Ad-XBP1s adenovirus.  (A) HUVEC 
migration was assessed at 4 and 8 hour time points by scratch assay, 24 hours post-transduction.  (B) 
The degree of HUVEC migration was determined relative to the migration of Ad-Null transduced cells 
after four hours.  The images are representative and the histogram shows the mean and standard 





















































Figure 52: Knockdown of XBP1 decreases HUVEC migration. 
HUVECs were transduced with 100 TU / cell of shRNA-NT and shRNA-XBP1 lentivirus.  (A) 
HUVEC migration was assessed at 4 and 8 hour time points by scratch assay, 72 hours post-
transduction.  (B) The degree of HUVEC migration was determined relative to the migration of 
shRNA-NT transduced cells after four hours.  The images are representative and the histogram shows 





3.5.4 Knockdown of IRE-1α reduces EC migration 
 
 Both isoforms of XBP1 appear to promote EC migration, although XBP1s 
appears to have a stronger effect.  EC migration promotes high levels of stress in the 
cellular environment and requires a morphological change between cell types (De 
Smet et al., 2009).  This requires the transcription of novel proteins and therefore 
there is the potential for the ER stress response to activate.  IRE-1α is crucial in 
mediating the conversion of XBP1u into XBP1s.  If the splicing process is crucial for 
EC migration then knock down of IRE-1α would adversely effect EC migration.  
HUVECs were transduced with shRNA-NT and shRNA-IRE-1α lentivirus.  The 
ability of HUVECs to migrate was subsequently assessed via wound healing assay 
(figure 53A).  The relative speed of migration was calculated by comparing the area 
covered by HUVECs at the 4 and 8 hour time points with the area migrated by 
HUVECs transduced with shRNA-NT after 4 hours (figure 53B).  Knock down of 
IRE-1α resulted in a significant (20%) decrease in the ability of HUVECs to migrate.  
This response was especially pronounced during the initial stages of migration.  These 
data demonstrate that XBP1, and the splicing of XBP1 in particular, is crucial for 
normal EC migration.  These experiments were repeated in low serum (2%) media to 
reduce the effects of cell proliferation on the results.  The data is not shown but the 















































Figure 53: Knockdown of IRE-1α decreases HUVEC migration. 
HUVECs were transduced with 100 TU / cell of shRNA-NT and shRNA-IRE1α lentivirus.  (A) 
HUVEC migration was assessed at 4 and 8 hour time points by scratch assay, 72 hours post-
transduction.  (B) The degree of HUVEC migration was determined relative to the migration of 
shRNA-NT transduced cells after the four hour time point.  The images are representative and the 





3.5.4 XBP1 splicing is enhanced during EC migration 
 
 We have demonstrated that XBP1 splicing is crucial for proper EC migration, 
which implies that the expression of XBP1s would be increased during migration.  To 
demonstrate this; HUVECs were induced to undergo migration and the expression of 
XBP1s was determined via Western blotting (figure 54).  To determine if XBP1 
splicing is enhanced during EC migration it was necessary to isolate ECs in a 
migratory phenotype.  Over 100 scratch assays were performed on the same confluent 
HUVEC monolayer in vitro.  Therefore, a large proportion of the ECs will be in a 
migratory phenotype in an attempt to close the gaps in the monolayer.  The HUVECs 
were harvested 0, 6 and 24 hours after scratch assay induction and the expression of 
XBP1s was determined.  The migration of ECs was assessed using microscopy.  The 
expression of XBP1s is significantly enhanced during EC migration. 
 
3.5.5 XBP1 does not influence eNOS expression or activity 
 
 Endothelial nitric oxide synthase (eNOS) plays a very important role in 
regulating vascular functions; from regulating vascular tone, to angiogenesis.  eNOS 
has also been shown to be crucial in regulating endothelial progenitor cell 
mobilisation and angiogenic properties (Everaert et al., 2010).  We were interested to 
see if XBP1 could influence the expression of eNOS and thereby regulate NO 
production.  HUVECs were transduced with Ad-Null or Ad-XBP1u adenovirus and 
the mRNA and protein was harvested 24, 48 and 72 hours post-transduction.  The 
expression of eNOS and XBP1u was determined by semi-quantitative PCR, real-time 
PCR and Western blotting (figure 55A-C).  There were no significant changes in 
eNOS expression after overexpression of exogenous XBP1u.  To determine the effect 
of XBP1 knockdown on eNOS expression HUVECs were transduced with shRNA-
NT or shRNA-XBP1 lentivirus.  The protein expression of eNOS and XBP1 was 
assessed 72 hours after transduction by Western blotting (figure 55D).  Knock down 
of XBP1 did not affect eNOS protein expression.  These data demonstrate that XBP1 
does not influence the expression of eNOS at the transcriptional or translational level. 
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We hypothesised that XBP1 may exert an effect on NO activity.  HUVECs 
were transduced with Ad-Null, Ad-XBP1u or Ad-XBP1s adenovirus and the level of 
nitrate in the supernatant was detected by ELISA (figure 56A).  There were no 
significant differences in nitrate production after XBP1u and XBP1s overexpression.  
Next, HUVECs were transduced with shRNA-NT, shRNA-XBP1 (figure 56B) and 
shRNA-IRE-1α (figure 56C) lentivirus.  There were no significant differences in 
nitrate production after knockdown of XBP1 or IRE-1α. To determine if NO 
production increases during EC migration HUVECs were induced to mass migrate via 
multiple scratch assays.  NO production was detected via ELISA 0, 4, 8 and 24 hours 
after the wound induction.  Migrating ECs produced more NO, although our previous 






Figure 54: XBP1 splicing is increased during HUVEC migration. 
A HUVEC monolayer was induced to migrate through creating multiple scratch wounds in the entire 
layer.  The level of XBP1s mRNA was assessed by (A) semi-quantitative PCR and (B) real-time PCR.  






































Figure 55: XBP1 has no effect on eNOS expression. 
A. HUVECs were transduced with 10 MOI of Ad-Null or Ad-XBP1u adenoviruses.  The mRNA and 
protein from the HUVECs was harvested 24, 48 and 72 (mRNA) hours post-transduction.  The 
expression of eNOS was assessed by (A) semi-quantitative PCR (B) real-time PCR and (C) Western 
blotting.  D. HUVECs were transduced with 100 TU / cell of shRNA-NT and shRNA-XBP1 lentivirus.  
Protein was harvested 72 hours post-transduction and the expression of eNOS, XBP1u, and GAPDH 
was determined by Western blotting.  The images and histogram depicts mean and standard deviation 


































































Figure 56: XBP1u and XBP1s do not influence the production of NO. 
A. HUVECs were transduced with 10 MOI Ad-Null, Ad-XBP1u or Ad-XBP1s adenoviral vectors.  The 
concentration of nitrate in the supernatant was detected via ELISA assay 48-hours post-transduction.  
The histograms depict mean and standard deviation of three independent experiments.  HUVECs were 
transduced with 100 TU / cell of shRNA-NT and (B) shRNA-XBP1 lentivirus or (C) shRNA-IRE-1α 
lentivirus.  The concentration of nitrate in the supernatant was detected via ELISA assay.  D. The level 
of nitrate was assessed 0, 4, 8 and 24 hours after the induction of migration via scratch assay in 




























3.5.6 XBP1 heterozygous CMECs migrate normally 
 
 We wanted to determine if knockdown of XBP1 in primary ECs reduced their 
ability to migrate.  We isolated wild type and XBP1 heterozygous coronary mouse 
ECs (CMECs) from 8-12 week old mice hearts.  CMECs were isolated alongside 
Simon Walker according to the protocol designed in Professor Shah’s (KCL, London) 
laboratory (Li et al., 2001).  The morphology of the CMECs after 48 hours in culture 
is shown in figure 57A.  The CMECs were characterised alongside Simon Walker and 
the expression of eNOS and CD31 was demonstrated in over 95% of the cells, whilst 
the expression of smooth muscle actin was absent (data not shown).  Wild type and 
heterozygous XBP1 CMECs were subjected to wound healing assays (figure 57B).  
There was no significant difference in the ability of wild type and XBP1 heterozygous 
CMECs to migrate.  It is impossible to compare CMECs from XBP1-null mice in this 
experiment as the global deletion of XBP1 is embryonic lethal.  We were therefore 
unable to determine the effect of XBP1-knockdown in these cells on migration.  In the 
case of the XBP1 heterozygous CMECs there remains one allele which contains a 
coding sequence for XBP1u, therefore in these cells it is possible that the quantity of 
XBP1u required in these cells is compensated for through increasing the activity of 
gene transcription at the remaining loci. 
 
3.5.7 XBP1-null cells migrate less efficiently 
 
 To determine if XBP1-null cells migrate less efficiently we used cells from 
wild type and XBP1-null embryos.  These cells are a mixed-population as described 
in the methods section.  The morphology of these cells is shown in figure 58A.  These 
cells were subjected to wound healing assays and the migration was characterised 
(figure 58B).  XBP1-null cells had a significant reduction in their ability to migrate 
than their wild type compatriots.  We have demonstrated that XBP1 is crucial for 
proper EC migration although the mechanism through which its effect is exerted 




3.5.8 Knockdown of XBP1 reduces EC migration and tube formation 
 
 To further confirm the role of XBP1 in EC migration Aortas from wild type 
and Tie2-Cre / XBP1
f/f 
mice were harvested and a 1-2mm ring segment was cut and 
cultured in vitro.  The aortic ring was placed on low growth factor matrigel which had 
been incubated at 37°C for 30 minutes to allow it to harden and form a basement layer.  
The ring was then cultured in growth media for 72 hours and the area of EC 
outgrowth was calculated (figure 59A, 59C).  The area was calculated by subtracting 
the area covered by endothelial cells from the total area of the matrigel basement.  
XBP1-null ECs were less able to migrate than their wild type counterparts. 
 
 One of the main functions of ECs is to form tubular structures.  We knocked 
down XBP1 and IRE-1α and then plated the HUVECs on a low-growth factor 
matrigel and observed their ability to form tubular structures.  Knock down of XBP1 
significantly reduced the ability of HUVECs to form tubular structures.  These data 

















Figure 57: The ability of wild type and XBP1 heterozygous CMECs to migrate is similar. 
A. The morphology of wild type and heterozygous CMECs.  B. CMECs were induced to undergo 
migration through a scratch assay.  The relative distance covered by wild type and heterozygous 
CMECs, after 4 hours of migration, was calculated and presented as a histogram.  The images and 












































Figure 58: XBP1-Null embryonic cells migrate slower than wild type cells. 
Embryonic day 13.5 embryos were removed from the mothers bred as XBP1 heterozygous crosses.  A. 
The morphology of wild type, heterozygous and XBP1-null cell populations.  C. The cells isolated 
from the embryo were cultured and the mRNA extracted for genotype analysis by semi-quantitative 
PCR.  B. The cells were also subjected to migration analysis by scratch assay for 4 and 8 hours, where 
the migration was determined relative to that obtained from wild type cells after 4 hours of migration.  
The histogram depicts mean and standard deviation of 3 independent experiments performed on each of 


































Figure 59: Knockdown of XBP1 reduces EC migration and tube formation. 
A. Ring outgrowth assay.  Aortas were harvested from wild type and Tie2-Cre / XBP1
f/f 
mice and ring 
sections were cut and grown in culture.  The outgrowth of ECs was determined after 24 hours.  B.  
Tube formation assay.  HUVECs were transduced with shRNA-NT, shRNA-XBP1 or shRNA-IRE-1α 
lentiviruses.  The HUVECs were then plated on low growth factor matrigel and tube formation was 
detected after 24 hours.  C. Analysis of ring growth assay, the area migrated has been calculated 
relative to the size of the image.  D.  Analysis of tube formation.  The tube count has been calculated as 
tubes per image.  The images and histograms depict mean and standard variation of 5 independent 

























































3.5.9 Knockdown of XBP1 reduces FAK expression 
 
FAK, is crucial in mediating the signalling pathways involved in the migration 
of tip cells at the start of angiogenesis, therefore we investigated the role of XBP1 in 
mediating its expression.  Endothelial sections from wild type and Tie2-Cre / XBP1
f/f 
mice were harvested and double immunofluorescence staining of CD31 and FAK was 
performed (figure 60).  Knockdown of XBP1 resulted in significant decreases in the 
detection of expressed FAK.  These data indicate that XBP1 may influence EC 
migration through mediating the FAK signalling pathway.  In order to fully confirm 
the effect of XBP1u on FAK expression future studies will focus on Western blotting 
studies and semi- and real-time PCR.  Negative staining controls were not performed 
therefore conclusions from this data are not as stringent as they could be.  In future all 




Figure 60: Knockdown of XBP1 reduces FAK expression. 
Artery sections from wild type and Tie2-Cre / XBP1
f/f 
mice were harvested and double immunostained 
for CD31 and FAK (or XBP1).  The images are representative of five independent experiments. 
  
We have demonstrated that XBP1 is crucial in mediating EC migration.  
Overexpression of XBP1 enhances the speed of migration, whilst knock down results 
in abrogated migration.  We have also shown that XBP1 may mediate these effects 







Chapter 4 - Discussion 
 
 In the present study, the requirement of XBP1u for the constitutive expression 
of HO-1 is reported.  We demonstrate that the expression of XBP1u is sufficient to 
induce the expression of HO-1 and the phosphorylation of Akt at serine 473.  This 
study also demonstrates that there is a requirement for the expression of XBP1u to 
promote HO-1 expression via Akt activation.  Furthermore, overexpression of XBP1u 
enhances the ability of ECs to survive under both normal and oxidative stress 
conditions, a state that is impaired through the loss of XBP1 expression.  XBP1u-
mediated induction of HO-1 expression is crucial for promoting EC survival under 
oxidative stress conditions. Moreover, the expression of XBP1u and HO-1 and the 
phosphorylation of Akt at serine 473 are enhanced in ECs under disturbed flow 
conditions.  The expression of XBP1u is crucial for mediating the disturbed flow-
induced upregulation of HO-1 expression and Akt phosphorylation at serine 473.  Our 
findings indicate that XBP1u is crucial in promoting EC survival during oxidative 
stress, through activation of Akt signalling pathways and expression of HO-1.  This 
study sheds new light on the mechanisms involved in protective signalling under flow 
and oxidative stress and provides evidence that XBP1u may be a novel target for 
therapeutic intervention in vascular disease. 
 
 This study has also identified a collaborative role between XBP1 and HDAC3.  
Knockdown of XBP1u prevents the disturbed flow-mediated upregulation of HDAC3, 
whilst knockdown of HDAC3 prevents XBP1u-mediated induction of Akt 
phosphorylation and HO-1 expression.  This study demonstrates that XBP1u and Akt 
physically interact with HDAC3 and that this interaction can occur simultaneously.  
These data identify novel HDAC3 binding partners, further enhancing our knowledge 
of the role of HDAC3 externally to the nucleus. 
 
 Furthermore, this study demonstrates a requirement for XBP1 in promoting 
EC migration.  The overexpression of XBP1u and XBP1s is sufficient to enhance the 
EC migration, whilst the knockdown of XBP1 and IRE-1α slows EC migration.  We 
demonstrate that XBP1 splicing is enhanced during the initial stages of EC migration.  
Moreover, the expression of XBP1 is crucial in mediating the migration of primary 
ECs and in promoting EC tube formation.  Our preliminary studies indicate that 
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XBP1-mediated regulation of FAK is responsible for mediating its effects on 
migration.  Our findings indicate that XBP1 is crucial for proper EC migration.  This 
data sheds new light on the mechanisms involved during the initial stages of 
angiogenesis and implicates XBP1 as a mediator of EC migration and integrity.  This 
study provides evidence that XBP1 may be a novel target for therapeutic intervention 
during vascular disease. 
 
4.1 XBP1 as a mediator of EC survival during shear stress 
 
 The study of ECs and their function is inherently complex due to the nature of 
their environment.  The human vasculature is a highly adaptable and mobile organ, 
which is subjected to a wide range of stresses.  One of the key features of ECs is their 
ability to sense and respond to shear stress.  The effect that shear stress exerts on ECs 
differs due to the location, pressure, direction and speed of the force detected.  ECs in 
linear regions of the vasculature are exposed to strong, pulsatile, unidirectional shear 
stress.  ECs exposed to high time-averaged, unidirectional shear stress are less 
susceptible to EC apoptosis and atherosclerosis (Cheng et al., 2006; Kadohama et al., 
2007).  The protective response of ECs to normal blood flow is predicted to involve 
mechanoreceptors, which transmit signals across the cell membrane, inducing gene 
transcription (Chien, 2008a, b; Johnson et al., 2011).  Laminar flow also induces the 
expression of antioxidant molecules, such as peroxiredoxin, which reduce the 
oxidative stress in the endothelium (Mowbray et al., 2008).  In contrast, regions of the 
endothelium that experience low time-averaged shear stress and oscillatory or 
disturbed flow have only transient activation of these protective signalling pathways 
and are more susceptible to apoptosis and atherosclerotic lesion formation (Tricot et 
al., 2000; White et al., 2001).  Importantly, the variations in shear stress promote 
different outcomes in ECs.  Low shear stress and oscillatory shear stress are both 
associated with atherosclerotic lesion formation, however only low shear stress was 
associated with inflammatory responses and correlated with the likelihood of lesion 
rupture (Cheng et al., 2006).  Disturbed flow has also been implicated in promoting 
oxidative stress through the promotion of ROS via upregulation and activation of 
NADPH oxidase (Hwang et al., 2003a; Hwang et al., 2003b).  Increased production of 
ROS also reduces the bioavailability of NO, an atheroprotective molecule, through 
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incorporation as peroxynitrate, further exacerbating oxidative stress (Harrison et al., 
2006).  Disturbed flow and sustained production of ROS can result in EC apoptosis 
(Tricot et al., 2000).  Hydrogen peroxide is commonly used to study oxidative stress-
induced apoptosis, due to its ability to permeate aqueous and lipid environments.  
Oxidative stress induces apoptosis through caspase-3 activation, upregulation of p53 
and sustained activation of JNK MAP kinase pathway signalling (Cook et al., 1999; 
Purdom and Chen, 2005).  Oxidative stress can induce apoptosis and increase EC 
turnover and lipid deposition, leading to a greater risk of atherogenesis.  The 
expression and activation of many atheroprotective and atherogenic genes has been 
linked to flow patterns (Dekker et al., 2006; Dekker et al., 2002; Dekker et al., 2005; 
Surapisitchat et al., 2001). 
 
 In this study, we explored the role of XBP1 in the vascular system.  Previous 
studies have demonstrated that the expression of XBP1 in ECs during the ER stress 
response mediates vascular inflammation and EC dysfunction during atherosclerosis 
development (Gargalovic et al., 2006).   We were curious to clarify the role of XBP1 
in maintaining EC integrity and atherosclerotic lesion formation.  Our studies 
demonstrate that the expression of XBP1 is intricately linked to flow pattern.  Very 
little XBP1 was detected in ECs comprising linear regions of the vasculature.  In 
contrast, XBP1 was highly expressed in bifurcation regions, subjected to disturbed 
flow, and around atherosclerotic lesions, which also create altered flow patterns.  
XBP1 has been shown to be ubiquitously expressed; however our data is the first to 
link the expression of XBP1 to shear stress (Clauss et al., 1993).  To clarify the role of 
flow in the expression of XBP1u we used an in vitro disturbed flow model.  Our flow 
model results in reduced, oscillatory time-averaged shear stress, although the range of 
shear stress experienced by individual ECs can range from 0 to 20 dyn/cm
2
.  Other 
methods that can be used to study the effects of disturbed flow in vitro include the 
step-flow chamber that allows a comparison between disturbed and laminar flow 
(Chien, 2008a).  Our model of disturbed flow was used as it is easy to replicate the 
identical conditions for multiple experiments and the equipment is more widely 
available.  Disturbed flow resulted in transient increases to XBP1s expression and a 
stable increase in the expression of XBP1u.  Our studies previously identified that 
chronic expression of XBP1s results in EC apoptosis and atherosclerotic lesion 
formation (Zeng et al., 2009).  These studies also demonstrated that laminar flow only 
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induced a transient activation of XBP1u expression.  These results correlate as the 
onset of laminar flow is sensed by ECs as disturbed flow, as it is an environmental 
state to which they have not adapted.  Combined, these data demonstrate that XBP1u 
is uniquely upregulated by disturbed flow conditions. 
 
 The role of XBP1u in cells remains poorly defined, although a functional role 
has previously been computationally predicted (Nekrutenko and He, 2006).  However, 
a recent study demonstrated that XBP1u acts as a negative regulator of XBP1s 
(Yoshida et al., 2006).  In an elegant series of experiments it was demonstrated that 
the expression of XBP1u is increased during the recovery phase, after ER stress has 
been ablated.  Using XBP1u mutation constructs it was determined that XBP1u 
contains a conventional nuclear export signal and can shuttle between the nucleus and 
the cytoplasm.  It was subsequently demonstrated that XBP1u and XBP1s form a 
complex that localises to the cytoplasm.  This complex is targeted for proteosome-
mediated degradation by the degradation domain present on XBP1u (Yoshida et al., 
2006).  We have also confirmed that XBP1u prevents EC apoptosis through targeted 
degradation of XBP1s.  However, our data also demonstrates that XBP1u is functional 
in its own right and promotes EC survival.  Knockdown of XBP1 was sufficient to 
reduce EC survival under normal culture conditions.  Furthermore, overexpression of 
XBP1u increased the ability of ECs to survive under oxidative stress conditions.  
These data imply that the balance between XBP1u and XBP1s is altered by differing 
flow conditions and the acute overexpression of XBP1u during the initial stages of 
disturbed flow promotes EC survival.  However, sustained stimulation by disturbed 
flow enhances XBP1 splicing resulting in EC apoptosis (figure 61).  EC survival was 
assessed via MTS tetrazolium assay.  This assay calculates cell number based on the 
detection of metabolically active and therefore viable cells.  Secondly, viable ECs 
were identified via TUNEL assay, where the terminal ends of nucleic acids, which 
occur more frequently during apoptosis, are identified via the addition of labelled 
dUTP molecules.  The role of XBP1 in cell survival was investigated for several 
reasons.  Sustained overexpression of XBP1s resulted in EC apoptosis and 
atherosclerotic lesion formation.   XBP1 was also demonstrated to promote cell 
survival during hypoxia in a tumour microenvironment (Koong et al., 2006).  We 





Figure 61: Schematic diagram depicting the influence of shear stress, XBP1u and XBP1s on EC 
survival and apoptosis. 
Laminar flow reduces ROS generation and promotes EC quiescence and survival.  Disturbed flow 
induces ROS generation which in turn promotes EC apoptosis and atherosclerotic lesion formation.  
Prolonged overexpression of XBP1s promotes EC apoptosis through caspase activation.  
Overexpression of XBP1u promotes EC survival and reduces ROS-mediated EC apoptosis. 
 
4.2 XBP1u enhances EC survival through Akt and HO-1 
 
 Microarray analysis of genes regulated by XBP1u overexpression identified 
several target genes that could be responsible for mediating the protection of ECs 
against oxidative stress.  HO-1 was identified as a prime target for further analysis.  
HO-1 catalyses the enzymatic conversion of haem into biliverdin, iron and carbon 
monoxide.  The products of haem degradation have all been demonstrated to initiate 
or perform anti-apoptotic or antioxidant functions.  HO-1 induces the export of iron 
from the cell and formation of ferritin, which neutralises the reactive iron and reduces 
apoptosis.  Iron has also been shown to activate NF-κB which initiates anti-apoptotic 
signalling (Choi et al., 2004).  Biliverdin protects against apoptosis through an 
antioxidant mechanism by scavenging ROS.  Recent studies have demonstrated a role 
for CO in many cell signalling events (Kaczorowski and Zuckerbraun, 2007).  CO 
inhibits TNFα-mediated apoptosis in mouse ECs through activation of MKK3 and 
p38 MAPK (Brouard et al., 2000).  CO has a direct role in anti-inflammatory 
signalling by inhibiting cytokine-mediated apoptosis.  HO-1 is upregulated during 
laminar flow in response to Nrf2 activation.  One of the main regulators of Nrf2 is NO; 
however, the upregulation of HO-1 is independent of eNOS (Warabi et al., 2007). 
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 These studies demonstrate for the first time that XBP1u enhances the 
expression of HO-1 at both the mRNA and protein level.  We demonstrate that the 
upregulation of HO-1 is uniquely activated by XBP1u and does not require the 
activation of the ER stress response.  Knockdown of XBP1 and the subsequent loss of 
HO-1 expression imply that XBP1u is required for the basal expression of HO-1.  
These studies imply that the expression of XBP1u is crucial for HO-1 expression.  
HO-1 expression is under the control of multiple enhancer elements, these include 
NF-κB, AP-1, BVR, Nrf2, CREB and ATF2 (Kim et al., 2011).  The expression of 
HO-1 has previously been shown to protect ECs from apoptosis, regulate vascular 
tone, attenuate the inflammatory response and participates in angiogenesis and 
vasculogenesis (Morsi et al., 2006; Otterbein et al., 2003a; Otterbein et al., 2003b).  
Together these studies suggest that HO-1 is a perfect candidate to mediate XBP1u-
dependent protection of ECs. 
 
 The total XBP1 knockout mouse is embryonic lethal, therefore we were 
unable to study the effects of XBP1 knockdown exclusively in the vascular system.  
To further our studies we developed a conditional XBP1 knockout mouse.  The 
ablation of XBP1 expression is dependent upon the expression of Cre recombinase, 
which we have linked to the Tie2 promoter.  Tie2 was initially identified as a specific 
vascular growth factor that governed several properties of ECs.  However, Tie2 has 
more recently been identified to maintain the quiescent status of haematopoietic stem 
cells in the bone marrow and it is expressed outside the vascular compartment in 
several cancers (Martin et al., 2008).  Tie2-expressing monocytes have also been 
identified which promote tumour angiogenesis and growth in mouse models (De 
Palma et al., 2003; Venneri et al., 2007).  Therefore, although XBP1 is not exclusively 
knocked out in ECs, there are very few other cell types and functions that will be 
affected by this deletion.  Our studies demonstrated that the expression of HO-1 was 
not ablated in XBP1-null ECs.  These contrasts with our in vitro data that implies 
XBP1 is essential for HO-1 expression.  It is likely that XBP1 is sufficient to induce 
the expression of HO-1; however, in vivo compensatory mechanisms may be activated 
to promote adequate HO-1 expression. 
 
 Our in vitro data demonstrates that XBP1u can enhance the expression of HO-
1 at the mRNA and protein level.  As XBP1u contains a functional DNA-binding 
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domain we hypothesised that XBP1u might directly activate the transcription of HO-1 
by binding to the HO-1 promoter.  After cloning the HO-1 promoter into a luciferase 
reporter vector and subsequent overexpression of XBP1u, we did not detect any 
activity from the HO-1 promoter.  This suggests that XBP1u does not bind directly to 
the HO-1 promoter but may induce its activity in an indirect manner.  Furthermore, 
the cloning of the HO-1 promoter may have modified the structural requirements for 
XBP1u binding. 
 
 XBP1u is upregulated in regions of disturbed flow and can enhance the ability 
of ECs to survive during oxidative stress and increases the expression of HO-1.  We 
hypothesised that XBP1u promotes EC survival during oxidative stress, which can be 
induced by disturbed flow, through the activation of HO-1 expression.  Although we 
do not demonstrate that our model of disturbed flow induces oxidative stress, this has 
been extensively determined previously (De Keulenaer et al., 1998; Laurindo et al., 
1994; Nigro et al., 2011).  Our data confirms that the expression of HO-1, as well as 
XBP1u, is enhanced during disturbed flow.  The upregulation of HO-1 and XBP1u is 
transcriptionally and translationally dependent.  The expression of HO-1 has already 
been linked with shear stress patterns.  Pulsatile, laminar flow of 19 dynes / cm
2
 
increased the expression of KLF2 and Nrf2, a key promoter of HO-1 expression 
(Fledderus et al., 2008).  In contrast to our data a report has been published stating 
that whilst laminar flow enhances the expression of HO-1, disturbed flow impairs the 
activation of HO-1 expression (Ali et al., 2009).  However, when compared in 
isolation their data is remarkably similar to our own.  When HUVECs under disturbed 
flow conditions for 24 hours are compared to HUVECs under static conditions they 
show a 3 fold induction in the expression of HO-1 mRNA.  In our hands the exposure 
of HUVECs to disturbed flow for 24 hours results in a 2-fold increase in HO-1 at the 
mRNA level and a significant 2-fold increase in the protein level of HO-1.  Their 
disturbed flow conditions of +/- 5 dynes / cm
2
 are similar to our conditions of 4.5 
dynes / cm
2
.  However, they show that laminar shear stress further enhances the 
expression of HO-1 and that the upregulation of HO-1 under disturbed flow is due to 
intermittent activation of the upstream signalling pathway.  We hypothesise that two 
separate signalling pathways are activated; one occurs under laminar shear stress 
conditions; whilst the second is activated in response to disturbed flow to attempt to 
mitigate against oxidative stress.  This second pathway involves the activation of 
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XBP1u expression.  Evidence for distinct pathways activated by disturbed flow, in 
comparison to static controls and laminar flow, has previously been suggested.  ECs 
exposed to disturbed flow exhibit increased levels of localised NF-κB, c-Jun and c-fos 
in their nuclei (Nagel et al., 1999).  Moreover, knock down of XBP1 prior to the 
induction of disturbed flow demonstrates that XBP1u is required for shear stress-
mediated upregulation of HO-1.  This is the first time that XBP1u has been identified 
as a shear stress mediated factor. 
 
 In the present study, we have used SnPPIX to inhibit HO-1 and determine if 
this impairs the ability of XBP1u to promote EC survival.  Indeed, inhibition of HO-1 
completely abolished the protective effect of XBP1u on ECs.  In accordance with 
these results XBP1u has previously been shown to prevent oxidative stress in mouse 
embryonic fibroblast (MEF) cells (Liu et al., 2009).  It was demonstrated that XBP1-
null cells were more sensitive to a loss in mitochondrial membrane potential and 
subsequent cell death after the application of hydrogen peroxide.  In these studies the 
MEFs were treated with 1 mM hydrogen peroxide for 12 hours as opposed to our 
experiments where the HUVECs were treated with 50 μM hydrogen peroxide for 24 
hours, which reflects the different abilities of these cells to deal with oxidative stress.  
Furthermore, in XBP1-deficeint cells there was a greater increase in ROS production 
after hydrogen peroxide treatment and the expression of several antioxidant enzymes 
was lower, including catalase.  It was demonstrated that XBP1u enhances the 
expression of catalase through the CCAAT box present in the catalase promoter.  
Moreover, it was demonstrated that knockdown of XBP1 ablated catalase expression 
and enhanced ROS generation.  These effects were reversed upon the addition of 
exogenous XBP1u. 
 
These results, combined with our data indicate a protective role of XBP1 
against oxidative stress.  The positive regulation of catalase and HO-1 may account 
for part of this function.  These results indicate that XBP1u is a crucial mediator of 




Figure 62: Schematic diagram depicting the influence of disturbed flow shear stress on XBP1u, 
HO-1 and EC survival and apoptosis. 
1. Disturbed flow induces the formation of an apoptotic, atheroprone phenotype in ECs that results in 
EC apoptosis.  One of the mechanisms that induces EC apoptosis is increased oxidative stress.  2. To 
promote EC survival, disturbed flow enhances the expression of both XBP1u and HO-1.  The 
expression of HO-1 is dependent on the presence of XBP1.  The expression of HO-1 promotes a non-
apoptotic EC phenotype and promotes EC survival.  Presumably a balance in XBP1u expression is in 
operation, potentially the sustained stimulation with disturbed flow will result in levels of oxidative 
stress that an upregulation of XBP1u is insufficient to deal with. 
 
 Having determined that XBP1u does not directly enhance the expression of 
HO-1 through interactions with its promoter region we searched for other candidates.  
Akt is a known activator of HO-1 expression.  We hypothesised that XBP1u may 
enhance the phosphorylation of Akt and thereby enhance the expression of HO-1.  
Akt regulates essential cellular functions such as migration, proliferation, apoptosis 
and metabolism. Akt is a serine/threonine kinase activated by PI-3-kinase signalling.  
Activated PI-3-kinase mediates the conversion of phosphatidylinositol-4,5-
bisphosphate into phosphatidylinositol-3,4,5-trisphosphate (PIP3).  PIP3 recruits 
PDK1 and Akt to the membrane through their plekstrin homology domains.  PDK1 is 
a known activator of Akt, which then translocates to subcellular compartments where 
it phosphorylates substrates and interacts with binding partners (Cantley, 2002).  For 
example, Akt-mediated phosphorylation of the apoptotic factor Bad, allows 
recruitment of 14-3-3 proteins, preventing the interaction of Bad with Bcl-2.  
Phosphorylation of Bad and the subsequent release of Bcl-2 prevents cell death 
induced by various stimuli, including hydrogen peroxide (Aikawa et al., 2000).  Akt 
phosphorylation occurs at threonine 308, which is present in the activation domain 
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and at serine 473, in the carboxyl terminus.  Phosphorylation of both sites contributes 
towards Akt activation (Alessi et al., 1996).  Akt phosphorylated at T308 alone is only 
10% as active as the fully phosphorylated form (O'Neill et al., 2012).  
Phosphorylation of Akt at S473 stabilises the active conformation and allows for full 
Akt activation (O'Neill et al., 2012). 
 
 In this study, we demonstrated that exogenous overexpression of XBP1u 
resulted in the enhanced phosphorylation of Akt at serine 473, but had no effect either 
on the expression level of Akt or the phosphorylation of Akt at threonine 308.  
Furthermore XBP1u promoted the accumulation of phosphorylated Akt at the cell 
membrane.  The presence of XBP1 is crucial for basal Akt phosphorylation at serine 
473, as knock down of XBP1 abolishes Akt phosphorylation under normal conditions.  
Previously XBP1u has not been linked to the activation of Akt phosphorylation.  
Indeed, inhibition of XBP1 splicing has been shown to have no effect on Akt 
phosphorylation induced by subtilase cytotoxin (Yamazaki et al., 2009).  However, 
we are the first to look at the effect of XBP1u on the phosphorylation status of Akt. 
 
 Using inhibitors of PI-3-kinase and VEGFR2 activity we demonstrated that 
XBP1u enhances the phosphorylation of Akt independently to this classical pathway.  
We used the pan-PI-3-kinase inhibitor LY294002, which can also cross-react with PI-
3-kinase related kinase such as mTOR and DNA-dependent protein kinases.  There 
are also problems with its solubility and high toxicity due to its ability to target a 
broad range of PI-3-kinase-related enzymes (Marone et al., 2008).  The general 
consensus is that Akt activation requires recruitment to the cell membrane via 
activation of PI-3-kinase (Polak and Buitenhuis, 2012).  However, several recent 
studies have identified several kinases that can activate Akt independently of PI-3-
kinase.  These include the tyrosine kinases; Ack1, Src and PTK6 and the serine / 
threonine kinases; TBK1, IKBKE and DNAPKcs.  These kinases activate Akt and 
promote its pro-proliferative signalling functions (Mahajan and Mahajan, 2012).  
These data imply that XBP1u promotes the phosphorylation of Akt through activation 
of a PI-3-kinase independent mechanism. 
 
 Our studies demonstrated that the activation of Akt phosphorylation was not 
ablated in XBP1-null ECs.  These contrasts with our in vitro data that implies XBP1u 
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is essential for Akt phosphorylation at serine 473.  It is likely that XBP1u is sufficient 
to induce the activation of Akt phosphorylation; however, in vivo compensatory 
mechanisms may be activated to promote adequate Akt phosphorylation. 
 
 In the present study, we demonstrate that constitutively active Akt promotes 
the expression of XBP1u and HO-1 at the protein level.  The upregulation of HO-1 by 
XBP1u was shown to be dependent on XBP1.  Moreover, Akt is not required for the 
induction of HO-1 by XBP1u.  These data show that XBP1u functions downstream of 
Akt (figure 3).  Activated Akt must interact with XBP1u to promote the expression of 
HO-1 in our system.  Previous reports have demonstrated that the activation of Akt is 
required for HO-1-mediated protection against carnosol-induced oxidative stress 
(Martin et al., 2004).  The levels of the ARE-binding transcription factor Nrf2 are also 
raised during the protective response against carnosol.  Recent studies have also 
shown that HO-1 expression is mediated by activation of Akt signalling by a 
mitochondrial redox-dependent pathway in ECs.  Celecoxib, a cyclooxygenase-2 
selective inhibitor, activates HO-1 expression through an Akt-dependent manner 
(Hamdulay et al., 2010).  These results indicate that activation of Akt is a key event in 
regulating the induction of HO-1 in response to cytokines and growth factors.  In 
combination these data demonstrate that XBP1u is crucial in mediating the activation 
of HO-1 expression by Akt.  We suggest that XBP1u may interact with a promoter 
element or an enhancer of HO-1 transcription to induce its expression. 
 
 In this study we also demonstrate that Akt phosphorylation can be enhanced 
by disturbed flow and that this can be abrogated by knockdown of XBP1, in a similar 
manner to that observed on the expression of HO-1 (figure 63).  Disturbed flow, 
which predominantly occurs in the bifurcation regions of the vasculature, predisposes 
these regions to atherosclerosis.  The lack of laminar shear stress detected by ECs in 
these regions leads to their transformation towards an atheroprone phenotype.  These 
cells undergo a higher degree of turnover than ECs in vascular regions subjected to 
laminar flow, allowing for increased macrophage penetration of the endothelium and 
thereby increasing the likelihood of lesion formation.  One of the main causes for EC 
turnover in these regions is an increase in oxidative stress, from inconsistent 
activation of cell survival pathways.  We also predict that there are several pathways 
which are activated within these cells to combat the increases in oxidative stress.  In 
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accordance with our findings, oscillatory flow has been determined to induce 
activation of Akt signalling in osteoblast-like cells (Lee et al., 2010).  Together these 
data demonstrate that disturbed flow induces the phosphorylation of Akt at serine 473 




Figure 63: Schematic diagram depicting the influence of XBP1u on Akt activation. 
1. Disturbed flow induces the formation of an apoptotic, atheroprone phenotype in ECs that results in 
EC apoptosis.  One of the mechanisms that induces EC apoptosis is increased oxidative stress.  2. To 
promote EC survival, disturbed flow enhances the expression of both XBP1u and HO-1 and enhances 
the phosphorylation of Akt.  The expression of HO-1 and the phosphorylation of Akt is dependent on 
the presence of XBP1.  Independently of disturbed flow, the activation of HO-1 expression by Akt is 
also dependent upon XBP1.  The expression of HO-1 promotes a non-apoptotic EC phenotype and 
promotes EC survival. 
 
 The results discussed above demonstrate for the first time the involvement of 
XBP1u in promoting EC survival during disturbed flow and oxidative stress.  XBP1u 
is crucial in mediating a protective signalling response through Akt phosphorylation 
and HO-1 expression.  Modulation of XBP1u activity may serve to increase EC 
integrity in a therapeutic setting. 
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4.3 HDAC3 is crucial for promoting XBP1u-mediated EC survival 
 
Previous studies in our lab have identified a role for HDAC3 in promoting EC 
survival (Zampetaki et al., 2010).  HDAC3 has already been demonstrated to play an 
important role in the biology of endothelial progenitor cells (Rossig et al., 2005).  It is 
expressed ubiquitously and its activity depends on its association with multisubunit 
repressor complexes.  HDAC3 is present in both the nucleus and the cytoplasm of 
ECs (Longworth and Laimins, 2006).  Our lab has demonstrated that HDAC3 is 
predominantly expressed in endothelial bifurcation regions.  In vitro studies showed 
that disturbed flow enhanced the stability of HDAC3 and overexpression of HDAC3 
increases Akt phosphorylation.  Furthermore Akt was demonstrated to interact with 
Akt, whilst knock down of HDAC3 induced EC dysfunction and atherosclerotic 
lesion formation (Zampetaki et al., 2010).  In our studies, we demonstrate that there is 
a significant overlap in the genes influenced by overexpression of exogenous XBP1u 
and HDAC3.  We have also seen that both proteins enhance the phosphorylation of 
Akt at serine 473.  We therefore investigated the ability of XBP1u and HDAC3 to 
interact in the protective signalling pathway.  These studies show that XBP1u does 
not influence the expression of HDAC3 under normal conditions.  We confirm 
previous data that demonstrated that the expression of HDAC3 at the protein level is 
enhanced by disturbed flow.  Furthermore, the expression of XBP1u is crucial for the 
disturbed flow-mediated upregulation of HDAC3. 
 
We were interested in determining how XBP1u and HDAC3 are upregulated 
during disturbed flow.  One of the main pathways predicted to influence Akt 
activation is through VEGFR2 / PI-3-kinase.  Therefore we inhibited these proteins as 
well as MEK1 and looked at the effect of disturbed flow on the expression of XBP1u 
and HDAC3.  Disturbed flow-mediated upregulation of HDAC3 and XBP1u is 
dependent on VEGFR2 and PI-3-kinase signalling.  Moreover, knockdown of 
HDAC3 ablated XBP1u-meditaed increases in Akt phosphorylation and HO-1 
expression, implying that there is a crucial interaction between these proteins that 
promotes EC survival.  Previously HDAc3 has been found to bind to several other 
proteins in the cytoplasm.  HDAC3 was found to localise to the plasma membrane 
independently of its NES, through interaction with the membrane bound tyrosine 
kinase, c-Src (Longworth and Laimins, 2006).  Furthermore, HDAC3 was found to 
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interact with Akt through residues 136-201 (Zampetaki et al., 2010).  Our studies 
confirm that HDAC3 can interact with Akt.  Furthermore, we demonstrate that 
XBP1u is able to interact with HDAC3 through residues 131-206 of HDAC3.  In 
addition the overexpression of XBP1u does not displace Akt from its interaction with 
HDAC3, suggesting that these molecules can interact at the same time. 
 
Our results have demonstrated that HDAC3 and XBP1u are crucial in 
maintaining EC integrity and survival.  Under disturbed flow conditions, both 
HDAC3 and XBP1u are upregulated.  XBP1u plays a critical role in mediating the 
stabilisation of HDAC3 during disturbed flow.  Our experiments also demonstrate that 
XBP1u and HDAC3 enhance the phosphorylation, and thereby the activation, of Akt 
at S473.  Activated Akt can induce the expression of HO-1, and under our 
experimental conditions XBP1u is also crucial in this role.  Our most recent studies 
demonstrate that both XBP1u and Akt can physically interact with HDAC3, and that 
overexpression of XBP1u does not displace or complete with Akt for a binding site 
with HDAC3.  Furthermore, knockdown of HDAC3 prevents XBP1u-mediated Akt 
phosphorylation and increased expression of HO-1.  We hypothesise that under 
disturbed flow conditions the expression (transcription and translation) of XBP1u is 
augmented.  XBP1u can then bind to HDAC3 and promote its stabilisation.  It is 
through this means that more Akt can be recruited to HDAC3 and undergo 
phosphorylation.  The subsequent cell survival pathways can then be activated.  Our 
particular area of interest demonstrated that Akt-mediated upregulation of HO-1 
requires XBP1u to be present (figure 64).  Furthermore disturbed flow acts through 
VEGFR2 and PI-3-kinase to initiate the stabilisation of HDAC3 and augment the 
expression of XBP1u. 
 
We hypothesise that the interaction between HDAC3 and XBP1u occurs in the 
cytoplasm.  The binding of XBP1u to HDAC3 may serve to mask the nuclear 
localisation signal present on both molecules.  Akt is activated at the cell membrane 
and we therefore hypothesize that these proteins form a complex that stabilises the 
recruitment and retention of Akt at the cell membrane.  Our data demonstrates that the 
presence of phosphorylated Akt is enhanced after overexpression of XBP1u, however 
we were unable to determine if XBP1u and HDAC3 are enhanced in our cell 
membrane isolations.  The stabilisation of this complex through mutual interactions 
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Figure 64: HDAC3 interacts with XBP1u and Akt to induce activation of HO-1. 
HDAC3 is required for XBP1u-mediated phosphorylation of S473-Akt and upregulation of HO-1 
expression.  HDAC3 also interacts with Akt and XBP1u in order for this process to occur. 
 
4.4 XBP1u promotes EC survival in response to disturbed flow 
 
 Disturbed flow induces endothelial cell apoptosis through increased oxidative 
stress.  One of the cells responses is to try and reduce oxidative stress through the 
expression of antioxidant molecules.  We have found that XBP1u can interact with 
HDAC3 to promote the recruitment and phosphorylation of Akt-S473.  Both activated 
Akt and XBP1u promote the expression of HO-1, thereby reducing oxidative stress 
and apoptosis.  All of these functions are physiologically relevant as XBP1u, HDAC3 
and phosphorylation of Akt all occur under disturbed flow conditions.  In addition 
disturbed flow-mediated regulation of XBP1u requires VEGFR2 and PI-3-kinase 
activity as inhibition of these molecules prevents upregulation of XBP1u (figure 65).  
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Figure 65: XBP1u promotes EC survival in response to disturbed flow. 
Disturbed flow induces endothelial cell apoptosis through increased oxidative stress.  One of the cells 
responses is to try and reduce oxidative stress through the expression of antioxidant molecules.  We 
have found that XBP1u can interact with HDAC3 to promote the recruitment and phosphorylation of 
Akt-S473.  Both activated Akt and XBP1u promote the expression of HO-1, thereby reducing oxidative 
stress and apoptosis.  All of these functions are physiologically relevant as XBP1u, HDAC3 and 
phosphorylation of Akt all occur under disturbed flow conditions.  In addition disturbed flow-mediated 
regulation of XBP1u requires VEGFR2 and PI-3-kinase activity as inhibition of these molecules 
prevents upregulation of 
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 In summary, we have shown that XBP1u enhances the survival of ECs during 
oxidative stress.  XBP1u-mediates this effect through an interaction with HDAC3 to 
promote Akt activation and the expression of HO-1.  This process may be crucial 
during disturbed flow and targeting XBP1u and HDAC3 may provide novel 
therapeutic interventions for vascular disease. 
 
4.5 XBP1 is crucial for EC migration 
 
 The occlusion of a blood vessel by thrombosis, atherosclerosis or injury will 
cause ischemia to local tissues, leading to cell death and loss of organ function 
(Kirton and Xu, 2010).  Angiogenesis contributes to the restoration of blood flow in 
ischemic tissues, in which EC migration and proliferation plays an important role.  In 
this study we demonstrated a crucial role for XBP1 in mediating EC migration. 
 
 Overexpression of both XBP1 isoforms was sufficient to enhance EC 
migration under normal and low serum (2%) conditions.  Furthermore knockdown of 
XBP1 ablated the ability of ECs to migrate during wound healing assays.  It was 
interesting to see that both isoforms of XBP1 enhanced EC migration.  These data 
were the first to link the expression of XBP1 with EC migration.  To determine if the 
splicing of XBP1u is crucial, the expression of IRE-1α was ablated via lentiviral 
transfer of shRNA.  We demonstrated that IRE-1α is crucial for proper EC migration.  
Furthermore, the expression of XBP1s is enhanced during the initial stages of 
migration.  Together these data demonstrate that XBP1s plays an important role in EC 
migration. 
 
To confirm the importance of XBP1 in vivo endothelial-like cells were 
harvested from wild type and XBP1-null embryos.  The migration of XBP1-null cells 
was dramatically reduced compared to wild type controls.  Furthermore knockdown 
of XBP1 in vitro reduced the ability of ECs to form tube-like structures.  Moreover, 
EC outgrowth from arterial rings taken from Tie2-Cre-XBP1
f/f
 mice demonstrated 
significantly less movement than wild type controls.  Our experiments remain at an 
early stage, although we have investigated the influence of XBP1 on the expression of 
FAK, a crucial mediator of EC migration (Hung et al., 2012; Shi et al., 2011).  Knock 
 195 
down of XBP1 abrogates the expression of FAK in aortic sections from Tie2-Cre-
XBP1
f/f
 mice.  Further experimentation will serve to enhance our understanding of the 
link between XBP1s and FAK. 
 
Thus, the present study provides for the first time phenotypic evidence by which 
XBP1 plays a significant role in maintaining endothelial integrity physiologically and 
promotes angiogenesis under pathophysiologic conditions. 
 
4.6 Importance of the study 
 
 This study demonstrates for the first time that XBP1u is crucial in promoting 
EC survival in response to oxidative stress.  This occurs through the activation of Akt 
phosphorylation and enhancing the expression of HO-1.  Furthermore, we 
demonstrate that XBP1u and HDAC3 are enhanced by disturbed flow and that this 
occurs in a VEGFR2 / PI-3-kinase dependent manner.  These studies implicate 
XBP1u as a potential therapeutic target for vascular disease.  Modulation of XBP1u 
function could enhance EC integrity and reduce atherosclerotic lesion formation. 
 
4.7 Limitations of the study 
 
 Although we have demonstrated that XBP1u and HDAC3 promote EC 
survival, several of our hypotheses require further experimentation.  We have not 
demonstrated that XBP1u promotes EC survival under disturbed flow conditions, only 
that survival is promoted in response to oxidative stress.  We have made the 
assumption that disturbed flow induces oxidative stress and that the signalling 
pathway we have uncovered functions during disturbed flow stimulation. 
 
 The interaction that we have demonstrated between XBP1u and HDAC3 is 
also crucial to our conclusions.  However, although we have demonstrated that 
XBP1u and HDAC3 are both responsible for promoting EC survival and 
phosphorylation of Akt, we have not shown that an interaction between the two 
proteins is crucial for this event.  In order to determine this it would be necessary to 
identify the sequence responsible for mediating the binding of XBP1u to HDAC3 and 
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mutate it so that the interaction could no longer occur.  If the overexpression of 
XBP1u is no longer able to induce EC survival in response to oxidative stress then we 
will have demonstrated that the interaction is crucial for EC survival. 
 
4.8 Future work 
 
 In order to more fully understand the role of XBP1u in promoting EC survival 
several experiments could be performed.  Firstly to confirm that HO-1 is indeed the 
transducer of XBP1u-mediated EC survival, knockdown of XBP1, which induces 
increased EC apoptosis, could potentially be rescued through the application of a CO 
donor.  We would predict that the application of a CO donor to XBP1-null ECs would 
promote EC survival in response to oxidative stress. 
 
 We have shown that XBP1u and HDAC3 are important in mediating the 
activation of Akt, however the kinase responsible for phosphorylation of Akt has not 
been identified.  It would be interesting to see if this kinase is recruited to the 
HDAC3-XBP1u-Akt complex and this is the mechanism through which EC survival 
is enhanced. 
 
 We have demonstrated that XBP1u and HDAC3 interact.  To more completely 
define the interaction it would be necessary to create several XBP1 deletion mutation 
constructs.  These could then be used to identify the particular region of XBP1u 
responsible for mediating the binding to HDAC3.  We would predict that the C-
terminal domain would most likely be responsible as the N-terminal domain is 
required for the interaction with DNA. 
 
 Our preliminary data implicates FAK in XBP1-mediated migration.  Further 
studies on the role of XBP1 in mediating the expression and function of FAK are 
required.  Cloning of the promoter region of FAK into luciferase vectors will allow us 
to determine if XBP1 can bind directly to the FAK promoter and stimulate its 
expression.  Furthermore, rescue experiments where XBP1 is knocked down and 
exogenous FAK is added to the HUVECs to determine if EC migration reverts back to 
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normal levels would enable a determination of the role of XBP1u and FAK in EC 
migration. 
 
 To demonstrate that migration promotes XBP1 splicing we have attempted to 
attach a GFP-tag to the XBP reading frame, such that the coding sequence for GFP 
would only be translated during XBP1 splicing.  We would therefore be able to 
monitor the splicing of XBP1 in EC tip cells during the initial stages of migration.  To 
convincing separate the role of proliferation from migration, the effect of XBP1 knock 
down on EC migration will be assessed using a Bowden chamber assay. 
 
 In the present study we demonstrated that knockdown of XBP1 impairs EC 
migration.  It would be interesting to determine if this impairment in migration has 
any physiological roles.  We have only recently obtained the conditional XBP1 
knockout mice.  These animals could be subjected to a hindlimb ischemia experiment.  
Here the femoral artery is ligated and lateral vessel growth is observed.  We would 
anticipate that vessel growth in the XBP1-null mice would be impaired, 
demonstrating that XBP1 is crucial in mediating in vivo EC migration. 
 
 Furthermore to identify the function of XBP1 on in vivo EC migration it 
would be interesting to perform a retinal vasculogenesis assay.  XBP1
loP/loxP
 mice bred 
to Tie2-Cre (Kisanuki et al., 2001) transgenic mice, which express Cre recombinase in 
ECs and bone marrow progenitor cells, which allows for the generation of EC 
conditional knockout mice. Retinal vasculogenesis could then be observed.  We 
would predict that the avascular area would be significantly larger in XBP1-null mice 
as compared to wild type mice.  This would imply that XBP1-null mice have delayed 
retinal vascular development.  Current studies have already implicated XBP1 in the 
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